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Abstract 
 
Cnidarians (classes Anthozoa, Scyphozoa, Cubozoa and Hydrozoa) are the oldest venomous 
animals on Earth, and they have evolved a diverse range of toxins to aid in prey capture, 
defence against predators, and intra- and inter-specific competition. More than a century of 
research on sea anemone venoms has shown that they contain a rich diversity of biologically 
active proteins and peptides. However, recent omics studies have revealed that much of the 
venom remains unexplored. By combining the complementary approaches of transcriptomics, 
proteomics, phylogenetics, mass spectrometry imaging and nuclear magnetic resonance 
spectroscopy this thesis provides the first holistic overview of the venom arsenal of sea 
anemones. 
In the last decade, next-generation sequencing has become a widely used tool to investigate the 
diversity of components in sea anemone venom. When compared to other venomous lineages 
outside of Cnidaria, sea anemones are atypical venomous animals, as they express venom 
throughout their body instead expressed in a specific venom gland. This makes it difficult to 
distinguish which toxin-like transcripts are functionally venomous. The first experimental part 
of this thesis (Chapter 2) highlights the importance of using proteomics of milked venom to 
correctly identify venom proteins/peptides, both known and novel, while minimizing the 
number of false positive identifications from non-toxin homologues identified in 
transcriptomes of venom-producing cells.  
The phylogenetic and molecular evolutionary histories of venoms contribute to our 
understanding of the different venom strategies employed across taxonomic families. 
Moreover, it can contribute to identification of functionally important amino acids and may aid 
in directing future biodiscovery efforts. Chapter 3 provides the first comprehensive insight into 
toxin recruitment events across a wide range of sea anemone taxa.  
Sea anemones are known to produce an array of biologically active peptides with different 3D 
folds. Some of these are potent neuroactive peptides, acting on a diverse range of ion channels, 
such as voltage-gated sodium (NaV) and potassium (KV) channels, transient receptor potential 
channels (TRP) and acid-sensitive ion channels (ASICs). Chapter 4 describes the discovery, 
3D structure, tissue localisation, and possible ion channel targets of a venom peptide with a 
newly identified 3D scaffold for sea anemone toxins. 
 ii 
Although there is still much to learn about the composition of sea anemone venoms and the 
role of individual venom components in prey capture, defence and intraspecific competition, 
this work provides a solid foundation for future research into the ecology and evolution of these 
venoms.  
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CHAPTER 1  
Proteomic, transcriptomic, and mass spectrometric profiling of 
the ancient venom system of sea anemones 
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1.1 Introduction 
Sea anemones, though known as the flowers of the sea, are exclusively marine animals that 
belong to the phylum Cnidaria (Figure 1.1A). Essentially laminar organisms, their two-
dimensional epithelial construction has shaped both behavioral and physiological responses 
and led to great ecological success despite their structural simplicity, as evidenced by their 
presence in all marine ecosystems. They also perform a key role in benthic–pelagic coupling 
as part of the benthic suspension feeding community (3), transferring energy to the benthos 
from the water column and releasing metabolites, gametes, and offspring back into the water 
column. 
Sea anemones belong to the class Anthozoa, which differ from all other cnidarians in that they 
lack a free-swimming medusa stage. Within Anthozoa, sea anemones form the hexacorallian 
order Actiniaria, which contains only solitary, sessile, benthic polyps. There are around 1200 
species of sea anemones organized in 46 families and they constitute the greatest diversity 
within Anthozoa. The life cycle of sea anemones comprises sexual reproduction and an 
asexually budding phase. Polyps may be single sex or both male and female, and the sexual 
life cycle is straightforward including four main stages: the fertilized egg, planula larvae, polyp 
and sessile sea anemone. Interestingly, sea anemones have great powers of regeneration (4) 
and can reproduce asexually in multiple ways: by budding, fragmentation, or by longitudinal 
or transverse binary fission (5). 
Relationships within Actiniaria as determined by phylogenetic analyses of DNA or 
morphological characters do not accord with the divisions of the traditional classification, and 
the order was consequently recently revised so that taxonomic divisions correspond to 
phylogenetic relationships (6). The primary division within the order is between the 
Anenthemonae and Enthemonae. Anenthemonae is the less species-rich of the suborders, 
containing members of families Actinernidae, Edwardsiidae, and Halcuriidae; the model 
organism Nematostella vectensis is the most familiar and well-studied member of this group. 
Enthemonae contains the overwhelming majority of species and anatomical diversity within 
Actiniaria and it is further subdivided into the superfamilies Actinioidea, Actinostoloidea, and 
Metridiodea (Figure 1.1B).  
Sea anemones are commonly considered a group of exclusively predatory animals, however 
they are also opportunistic, omnivorous suspension feeders. The dietary composition of species 
varies markedly between different marine habitats, reflecting the different composition of the 
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macrobenthic organismic assemblages in different areas (7). Sea anemones capture prey that 
come within reach of their tentacles, enabling them to immobilize the prey with their venom. 
The mouth can stretch to help in prey capture and ingestion of larger animals such as crabs, 
molluscs and even fish (8). However, some sea anemones also feed on organic detritus, which 
are caught with the aid of a mucus secretion. In addition, many sea anemones form a 
facultative symbiotic relationship with zooxanthellae, zoochlorellae or both. These single-
celled algal species reside in the anemone’s gastrodermal cells, especially in the tentacles and 
oral disc. The sea anemone benefits from the products of the algae's photosynthesis and the 
algae in turn are assured protection and exposure to sunlight (9). 
 
 
 
 
 
Figure 1.1 – (A) Phylogenetic tree of Cnidarians. Representative Medusozoa depicted here are Hydra viridis 
(Hydrozoa), Aurelia aurita (Scyphozoa), Chironex fleckeri (Cubozoa) and Haliclystus sp (Staurozoa). The 
Anthozoa are the sea anemone Nematostella vectensis (left) and the coral Acropora millepora (right). Figure 
modified from Technau & Schwaiger (1). (B) Phylogenetic relationships among major lineages of sea anemones 
(After Rodrigues et al,, 2013 (2)). 
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1.2 Venom tissue 
Cnidarians represent the only lineage of venomous animals that lack a centralized venom 
system. Instead of a venom gland, sea anemones produce venom in tissues throughout the body 
using two different type of cells, known as nematocytes and ectodermal gland cells (10, 11). 
Nematocytes, which are present in all cnidarians, produce highly complex venom-filled 
organelles known as nematocysts. Nematocysts are the primary venom delivery apparatus of 
cnidarians, and they are made of a capsule containing an inverted tubule capable of extremely 
fast and powerful discharge (12, 13). There are at least 25 different types of nematocysts found 
in sea anemones, with multiple types harboured by a single specimen (14). Moreover, distinct 
morphological regions of a sea anemones have specialized structures and they are defined by 
a specialized complement of nematocysts (15). Examples of functional specialization of the 
venom in different tissues includes tentacles used for prey capture, immobilisation and defence; 
acrorhagi for competition and defence; column for external defence; and actinopharnyx and 
mesenterial filaments, both used in prey immobilisation and digestion (16). The ecological and 
evolutionary success of cnidarians since the Cambrian explosion may be to a large degree 
attributed to this complex organelle system and the toxins it contains. 
In addition to nematocytes, sea anemones also produce toxins in a second type of cell known 
as an ectodermal gland cell, which may or may not produce distinct repertoires of toxins 
compared to nematocysts (10, 17). The reason why sea anemones have their toxins located in 
two different types of cells remains unknown. However, secretion by gland cells may allow for 
delivery of larger amounts of the toxin, and present an opportunity to extend the reach of venom 
use by the anemone beyond direct contact. So far, gland cells have only been reported to be 
present in Anthopleura elegantissima, Anemonia viridis and Nematostella vectensis (18). Thus, 
whether venom-secreting ectodermal gland cells are an adaptation to the environment and diet 
of some anemones, or whether they represent the ancestral venom-secreting cell type, remains 
to be determined through investigation of additional sea anemones species. 
In general, most sea anemones are relatively harmless to humans. However, the venom of some 
species can cause severe effects. The envenomation capabilities may be linked to size and types 
of nematocysts. For example, the extremely large basitrich nematocysts found in the balloon-
like extensions of branching tentacles (acrospheres) of some sea anemones (19) may be capable 
of penetrating the epidermis, explaining the severe symptoms observed in humans (20, 21). 
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1.3 Venom composition 
Although sea anemones are flexible in the ways in which they obtain nutrition (22), they are 
fundamentally predatory animals, using their tentacles to catch prey. Because they lack true 
muscle tissue, have no visual capacity, and lack a centralized or coordinated nervous system, 
prey capture relies heavily on toxins to subdue prey. Like many venomous lineages, 
characterization of toxic components in sea anemones has been done mostly through an 
opportunistic approach, focusing on peptides and taxa that are easily accessible and that 
potentially have therapeutic relevance. As a result, the venom composition in most species 
remains unknown despite decades of research (23, 24). Nevertheless, sea anemone venoms 
have been shown to be complex mixtures of proteins, peptides and non-proteinaceous 
compounds. The main components found in the sea anemone venom are traditionally grouped 
into four functional types: (1) Phospholipase A2 that degrades membrane phospholipids of 
neuronal and muscle cells, causing nerve damage and muscle inflammation (25); (2) Cytolysins 
that act on cell membranes and cause cell lysis (26); (3) Neurotoxins that interact with voltage-
gated ion channels, acid-sensing ion channels (ASICs), and transient receptor potential ion 
(TRP) channels (23, 27-29), thereby altering neural transmission (30, 31); (4) Non-
proteinaceous compounds (e.g. purines, biogenic amines) that are believed to induce pain 
during envenomation.  
Until recently, no systematic nomenclature existed for naming and organising sea anemone 
toxins. This resulted in multiple names being assigned to the same toxin, toxins from unrelated 
species being designated by the same name, and ambiguous name designations. However, in 
2012 two articles were published that suggested a rational nomenclature for naming sea 
anemones toxins. Kozlov and Grishin (32) suggested a nomenclature for cysteine-rich 
polypeptides toxins from sea anemones, while Oliveira and colleagues (33) suggested a more 
general nomenclature for naming any kind of sea anemones toxin. Moreover, Norton (34) 
suggested that in order to avoid confusion with sea anemone toxins and other anemone venom 
peptides, the nomenclature could be modified to include toxin type, such as Types K1, K2, and 
K3 for potassium channel toxins.  
Here, the criteria stipulated by Oliveira are followed, because they can be used for all types of 
toxins, the species can be identified, and it avoids confusions with similar names. This sea 
anemone toxin nomenclature is similar to that previously proposed for spider toxins by King 
and colleagues (35) and adapted by Undheim and colleagues (36) for naming centipede toxins. 
This nomenclature consists of five terms: The first term is a Greek symbol that serves as a 
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broad activity descriptor denoting the molecular target. The second term is a generic name 
indicating the taxonomic family. The third term is a three-letter code signifying the species of 
origin, and consists of an initialuppercase corresponding to the first letter of the genus, 
followed by twolowercase letters that indicate species. The two laststerms are formed by an 
alphanumeric descriptor to assign the chronologicalorder of sequence deposition into public 
database or original publication related to the toxin. The alphabetic characterindicates the 
paralogous relationship which is assignedbased on amino acid sequence analysis. Within the 
same species, toxins sharing a high level ofsequence identity and similarity are clustered in 
an isoform or isotoxin group. In each isotoxin group, lowercase Latinletters are also given in 
alphabetic order according to thedate of the toxin sequence published. The nomenclature is 
notitalicized, has hyphens to separate the first three terms, andrelies on the taxonomic sea 
anemone names included in the Hexacorallians of the Word database 
(http://geoportal.kgs.ku.edu/hexacoral/ anemone2/index.cfm) togenerate a three-letter code 
for designating sea anemonespecies. 
Sea anemone toxins have traditionally been classified according to their activity, similarity of 
amino acid sequence, and the pattern of disulfide bridges (number and distribution of cysteines) 
(30). In this way, the toxins are first divided by their molecular target (e.g. NaV, KV, etc.) and 
then by types according to their similarity and mechanism of action. However, it is known that 
proteins and peptides with certain structural characteristics have been more often recruited into 
venoms and subsequently undergone functional radiation (37). In most cases, the stabilization 
of these molecular scaffolds through disulfide bonds facilitates modifications of non-structural 
residues, allowing alterations of surface-exposed residues without affecting the structural core 
(38). This means that the current classification system suffers from vulnerability to functional 
convergence (e.g. toxins with Kunitz or defensins scaffolds both interact with KV channels) as 
well as functional promiscuity (e.g. APETx2 interacts with both ASIC and KV channels). In 
addition, for most known sea anemone toxins, the exact receptors they target (e.g. ion channel 
subtypes) is either unknown, or at best incomplete. Because of this, the following discussion 
on the main components of sea anemone venoms is not divided into the traditional toxin types. 
Instead distinctions are made firstly between proteins and non-proteinaceous compounds, 
secondly between enzymes and other proteins without enzymatic activity, then according to 
the structural scaffold, and finally according to molecular targets.  
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1.3.1 Non-proteinaceous venom components 
Sea anemones are known to be a rich source of protein and peptide toxins. In contrast, little is 
known about the non-peptidic components of their venoms. The first small molecule described 
from a sea anemone was a purine derivative isolated in 1986 from the Brazilian sea 
anemone Bunodosoma caissarum and named caissarone (39). Caissarone induced twitching in 
electrically stimulated guinea pig ileum-myenteric plexus, and this was attributed to 
antagonistic actions on the adenosine receptor (40). Years later, several groups began 
investigating small-molecule fractions based on a study reporting the antagonism of glutamate 
receptors by a low molecular weight fraction from venom of the Caribbean sea anemone 
Phyllactis flosculifera (41). As result of these studies, an acylated amino acid, bunodosine 391, 
was isolated from venom of the Brazilian sea anemone Bunodosoma cangicum, which likely 
acts on 5-hydroxytryptamine (5-HT; serotonin) receptors. Bunodosine 391 was analgesic in 
animal models of pain, and this activity was completely blocked by methysergide, a 
nonselective 5-HT receptor antagonist, but not the opioid receptor antagonist naloxone. 
Although this is an interesting topic with therapeutic relevance, nothing further has been 
published, and small molecules from sea anemone venoms remain unexplored. 
 
1.3.2 Enzymes 
There is a large discrepancy between the types of enzymes reported from transcriptomic studies 
of sea anemones with those reported from studies on milked venom. As previously mentioned, 
sea anemones do not have a centralised venom gland, and it is therefore difficult using 
transcriptomic techniques to distinguish between enzymes that have housekeeping roles and 
those that play a role in envenomation. Because of this uncertainty, only enzymes purified from 
sea anemone venom will be described in this chapter. 
To date, PLA2 is the only enzyme identified in the milked venom of sea anemones. PLA2 
catalyses the hydrolysis of phospholipids into free fatty acids and lysophosholipids. As 
phospholipids are one of the main chemical constituents of the cell envelope, enzymes capable 
of hydrolyzing these molecules, such as PLA2, are likely to cause membrane disruption. The 
PLA2 superfamily currently contains 15 separate groups and numerous subgroups of PLA2 
(42). In addition to sea anemones, PLA2s are present in the venom of a wide range of venomous 
taxa, including snakes, bees, wasps, lizards, and centipedes (43). All these compounds belong 
to the group of secreted low molecular weight PLA2s.  
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Sea anemone PLA2s are poorly studied. So far, sequences have been reported for only PLA2s 
isolated sea anemone venom. However, several studies have shown that sea anemone extracts 
(whole animal, tentacles, acontia) have PLA2 activity. Purification and sequencing of these 
proteins will be important to classify and understand the ecological importance of PLA2 in sea 
anemone venom. 
 
1.3.3 Non-enzymatic proteins – Cytotoxins 
Cytolysins are a group of sea anemone toxins that form pores in cell membranes, and therefore 
belong to a larger group of ‘pore forming toxins’ (PFTs) (44). The formation of pores by PFTs 
can be achieved by inserting either α-helices or β-hairpins within the cell membrane. Moreover, 
these proteins show a dual behaviour at the water-membrane interface. In water, they remain 
mostly monomeric and stably folded but, when they interact with lipid membranes of specific 
composition, they become oligomeric integral membranes structures. So far, cytolysins from 
more than 32 different sea anemones species have been isolated. Based on their primary 
structure and functional properties, cytolysins have been classified into at least four 
polypeptide types (types I–IV). 
Type I cytolysins are 5–8 kDa peptides that form pores in phosphatidylcholine membranes, 
and additionally have antihistamine activity.  So far, this type has been reported in just a few 
species, such as Tealia felina (accepted name Urticina feline) (45), and Heteractis crispa 
(previously known as Radianthus macrodactylus) (46). RmI (5.1 kDa) and RmII (6.1 kDa) are 
two cytolysins from H. crispa that have been biochemically characterized to some extent. They 
are basic peptides with pI values of about 9.2, and, in contrast to 20 kDa cytolysins, they contain 
cysteine residues and lack tryptophan. The structural features of this group of cytolysins are 
unknown. 
Type II cytolysins are the most abundant and best studied cytolysins from sea anemone, and 
they consist of the family of the α-pore-forming toxins (α-PFTs) (47). These toxins are also 
known as actinoporins due to their ability to bind membrane phospholipids domains of the host 
organism, then oligomerize to form cation selective pores (48). Actinoporins are comprised of 
a single domain (~20 kDa), they lack cysteine residues, and they are equipped with functionally 
important regions conserved throughout the toxin gene family (49, 50). Moreover, they appear 
as multigene families (51), resulting in many protein isoforms. Although they display high 
levels of sequence identity (60–80%), the sequence differences are sufficient to cause large 
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differences in solubility and hemolytic activity (52). 
Actinoporins have not been identified in nematocysts (53, 54), although their genetic 
architecture, which includes signal and propeptide motifs, indicate that they are likely 
synthesized in the Golgi apparatus during nematocyst development (55). Tissue-specific 
studies revealed that actinoporins are expressed in mesenterial filaments, suggesting that 
they play a role in digestion (56). 
Despite most prey or predator species having a relatively conserved and ubiquitous 
actinoporin target site (sphingomyelin), many highly conserved actinoporins exhibit 
variable rates of cytolytic activities (57). This suggests that minor changes in amino acids 
across actinoporins may have co-diversified to target cell membranes in specific lineages 
(26, 55). Several residues have been manipulated to identify functionally important regions 
within actinoporins (58), revealing an aromatic-rich region that forms the phosphocholine 
(POC) binding site, with a single amino acid residue (W112 in Equinatoxin II (EqII or D-
actitoxin-Aeq1a)) playing a key role in initiating sphingomyelin recognition and pore 
formation (58, 59). Although events leading to oligomerization remain uncertain, both the 
RGD domain (R144, G145, and D146 in EqII) and a single valine residue (V60 in EqII) are 
thought to direct protein attachment and play a key role in this process (60). Finally, a key 
arginine residue (R31 in EqII) and various hydrophobic residues in the α-helix at the N-
terminal region are involved in cell membrane penetration and the formation of the ion 
conduction pathway (discussed below) (47). 
3D structures have been reported for only three sea anemone cytolysins (Figure 1.2) and all of 
them are type II cytolysins (actioporins). Basically, their structure is composed of a tightly 
folded β-sandwich core flanked on two sides by α-helices (Figure 1.2). The first 30 residues 
encompass one of the helices. This is the only part of the molecule able to undergo a 
conformational change without any structural modification of the β-sandwich. A prominent 
patch of aromatic amino acids is located on the bottom of the molecule (61, 62). 
Actinoporins are interesting toxins to study the ability that PFTs have to become integral 
membrane proteins, once they are relatively small and cysteineless. The molecular details of 
the mechanism by which the actinoporins so potently form pores in target membranes remain 
elusive. However, based on many functional studies and the structures of EqtII and StII, it is 
proposed that following steps occur during pore formation by the actinoporins: First the toxin 
attaches to the membrane via specific recognition of sphingomyelin using the aromatic-rich 
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region and adjacent POC binding site (59, 61-63); second, the N-terminal segment is 
transferred to the lipid–water interface (62, 64, 65); finally,  the toxin oligomerises on the 
surface of the membrane and α-helices from 3 or 4 monomers insert into the membrane and 
form a cation-selective conduction pathway of diameter 1–2 nm (64, 66-68). This last step 
includes an important contribution by membrane lipids and the monomers are likely arranged 
in a so-called toroidal pore arrangement (69, 70). 
 
 
Actinoporins have been used to elucidate cell membrane dynamics, and their potential for 
biomedical applications has been explored (71, 72). One possible usage could be as 
immunotoxins (ITs), since they are extremely cytotoxic and cytolytic to a variety of cells 
and their vesicular organelles (73, 74). ITs are chimeric molecules in which a cell binding 
ligand, such as a monoclonal antibody or a growth factor are coupled to a killer toxin (in 
this case actinoporins) in order to address its activity towards a specific cell (for a review 
see Refs (75, 76)). 
Type III cytolysins are 25–45 kDa proteins with or without PLA2 activity. They were first 
detected in the venom of Aiptasia pallida (77) and later in venom of sea anemones from the 
genus Urticina (U. crassicornis and U. piscivora) (78, 79). In contrast with the actinoporins, 
these cytolysins contain several cysteine residues (78). They cause hemolysis of rat, guinea 
Figure 1.2 – 3D structures of actinoporins as exemplified by (A) Sticholysin I (PDB accession code 2KS4) 
and (B) Equinatoxin II (PDB accession code 1KD6). The N- and C-termini are labelled. 
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pig, dog, pig and human red blood cells at concentrations as low as 10−10 M. Interestingly, the 
hemolytic activity of Type III cytolysins is inhibited by sphingomyelin but not by cholesterol, 
which is not common for actinoporins (80). 
Type IV cytolysins were isolated from sea anemone homogenate as a cholesterol-inhibitable 
cytolysin (81). Metridiolysin from Metridium senile is so far the only representative of this 
group (26). It has a molecular mass of 80 kDa and, similarly to a group of bacterial toxins, it is 
activated by thiols to produce ring structures on membranes (82). Metridiolysin binds 
nonspecifically to lipid membranes (26), and it forms fluctuating K+-permeable pores in planar 
lipid membranes (26). 
Type V cytolysins are similar to the membrane-attack complex/perforin (MACPF) family of 
proteins. They were first discovered in nematocysts of the stinging sea anemone Phyllodiscus 
semoni. MACPF family proteins were originally identified as pore-forming factors utilised in 
the mammalian host defence immune system (83, 84). Similar to perforins, Type V cytolysins 
have an EGF-like domain close to the MACPF domain, but lack the C2 domain for attachment 
to lipid membranes. 
Type V cytolysins were the first MACPF proteins found in non-mammalian species, and the 
first reported case of MACPF proteins recruited into venom. Sea anemone MACPF-cytolysins 
have a mass of ~60 kDa. Thus far, only three have been described (AvTx-60A from Actineria 
villosa, PsTx-60A and B from Phyllodiscus semoni), but they are predicted to be present in 
Nematostella vectensis based on the genome sequence of this anemone (85). The discovery and 
characterization of MACPF-cytolysins in sea anemones has aided our understanding of the 
mechanism of membrane permeabilization by MACPF proteins as well as the evolution of 
MACPF superfamily.  
 
1.3.4 Non-enzymatic proteins – Neurotoxins 
Neurotoxins are toxins that interfere with the transmission of nerve impulses by modifying the function 
of ion channels in nerve or muscle cells (86). Diverse venomous animals have evolved neurotoxins that 
interact with ion channels to immobilise prey and/or deter predators. Because sea anemones are sessile 
animals, venom neurotoxins play a critical role in immobilisation of prey and defence against predators. 
Neurotoxins are among the best characterized components of sea anemone venoms in terms of their 
mechanisms of action. They interact with a wide range of ion channels, including ASICs (24, 87, 88), 
TRP channels (23, 27-29), voltage-gated sodium (NaV) channels (89-92) and voltage-gated channels 
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potassium (KV) channels (93-95). Of these, KV toxins comprise 136 of the 320 sea anemone toxins 
reported in UniProtKB to date (96) and thereby constitute the most diverse group, with NaV toxins in 
close second place. The diversity of structural scaffolds among sea anemone neurotoxin is also 
remarkable. To date, eight unique structural folds have been identified based on 3D structure and/or 
cysteine-pattern: ATX-III, b-defensin-like, boundless b-hairpin, EGF-like, inhibitor cystine-knot 
(ICK), Kunitz-domain, small cysteine-rich peptides (SCRiPs), and ShK.  
 
1.3.4.1 ATX III 
ATX III toxins form a compact structural motif composed of 27–32 residues that consists of 
only turn-based secondary-structure elements reticulated by three disulfide bonds (Figure 1.3). 
These toxins lack both α-helices and β-strands (Figure 1.4) (31, 97). Several residues located 
on the surface of the molecule form a hydrophobic patch that may constitute part of the NaV 
channel binding surface (97). To date, only six ATX III toxins have been identified from three 
species (Anemonia viridis, Dofleinia armata and Entacmaea quadricolor), and all of them 
target NaV channels, delaying the process of channel inactivation. These toxins are inactive 
against mice (98, 99), but highly active on insects and crustaceans (100).  
 
 
Figure 1.3 – Alignment of representative sea anemone toxins that adopt ATXIII motif. Disulfide bridge 
connectivities are indicated above the sequence alignment. Amino acid identities (black boxes) and similarities 
(grey boxes) are shown. 
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1.3.4.2 β-defensins 
The β-defensin-fold generally consists of a short helix or turn followed by a small twisted anti-
parallel β-sheet (Figure 1.5). The six cysteine residues, which are paired in a 1–5, 2–4, 3–6 
fashion, are crucial for maintaining the compact core configuration of β-defensins. The last two 
cysteines are consecutively situated (in a CCXn pattern where n ≥ 1) near the C-terminus. β-
Defensins are antimicrobial peptides that are secreted as part of the innate immune response in 
a wide range of taxa (101, 102). However, in sea anemone venoms, β-defensin-like peptides 
have become weaponized to serve as neurotoxins that modify the activity of voltage- and 
ligand-gated ion channels; this family of peptides includes KV type 3, NaV type 1, 2 and 4 and 
ASIC toxins (103-106) (Figure 1.5). 
KV type 3 sea anemone toxins are composed of peptides of 42–43 residues. APETx1 (k-
actitoxin-Ael2a) from Anthopleura elegantissima (107) and BDS-I (Dk-actitoxin-Avd4a) and 
BDS-II (Dk-actitoxin-Avd4b) from Anemonia sulcata (108) are representative of this type. 
Although they share the same structural motif and have 40% sequence identity with BDS 
toxins, APETx1 has a different activity on KV channels. Despite their classification as KV 
channel toxins, it was recently shown that some KV type 3 toxins also interact with NaV 
channels (109, 110). The name BSD is an abbreviation of “Blood Depressing Substances”, 
because these toxins were first characterized as antihypertensive and antiviral compounds 
(111). BDS-I and BDS-II have 93% sequence identity, and they both block the subtypes KV3.1, 
KV3.2 and KV3.4 at nanomolar concentration (108, 112). Both toxins also induce a positive 
shift of the activation curve of KV3.1 and KV3.2 currents. At high concentrations they also 
Figure 1.4 – 3D structure of the sea anemone toxin Av3 (PDB accession code 1ANS). The three disulfide bonds 
are represented by orange tubes. 
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weakly block KV1.1-5, KV2.1–2, KV4.1 and KV4.3 currents by  2–20% (93). BDS-I is capable 
of modulating NaV channel gating in a manner similar to previously known neurotoxin receptor 
site 3 anemone toxins, but with different isoform sensitivity (109). 
 
 
APETx1 is a potent blocker (IC50 34 nM) of the human ether a go-go related gene (hERG) K+ 
channel. The toxin induces a shift in the voltage dependence of both activation and inactivation, 
resulting in a block of potassium currents (107). In addition, it was recently shown (110) that 
APETx1 can inhibit the conductance of NaV channels (NaV1.2–NaV1.6 and NaV1.8). Contrary 
to what is reported for hERG modulation, APETx1 does not change the voltage dependence of 
activation or steady-state inactivation of NaV channels. 
Figure 1.5 – 3D structure of sea anemone toxins adopting a β-defensin structural motif. (A) . The three 
disulfide bonds are represented by orange tubes. Toxins are grouped according to their molecular targets. (B) 
Alignment of representative sea anemone toxins that contain a β-defensin motif. Disulfide connectivities are 
indicated above the sequence alignment. Amino acid identities (black boxes) and similarities (grey boxes) are 
shown. 
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NaV type 1 and 2 are the largest NaV channel toxins from sea anemones, with 46–54 residues. 
Although they are divided into two types, they share up to 50% sequence identity. Moreover, 
due to the fact that certain toxins from Halcurias sp., Nematostella vectensis and Condylactis 
gigantean resemble both type 1 and 2 sequences (113, 114), Moran and co-workers (89) have 
suggested that this classification should be revaluated (Figure 1.6). The 3D structures of both 
type 1 and 2 consist of an anti-parallel β-sheet composed of four β-strands and a highly flexible 
loop, which has been named the ‘Arg14 loop’, because Arg14 is the most conserved residue 
(Figure 1.6) (115-119). Site-directed mutagenesis of AP-B (D-actitoxin-Axm1b) revealed that 
the flexibility of this loop is important for the selectivity and binding of these toxins to NaV 
channels. 
 
Figure 1.6 – Superimposed cartoon representation of the structures of CgNa (D-actitoxin-Cgg1a) and ApB 
(left) and CgNa and ShI (D-stichotoxin-She1a) (right). CgNa is coloured green and dark grey. Figure modified 
from Salceda et al. (119). 
 
NaV type 1 sea anemone toxins are highly potent modulators of NaV channels. These toxins 
bind to a region of the channel named receptor site-3 (i.e., the extracellular S3−S4 loop in 
domain 4), which is also recognized by scorpion α-toxins (120). Given the close evolutionary 
relationship between crustaceans (sea anemones prey and predator) and insects, sea anemone 
toxins also have a profound effect on insect NaV channels. For this reason, these peptides have 
been considered as lead compounds in the development of bioinsecticides (91). Anthopleurins 
(type 1 NaV channel toxins isolated from the genus Anthopleura) and related type 1 NaV 
channel toxins have also been considered for therapeutic applications. It was believed that these 
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toxins could be used in the cardiovascular field but these expectations were not met, in part 
because of arrhythmogenic activity in the heart (121). 
The NaV type 4 sea anemone toxin family is comprised of only two isotoxins, Calitoxin I (D-
hormotoxin-Cpt1a) and II (D-hormotoxin-Cpt1b), both isolated from Calliactis parasitica 
(122, 123). These toxins contain 46 amino acid residues with only a single amino acid 
difference (Glu8 versus Lys8). In crustacean nerve muscle preparations, they interact with 
axonal, but not with muscle, membranes, inducing a massive release of neurotransmitter that 
causes a strong muscle contraction. They resemble NaV type 1 and 2 toxins with regard to chain 
length and the number of disulfide bridges (three) but not in amino acid sequence, sharing only 
~45% sequence identity. Evaluation of the NaV subtype selectivity of these toxins and isolation 
of more members of this type should help in future classification of this group. 
APETx2 from Anthopleura elegantissima was the first ASIC-targeting peptide isolated from 
sea anemone venom and only the second from any venomous animals (106). APETx2 (p-
actitoxin-Ael2b) is a 4558 Da peptide (42 residues) that selectively blocks ASIC3 homomeric 
channels (IC50 63 nM) and the ASIC3-containing heteromers ASIC2b-ASIC3 (IC50 117 nM), 
ASIC1b-ASIC3 (IC50 0.9 µM) and ASIC1a-ASIC3 (IC50 2 µM). The structure of APETx2 was 
determined using two-dimensional 1H NMR spectroscopy using the native toxin (104) (Figure 
1.5). It belongs to the disulfide-rich all-β structural family with a fold typical of the β-defensin 
family (124). To date, three peptides have been isolated from sea anemone venoms that target 
ASIC channels and, interestingly, they do not have the same structural fold. This structural 
diversity highlights sea anemone venoms as excellent sources of novel ion channel modulators.  
 
1.3.4.3 Boundless β-hairpin 
Osmakov and collegues (125) reported three peptides with uncommon β-hairpin structure 
isolated from venom of the sea anemone Urticina grebelnyi. One of these peptides, Ugr9-1 (p-
actitoxin-Ugr1a), reversibly inhibits both transient and sustained currents mediated by human 
ASIC3 channels. NMR spectroscopy revealed that Ugr9-1 has an unusual structure, stabilized 
by two disulfide bonds, with three classical β-turns and a twisted β-hairpin devoid of interstrand 
disulfide bonds (Figure 1.7). Although the authors suggested that this represents a novel 
peptide fold, which they named the boundless β-hairpin (BBH), other sea anemone toxins with 
similar disulfide framework had in fact been reported previously (126, 127). These toxins 
belong to KV type 4, which is comprised of three toxins, Bcg-III-23.41 and SHTX-1/SHTX-2 
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(k-stichotoxin-Shd1a/b) (Figure 1.8). The activity of SHTX-I was indirectly assayed by 
competitive inhibition of the binding of 125I--dendrotoxin to rat synaptosomal membranes 
but its channel blocking specificity is not yet known. The only difference between SHTX-I and 
II is a posttranslational modification of Pro6 in SHTX-II to a hydroxyproline in SHTX-I. 
 
Another toxin with similar framework was found in the venom of Stichodactyla duerdeni, and 
named U-SHTX-Sdd1. Although its pharmacological activity remains to be determined, U-
SHTX-Sdd1 was the first sea anemone toxin described with an O-linked hexose-N-acetyl 
posttranslational modification, in this case of the N-terminal threonine (128). Recently, a novel 
BBH peptide that produces a significant potentiating effect on allyl isothiocyanate- and 
diclofenac-induced TRPA1 currents was isolated from venom of the sea anemone Metridium 
senile (129). Ms 9a-1 acts as a positive modulator of TRPA1 in vitro but did not cause pain or 
thermal hyperalgesia when injected into the hind paw of mice. The Ms 9a-1 protein precursor 
also encodes two homologous toxins named Ms 9a-2 and Ms 9a-3 that are distinguished from 
Ms 9a-1 by a shorter C-terminal tail and a non-homologous region between the 2nd and 3rd Cys 
residues (Figure 1.8). 
 
Figure 1.7 – 3D structure of the sea anemone toxin Ugr9-1 (PDB accession code 2LZO). The two disulfide 
bonds are represented by orange tubes. 
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Figure 1.8 – Alignment of representative sea anemone toxins that adopt the BBH motif. Disulfide 
connectivities are indicated. Amino acid identities (black boxes) and similarities (grey boxes) are shown. 
 
1.3.4.4 EGF-like peptides 
Gigantoxin I (w-stichotoxin-Sgt1a) is a peptide toxin from Stichodactyla gigantea that has 
homology with mammalian epidermal growth factor (EGF). In accordance with this sequence 
homology, this toxin exhibits EGF activity as evidenced by rounding of human epidermoid 
carcinoma A431 cells (130). Gigantoxin I also modulates the activity of TRPV1 channels 
(131), but this activity results from the involvement of the epidermal growth factor 
receptor/PLA2/arachidonic acid/lipoxygenase pathway in indirect activation of TRPV1. 
Gigantoxin I was the first toxin described that induced this effect. Because of this, Cuypers and 
co-workers (131) suggested that this new group of toxins might help to better understand the 
regulation of TRPV1 channels. 
 
1.3.4.5 Inhibitor Cystine Knot fold 
Although the 3D structure of sea anemone ICK peptides remain to be confirmed, two different 
types of sea anemone toxins display cysteine patterns characteristic of the ICK structural 
scaffold, namely KV type 5 toxins and the ASIC toxin PhcrTx1 (p-phymatoxin-Pcf1a) (Figure 
1.9) (88). 
PhcrTx1, the first peptide characterized from venom of Phymanthus crucifer, is a 32-residue 
peptide with three disulfide bonds (88). Although its disulfide framework and 3D structure 
remain to be determined, the distribution of cysteines has the “classic” ICK signature (i.e., 
CXnCXnCCXnCXnC, where X is any amino acid and n indicates a variable number of amino 
acid residues). If confirmed, this would be the first sea anemone toxin reported to contain an 
ICK motif. PhcrTx1 reversibly inhibits ASIC currents in rat dorsal root ganglia neurons with 
an IC50 of 100 nM.  
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KV type 5 toxins contain only a single recently reported toxin, namely BcsTx3 (k-actitoxin-
Bcs4a) from B. caissarum (132), although there are putative members of this family from 
Nematostella vectensis (NvePTx1) and Metridium senile (MsePTx1). BcsTx3 is a single-chain 
peptide containing 50 residues crosslinked by four disulfide bridges. Its cysteine framework is 
similar to an ICK with an additional disulfide bridge, although like PhcrTx1, the structure of 
this toxin remains to be determined. BcsTx3 has high affinity for Drosophila Shaker IR 
channels (IC50 94 nM) over KV1.2 (IC50 173 nM), KV1.3 (IC50 1007 nM) and KV1.6 (IC50 2246 
nM) channels. 
 
 
Figure 1.9 – Alignment of sea anemone toxins that likely adopt an ICK motif. Predicted disulfide 
connectivities are indicated. Amino acid identities (black boxes) and similarities (grey boxes) are shown. 
 
1.3.4.6 ShK motif 
The ShK motif was named after the toxin ShK (k-stichotoxin-She3a), which was identified 
from the venom of Stichodactyla helianthus. This toxin belongs to KV type 1, which is 
comprised of toxins with 35–37 amino acid residues that block KV1 channels. The solution 
structure of ShK (133) consists of two short α-helices encompassing residues 14–19 and 21–
24, and an N-terminus with an extended conformation up to residue 8, followed by a pair of 
interlocking turns that resemble a 310-helix (Figure 1.10). It contains no β-strands. 
ShK blocks KV1.1, KV1.3 and KV1.6 channels with picomolar potency, and three other 
channels (KV1.2, KV3.2 and KCa3.1) with nanomolar potency (134). The surface of ShK 
involved in binding to KV channels has been probed using alanine scanning mutagenesis and 
selected toxin analogues (135). These studies revealed that two residues, Lys22 and Tyr23, are 
crucial for ShK activity, as also found subsequently for BgK toxin (136), while other residues 
contribute to the KV channel-binding surfaces. However, Gasparini and colleagues (137) 
proposed that the Lys-Tyr motif be more broadly defined as a lysine and a neighbouring 
hydrophobic residue. ShK blocks KV channels by binding to a shallow vestibule at the outer 
entrance to the ion conduction pathway and occluding ion entrance to the pore (138-140). 
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Although it inhibits several KV subtypes, ShK most potently blocks KV1.3 with an IC50 of ~10 
pM. KV1.3 plays a critical role in subsets of T and B lymphocytes implicated in autoimmune 
disorders, and ShK has therefore been studied as potential immunomodulator for therapy of 
autoimmune diseases. ShK analogs were developed to be more specific to KV1.3 (138). One of 
these analogs, ShK-186, is being developed as a therapy for autoimmune diseases. ShK-186 
(dalazatide) was well tolerated in a recently completed human phase 1A safety trial (141), and 
it is being advanced by Kineta Inc. (Seattle, WA, USA) into Phase 2 clinical trials (142). 
Similar to ShK, BgK inhibits KV1.1, KV1.2, KV1.3, KV1.6 and KCa currents at nanomolar 
concentrations (136), although it has a high affinity for KV1.1 (Kd = 6 nM for Kv1.1, 15 nM 
for KV1.2, 10 nM for Kv1.3). Beraud and co-workers (143) proposed that KV1.1 blockade has 
broad therapeutic potential in neuroinflammatory diseases (multiple sclerosis, stroke, and 
trauma). They therefore used an analog of BgK, BgK-F6A, which has the same high affinity 
for KV1.1 (IC50 0.72 nM) but decreased affinities for KV1.2 (IC50 400 nM) and KV1.3 (IC50 800 
nM), to provide preclinical evidence that KV1.1 blockers could be used to treat 
neuroinflammatory diseases. 
 
Figure 1.10 – 3D structure of KV type 1 sea anemone toxins. (A) Structure of BgK (PDB accession code 
1BGK). (B) Structure of ShK (PDB accession code 1ROO). The three disulfide bonds are represented by orange 
tubes. 
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1.3.4.7 Kunitz-domain 
The Kunitz-type protease inhibitors are the best-characterized family of serine protease 
inhibitors, probably due to their abundance in several organisms. The Kunitz-type motif 
consists of a peptide of ~60 amino acid residues stabilized by three disulfide bridges (C1–C6, 
C2–C4, C3–C5). Its 3D structure is characterized by an α/β/α motif (144) (Figure 1.11) with a 
hydrophobic core. The first reports on the existence of protease inhibitors in sea anemones date 
from the 1970s (145, 146). To date, protease inhibitor peptides and neurotoxins have been 
isolated from sea anemone whole bodies, tentacles, secreted mucus and aggressive organs such 
as acrorhagi, which is present in some species from the family Actiniidae (147). Several 
protease inhibitors have already been isolated or partially purified and characterized from 
several sea anemone species. 
KV type 2 sea anemone peptide toxins block KV1 channel currents, although with much less 
potency than KV type 1 toxins (31, 148, 149). Their biological role is still unclear. It is supposed 
that these protease inhibitors could: (1) defend sea anemones from the proteases of their 
victims; (2) protect the toxins injected into prey or predators from degradation by host 
proteases; (3) act on the regulation of digestive mechanisms, including self-digestion by their 
own enzymes or by those of symbiotic microorganism; (4) also, due to their dual activity, they 
could also be used to paralyze prey (150). The sea anemone kalicludines (AsKC1 to AsKC3, 
kp-actitoxin-Avd3b-d) from Anemonia sulcata, APEKTx1 (kp-actitoxin-Ael3a) from 
Anthopleura elegantissima, SHTX-3 (kp-stichotoxin-Shd2a) from Stichodactyla haddoni, and 
Sh1 (d-SHTX-She1a) from Stichodactlyla helianthus, are examples of toxins with both 
protease inhibitor and potassium channel blocking activities (127, 149, 151). 
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Many protease inhibitors were isolated from a body extract of H. crispa, but only a few have 
been fully characterized. Protease inhibitors were obtained from a water-ethanol extract of H. 
crispa, and the primary structure was elucidated for one of them, named Kunitz-type trypsin 
inhibitor IV or Jn-IV (152). Four trypsin inhibitors were subsequently isolated (InI–InIV), one 
of which (InI) was partially characterized. Later on, also from Heteractis crispa extract, a 
Kunitz-type toxin designated InhVJ was isolated (153, 154). InhVJ is highly specific toward 
trypsin and α-chymotrypsin and does not inhibit other serine (such as thrombin, kallikrein and 
plasmin), cysteine (papain) or aspartic (pepsin) proteases. Recently, APHC1 (t-stichotoxin-
Hcr2b) (28) and two homologous peptides (APHC2 and APHC3, t-stichotoxin-Hcr2b and -
Hcr2c) (155) were characterized from H. crispa. The APHC toxins contain 56 residues and 
have high sequence similarity to the Kunitz-type protease inhibitor family (32). Consistent with 
this, APHC1 and APHC3 are weak inhibitors of serine proteases (156, 157). Its main activity 
is related to an effect on TRPV1 channels (28). TRPV1 was previously described as a 
pharmacological target of other cnidarians venoms, such as jellyfish (158). However, APHC1 
was the first peptidic TRPV1 modulator isolated from sea anemone venom (156). The primary 
structure of APHC1 (UniProt B2G331) and APHC3 (UniProt C0HJF4), differ in only four 
amino acid residues (Figure 1.12). These substitutions result in differences in their ability to 
modulate TRPV1. 200 nM APHC1 inhibits ~32% of capsaisin-induced currents 200 nM (156), 
while APHC3 has a lower inhibitory effect (25%) at higher concentrations (300 nM) (159). 
Figure 1.11 – 3D structure of the KV type 2 sea anemone toxin ShPI-I (p-stichotoxin-She2a) (PDB accession 
code 3OFW). Peptides of this type are homologous to Kunitz-type inhibitors of serine proteases. The three 
disulfide bonds are represented by orange tubes. 
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Nevertheless, both toxins have antinociceptive and analgesic activity in vivo at doses of 0.01–
0.1 mg/kg due to their inhibition of TRPV1. Andreev et al. (159) suggested that APHC1 and 
APHC3 might represent a new class of TRPV1 modulators that produce a significant analgesic 
effect without hyperthermia. 
Figure 1.12 – Aligment of APHC1, 2 and 3 (UniProt B2G331, C0HJF3 and C0HJF4, respectively). Cysteines 
are highlighted in bold, mutations are marked with dots, and conserved positions are marked with *. 
 
1.3.4.8 SCRiPs 
SCRiPs were originally identified as genes unique to reef-building corals (Scleractinia) that are 
downregulated during heat stress (160). Given the similarity in the temporal expression pattern 
they share with galaxin, a key protein involved in the biomineralization process (161), SCRiPs 
were implicated in calcification of the coral skeleton (160). However, Jouiaei et al. (90) showed 
that SCRiPs from coral reef (Acropora millepora) cause profound neurotoxic effects in fish 
and it is most likely that they are employed as neurotoxins. Moreover, BLAST searches 
uncovered SCRiP homologues in the sea anemones Anemonia viridis and Metridium senile 
(90). Recently, the first SCRIP was isolated from a sea anemone by Logashina and co-workers 
(23), who isolated and characterized a peptide from Urticina eques, Ueq 12-1 (τ-AnmTx 
Ueq 12-1) (Figure 1.13). This study confirmed that SCRiPs act as toxins as predicted by 
Jouiaei and colleagues; Ueq 12-1 was found to be a bifunctional molecule that exhibits both 
antimicrobial and TRPA1 potentiating activity, producing an analgesic effect in animal models 
of pain (23). 
 
 
Figure 1.13 – Representative sea anemone SCRiP toxins. Disulfide connectivities are indicated above the 
sequence alignment. Amino acid identities (black boxes) and similarities (grey boxes) are shown. 
 
SCRiPs contain 8–10 cysteine residues, including a characteristic triplet of cysteines near the 
C-terminus (Figure 1.13). The 3D structure of Ueq 12-1 reveals that SCRiPs are organized into 
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a W-shaped structure (Figure 1.14), the core of which is formed by a three-stranded antiparallel 
β-sheet, a small two-stranded parallel β-sheet, and one turn of a 310 helix stabilized by 4–5 
disulfide bridges (C1–C2, C3–C8, C4–C7, C5–C9 and C6–C10). The surface of the peptide is 
polar without pronounced clusters of positively or negatively charged side chains (23). 
 
 
1.4 Summary and significance of project 
As detailed in this introduction, sea anemones have complex venoms that they depend on for 
defense, prey capture, and competitor deterrence. These venoms contain an impressive variety 
of both proteinaceous and non-proteinaceous substances. Peptide toxins in sea anemone 
venoms are known to act on a wide range of ion channels, including ASIC, TRP, NaV and KV 
channels. 
Even though significant progress has been made over the past few years in understanding the 
ecology, evolution and composition of sea anemone venom, the venom of only ~40 of the more 
than 1200 recorded species of sea anemones have been investigated. In addition, like many 
venomous lineages, characterization of toxic components in sea anemones has been done 
mostly through an opportunistic approach, focusing on peptides and taxa that are easily 
accessible. This means that the venoms of these animals contain a huge diversity of compounds 
that remain to be investigated. Access to the composition of the venom is essential for 
understanding its ecological role and the evolutionary processes involved in toxin recruitment. 
Figure 1.14 – 3D structure of the sea anemone toxin Ueq 12-1 (PDB accession code 5LAH). The three 
disulfide bonds are shown as orange tubes. 
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Improvements in the techniques used and investigation of a wider array of species will facilitate 
the discovery of new compounds, some of which might be useful as pharmacological tools, or 
as leads for development of drugs and insecticides. 
 
1.5 Aims 
The primary aim of this thesis is to provide the first comprehensive insight into the evolution, 
diversification and biodiscovery potential of sea anemone venoms. I used four distinct 
approaches to fulfill these aims:  
 
1. The overall composition of Australian sea anemone venoms was mapped using an 
integrated proteomic/transcriptomic approach, the first time this approach has been 
used for any sea anemone venom;  
2. Bioinformatic analysis of the transcriptomic and proteomic data was undertaken to 
understand the molecular evolution of sea anemone toxins. In addition, the 
pharmacological activity and three-dimensional structure of selected novel toxin 
scaffolds was determined using a combination of electrophysiology and NMR 
spectroscopy. 
3. Toxin function was inferred by examining the tissue distribution of toxins using 
imaging mass spectrometry approach; 
 
This thesis has contributed to our understanding of the evolution and ecological role of sea 
anemone venoms, and provided data that will allow better classification of sea anemone toxins 
and the discovery of new toxin folds. 
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CHAPTER 2  
Revisiting venom of the sea anemone Stichodactyla haddoni: omics 
techniques reveal the complete toxin arsenal of a well-studied sea 
anemone genus 
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Abstract 
More than a century of research on sea anemone venoms has shown that they contain a diversity 
of biologically active proteins and peptides. However, recent omics studies have revealed that 
much of the venom proteome remains unexplored. We used, for the first time, a combination 
of proteomic and transcriptomic techniques to obtain a holistic overview of the venom arsenal 
of the well-studied sea anemone Stichodactyla haddoni. A purely search-based approach to 
identify putative toxins in a transcriptome from tentacles regenerating after venom extraction 
identified 508 unique toxin-like transcripts grouped into 63 families. However, proteomic 
analysis of venom revealed that 52 of these toxin families are likely false positives. In contrast, 
the combination of transcriptomic and proteomic data enabled positive identification of 23 
families of putative toxins, 12 of which have no homology known proteins or peptides. Our 
data highlight the importance of using proteomics of milked venom to correctly identify venom 
proteins/peptides, both known and novel, while minimizing false positive identifications from 
non-toxin homologues identified in transcriptomes of venom-producing tissues. This work lays 
the foundation for uncovering the role of individual toxins in sea anemone venom and how 
they contribute to the envenomation of prey, predators, and competitors. 
 
Biological significance 
Proteomic analysis of milked venom combined with analysis of a tentacle transcriptome 
revealed the full extent of the venom arsenal of the sea anemone Stichodactyla haddoni. This 
combined approach led to the discovery of 12 entirely new families of disulfide-rich peptides 
and proteins in a genus of anemones that have been studied for over a century. 
 
Highlights 
• Proteomic/transcriptomic analysis revealed the venom proteome of Stichodactyla haddoni  
• We identified 12 new families of disulfide-rich peptides/proteins in S. haddoni venom  
• There was a poor correlation between toxin transcript levels and abundance in venom  
• Proteomics data was essential to reliably identify toxins in tentacle transcriptome 
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2.1 Introduction 
Sea anemones belong to the phylum Cnidaria, the oldest extant lineage of venomous animals, 
with molecular and fossil data placing their origin prior to the Ediacaran period ~750 million 
years ago (162). Sea anemones are solitary marine invertebrates that have achieved great 
ecological success despite their structural simplicity. Essentially laminar organisms, their two-
dimensional epithelial construction has shaped both behavioral and physiological responses 
and led to great diversity, as evidenced by their presence in all marine habitats and at all depths 
and latitudes. 
Like other cnidarians, sea anemones secrete venom from specialized cells known as penetrant 
nematocysts that contain an eversible hollow tubule filled with venom (162). Contact with prey 
induces explosive eversion of the tubule, which penetrates the target organism and discharges 
the venom. Sea anemones use venom for predation, defense, and competitor deterrence (163). 
Their venom has been studied in more detail than other cnidarians, beginning with pioneering 
work by the French physiologist Charles Richet who in 1903 partially purified and 
characterised two active components from tentacular extracts of the sea anemones Actinia 
equina and Anemonia sulcata (164, 165). However, despite Richet’s work and the development 
of chromatographic methods that enable separation of venom components, most investigators 
of marine toxins were still studying crude extracts from whole animals or tentacles up until the 
1970s (166). It was not until 1976 that the first amino acid sequence was reported for a sea 
anemone venom peptide (167). In 2007, the study of sea anemone venom entered the ‘omics’ 
era when the genome of Nematostella vectensis was reported (85), the first for any venomous 
animal. Since then, sea anemone venoms have been investigated using both transcriptomics 
(168) and proteomics (10), resulting in the discovery of new types of toxins (88, 94) and tissue-
specific patterns of toxin expression (10, 169, 170). However, an integrated 
proteomic/transcriptomic approach has not yet been used to characterise the overall 
composition of any sea anemone venom, hampering both our understanding of the evolution 
of their venoms and the complexity of their venom arsenal. 
Most studies of sea anemone venoms have used large, easily accessible species, and/or species 
harmful to humans. Many studies employed carpet anemones of the genus Stichodactyla, which 
is comprised of five species (S. gigantea, S. haddoni, S. helianthus, S. mertensii, and S. 
tapetum). Although these species are restricted to the tropics, Stichodactyla are common in the 
aquarium trade, which, along with their large size and venom yield, makes them attractive 
subjects for venom-based studies. However, despite >100 publications on Stichodactyla 
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venom, sequences have been reported for only 17 peptide/protein toxins from four species 
(127), a figure that is at odds with the abundance and diversity of toxins reported for most 
marine and terrestrial invertebrate venoms (171-175). 
Sea anemone venoms contain a variety of both proteinaceous (peptides and proteins) and non-
proteinaceous substances (e.g., purines, quaternary ammonium compounds, and biogenic 
amines) (176). The proteinaceous toxins that have been well characterized can be organized 
into three major groups: phospholipase A2, cytolysins, and neurotoxins (177). Both cytolysins 
and neurotoxins are functional terms, and these two groups actually comprise multiple protein 
and peptide families — the cytolysin group currently includes five protein families ranging in 
size from 5 to 80 kDa, while the neurotoxins include cysteine-rich peptides distributed across 
eight unique structural scaffolds. However, recent proteomic (178) and transcriptomic (177) 
studies have revealed a large diversity of novel, uncharacterised compounds in sea anemone 
venoms. 
Here, we highlight the power of using a combined transcriptomics/proteomics approach to 
provide a holistic overview of the complexity of the venom arsenal of sea anemones. 
Application of this approach to a representative of the well-studied genus Stichodactyla 
uncovered twelve new families of putative toxins, illustrating how much there is still to be 
learnt about sea anemone venoms. 
 
2.2 Materials and methods 
2.2.1 Specimen and Venom Collection 
Sea anemones were collected (based on species identification by marine biologists B.M. and 
E.A.B.U.) at North Stradbroke Island, Queensland, Australia (27°15 S, 153°15 E) then housed 
in aquaria at the University of Queensland. Venom was obtained after a starvation period of at 
least 48 h. Briefly, the sea anemone was rinsed, placed in a minimal volume of artificial 
seawater, and the nematocysts induced to discharge by electrical stimulation (179). The water, 
which contains the venom, was lyophilized and then the venom was desalted by dialysis at 4°C 
(Biotech Cellulose Ester membrane, 0.1–0.5 kDa cut-off; Spectrum Labs, USA). 
 
2.2.2 2DE Analysis 
Desalted venom (0.4 mg) was solubilized in 125 µL of DeStreak Rehydration Solution (GE 
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Life Sciences, USA). The sample was mixed and centrifuged to pellet insoluble material, then 
1% Immobilized pH Gradient (IPG) buffer (pH 3–10 NL; GE Life Sciences) and 10 mM DTT 
were added to the supernatant before loading onto isoelectric focusing (IEF) strips (ReadyStrip, 
non-linear pH 3–10, 7 cm; Bio-Rad, USA) for 24 h passive rehydration. Proteins were 
electrophoresed in an Ettan IPGphor3 IEF system (GE Life Sciences, USA) under the 
following conditions: 100 V for 1 h, 300 V for 200 Volt-hours (V-h), 300 to 1000 V for 300 
V-h, 1000 to 5000 V for 4000 V-h, and 5000 V for 1250 V-h. The IPG strip was then 
equilibrated for 10 min in reducing equilibration buffer (50 mM Tris-HCl, pH 8.8, 6 M urea, 
2% SDS, 30% glycerol, 1.5% DTT) followed by a second incubation for 20 min in alkylating 
equilibration buffer (50 mM Tris-HCl, pH 8.8, 6 M urea, 2% SDS, 30% glycerol, 2% 
iodoacetamide). The IPG strip was then embedded on top of a 12.5% polyacrylamide gel 
(PowerPac Electrophoresis unit; Bio-Rad) and covered with 0.5% agarose. Second dimension 
electrophoresis was performed at 4°C for 1 h at 150 V per gel. The resulting gel was stained 
overnight with 0.2% colloidal Coomassie brilliant blue G250 (34% methanol, 3% phosphoric 
acid, 170 g/L ammonium sulfate, 1 g/L Coomassie blue G250), then destained in 1% acetic 
acid/H2O. Visible spots were subsequently picked from the gel and digested overnight at 37°C 
using sequencing-grade trypsin (Sigma, USA). Briefly, gel spots were washed with ultrapure 
water, destained (40 mM NH4CO3/50% acetonitrile (ACN)) and dehydrated (100% ACN). Gel 
spots were rehydrated in 10 µL of 20 µg/ml proteomics-grade trypsin (Sigma-Aldrich) and 
incubated overnight at 37°C. Digests were eluted by washing the gel spots for 30 min with 
each of the following solutions: 50 µL 50% ACN/1% formic acid (FA), followed by 50 µL 
70% ACN/1% FA. The samples were then dried by evaporation using a vacuum centrifuge and 
reconstituted in 20 µL of 1% FA prior to analysis by LC-MS/MS. 
 
2.2.3 HPLC 
Reversed-phase (RP) HPLC analysis of crude S. haddoni venom was performed using a 
Shimadzu Prominence system. Venom (1 mg) was fractionated on a C18 column (4.6 × 250 
mm, 5 µm particle size, 300 Å pore size) using a flow rate of 1 ml/min and the following 
gradient of solvent B (0.043% trifluoroacetic acid (TFA) in 90% ACN) in solvent A (0.043% 
TFA in water): 10% solvent B for 15 min, 10–65% solvent B over 50 min, 45–70% solvent B 
over 5 min. Fractions were collected manually, dried by evaporation using a vacuum 
centrifuge, then prepared for LC-MS/MS analysis as described below. 
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2.2.4 Protein identification using LC-MS/MS 
To identify proteins present in the milked venom we used a bottom-up proteomics approach to 
analyze the digested 2DE gel spots, RP-HPLC fractions, as well as crude desalted venom. 
Reduction and alkylation of cysteine residues in venom proteins and peptides was performed 
as reported previously (180). Reduced/alkylated venom was incubated overnight at 37°C in 
10 µL of 40 ng/µL proteomics-grade trypsin (Sigma) in 40 mM NH4CO3, pH 8. The digested 
reduced/alkylated samples were then resuspended in a final concentration of 1% FA and 
centrifuged for 15 min at 12,000 g prior to LC-MS/MS. For analysis of RP-HPLC fractions 
and in-gel digests, tryptic peptides were fractionated on an Agilent Zorbax stable-bond C18 
column (2.1 mm × 100 mm, 1.8 µm particle size, 300 Å pore size) using a flow rate of 180 
µl/min and a gradient of 1–40% solvent B (90% ACN, 0.1% FA) in 0.1% FA over 15 min on 
a Shimadzu Nexera UHPLC coupled with an AB SCIEX 5600 mass spectrometer equipped 
with a Turbo V ion source heated to 500°C. MS/MS spectra were acquired at a rate of 20 
scans/s, with accumulation time of 0.25 ms, resulting in a cycle time of 2.3 s, and optimized 
for high resolution. Precursor ions with m/z of 300–1,800 m/z, a charge of +2 to +5, and an 
intensity of at least 120 counts/s were selected, with a unit mass precursor ion inclusion window 
of ± 0.7 Da, and excluding isotopes within ±2 Da for MS/MS. The crude venom digest was 
analyzed as above except using a gradient of 1–40% solvent B (90% ACN, 0.1% FA) in 0.1% 
FA over 60 min. 
Mass spectra were searched against predicted coding sequences (CDSs) from the assembled 
transcriptome (see below) using ProteinPilot v4.5 (AB SCIEX). Searches were run as thorough 
identification searches, specifying tryptic digestion and the alkylation reagent as appropriate. 
Biological modifications and amino acid substitutions were allowed in order to maximize the 
identification of protein sequences from the transcriptome despite the inherent variability of 
toxins, potential isoform mismatch with the transcriptomic data, and to account for 
experimental artifacts leading to chemical modifications. We used a stringent detected protein 
threshold score of 1% false discovery rate (FDR) as calculated by decoy searches. All mass 
spectrometry and ProteinPilot data were submitted to the ProteomeXchange Consortium via 
the PRIDE (181, 182) partner repository with the dataset identifier PXD006253. 
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2.2.5 Transcriptome sequencing, assembly, and expression analysis 
Little is known about the regeneration of sea anemone toxins. In order to maximize the toxin-
gene expression levels for transcriptome sequencing, we performed a preliminary study on 
toxin expression levels at 0, 24, 48, and 72 h after venom extraction. Using primers based on 
available toxin sequences from Stichodactyla, PCR experiments indicated that toxin transcripts 
are robustly expressed at 72 h after venom extraction, consistent with active replenishment of 
the toxin arsenal. Although the dynamics of toxin regeneration in sea anemones warrants more 
thorough investigation, such as examining a representative selection of toxin families and 
distinguishing toxins produced in glandular cells versus nematocytes, we decided to sequence 
the transcriptome of tentacles collected from S. haddoni at 72 h after venom extraction. 
Tentacle tissue from the same animals used for proteomic analyses were collected with 
tweezers and flash frozen before total RNA was extracted using TRIzol (Life Technologies) 
and enriched for mRNA using a DynaBeads Direct mRNA kit (Life Technologies). mRNA 
(350 ng) was supplied to the Institute for Molecular Bioscience Sequencing Facility for library 
preparation and sequencing. A paired-end cDNA library (180 bp insert size) was prepared 
using the TruSeq-3 library kit and sequenced on an Illumina NextSeq 500 (mid-output, 150 bp 
paired-end reads). The resulting reads were trimmed using Trimmomatic (183) to remove 
adapter sequences and low-quality reads. Window function-based quality trimming was 
performed using a windowsize of 75 and a windowquality of 34, and sequences with a resulting 
length of <100 bp were removed. After quality control, paired-end sequences were de novo 
assembled into contigs using Trinity v2.0.6 (184) using default parameters. The relative 
abundance of each transcript was estimated by mapping the paired trimmed reads back to the 
transcriptome assembly and calculating values of Transcripts Per Million (TPM) using RSEM 
(version 1.1.17) (185) compiled for Galaxy (186). Mapped reads were visualized using the 
Integrated Genome Viewer (187, 188) and polymorphic sites identified if supported by more 
than five reads or frequency greater than 5%. Raw sequence reads (SRA: SRR5397293) and 
Trinity-assembled contigs have been deposited with links to BioProject accession number 
SAMN06670449 in the NCBI BioProject database (www.ncbi.nlm.nih.gov/bioproject/). 
 
2.2.6 Functional annotation of transcriptome 
In order to identify potential toxin-like transcripts, we compared the translated transcriptome 
to all curated animal toxin sequences. Coding sequences (CDSs) were identified using the 
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Galaxy tool ‘Get open reading frames (ORFs) or coding sequences (CDSs)’ (189). A minimum 
CDS length cut-off of 30 residues was used to minimize the probability of not identifying short 
toxin CDSs. BLASTp searches of the resulting translated CDSs against the UniProt animal 
venom database (190) (accessed on April 2016) were performed with the upper-limit for the 
E-value set to 1E-3. Candidate toxin-like transcripts were further processed by removing 
redundant protein sequences using CD-HIT (191) as well as sequences not containing a signal 
peptide that could be detected using SignalP (version 4.1) (192). Finally, the toxin candidates 
were classified into categories according to predicted structure and/or function. 
 
2.2.7 Functional annotation of proteomics data 
CDSs from the venom transcriptome were used as a protein database for proteomic analyses. 
LC-MS/MS spectra were searched against the CDS database using ProteinPilot v4.5 (AB 
SCIEX). Sequences with less than two peptides with 95% confidence were excluded; the 
selected sequences from ProteinPilot were extracted using Galaxy tools. These sequences were 
then BLAST searched against the UniProt animal toxin database 
(www.uniprot.org/program/toxins) and annotated according to the methodology described for 
the transcriptome annotation. Sequences without matches to the UniProt toxin database were 
functionally annotated using a combination of BLAST searches against the NCBI non-
redundant protein database and InterProScan (193) using Blast2GO (194). Sequences without 
known functional or structural motifs were considered "unknowns". To identify the full 
molecular diversity contained within each of the putative toxin families, sequences identified 
in the milked venom were then BLAST searched against the translated transcriptome. 
Redundant protein sequences were removed using CD-HIT and only sequences containing a 
predicted signal peptide were considered as putative toxin candidates. 
 
2.3 Results 
2.3.1 Transcriptome sequencing, assembly and annotation 
We used next-generation sequencing of poly-A enriched RNA extracted from tentacles that 
were actively regenerating their venom (see ‘Experimental procedures’) to investigate the 
diversity of toxin-like sequences in sea anemone venom. De novo assembly with Trinity 
yielded 269,628 contigs, a number comparable to previous Illumina-sequenced sea anemone 
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transcriptomes assembled using Trinity (20, 170), which translated to over 1.8 million potential 
CDS. As previously reported for sea anemones (170) and other cnidarians (195), we found that 
the majority of transcripts were not related to the envenomation process, consistent with the 
tentacles being composed of much more than just the toxin producing nematocytes and gland 
cells. Nevertheless, by combining BLAST searches with searches for structural and functional 
domains, we identified 508 unique sequences as putative toxins of which 68% were proteins 
and 32% were peptides (i.e., < 75 residues). We were able to group these toxins into 63 families 
(Figure 2.1). 
 
 
Figure 2.1 – Putative toxin families identified in the transcriptome of S. haddoni by BLAST search against 
UniProt. The 508 unique protein sequences with significant BLAST hits to the manually curated list of animal 
toxins in UniProt (www.uniprot.org/program/Toxins) were sorted into toxin families according to their cysteine 
scaffold and amino acid sequence. The pie chart shows the proportional contribution of each toxin family to the 
predicted venom proteome. The number of homologues identified for each protein and peptide family is shown 
in parentheses after the family name. 
 35 
 
Protein toxins: The putative protein toxins with the greatest number of homologues identified 
by BLAST searches were factor V-like (46 homologues), ficolin-like (46 homologues), and 
latrotoxin-like (32 homologues). However, great caution needs to be exercised in interpreting 
such hits. Latrotoxins are the largest and most potent neurotoxins isolated from arthropod 
venoms. They have a molecular mass of 110–140 kDa (196) and exert a neurotoxic effect on 
insects or vertebrates by inducing massive neurotransmitter release at presynaptic nerve 
terminals (197). Despite claims to the contrary, they are found only in the venom of widow 
spiders (i.e., the genera Latrodectus, Steatoda, and Parasteatoda) (198). However, because 
latrotoxins contain 20 or more ankyrin repeat domains (196), one of the most ubiquitous 
protein-protein interaction motifs known, there are numerous instances where venom-gland 
transcripts from a wide variety of venomous animals (199-201) have yielded hits to one or 
more of these domains, but not other regions of the latrotoxin protein; hence, these hits are not 
true latrotoxin homologues. This was also the case in the current study — the family of sea 
anemone proteins with hits to latrotoxin are smaller and highly variable in size (8.1–60.1 kDa) 
and the sequence homology is confined to the ankyrin repeat domains. Moreover, proteomic 
analysis of milked venom (see below) did not provide evidence for expression of these proteins 
in the venom, suggesting that they are not venom toxins. Since these sea anemone proteins 
contain 1–6 ankyrin repeat domains (InterPro IPR002110; SMART SM00248; Pfam 
PF00023), we refer to them as "ankyrin repeat proteins" rather than latrotoxin homologues. 
Ficolins are large oligomeric lectins (~35 kDa) comprised of an N-terminal domain followed 
by a long collagen-like stretch that precedes a C-terminal fibrinogen-like globular (FBG) 
domain (InterPro IPR002181; SMART SM00186; Pfam PF00147). Human ficolins serve as 
lectin-type pattern recognition receptors that recognise carbohydrates on the surface of 
microbial pathogens and activate the lectin pathway of the complement system (202). They are 
rare in animal venoms, with only five reported to date from reptiles (203, 204). In contrast to 
these reptilian ficolins, the sea anemone proteins with hits to ficolin are highly variable in size 
(9.2–162.5 kDa), the sequence homology is confined to the FBG domain of ficolin, and 
proteomic analysis of milked venom did not provide evidence for their expression in the 
venom. We conclude that they are not venom toxins and refer to them as "FBG domain 
proteins" rather than ficolin homologues. 
Factor V is a key non-enzymatic component of the mammalian coagulation system (205). It is 
a large protein with domain architecture A1-A2-B-A3-C1-C2 (206). Factor V-like toxins with 
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the same domain architecture are found in snake venoms, where they interfere with the 
coagulation and hemostatic systems of envenomated mammalian prey (206). In contrast, the 
sea anemone transcripts with hits to Factor V are highly variable in size (13.6–223 kDa), the 
sequence homology is confined to the C-terminal repeat domain found in both Factor V and 
Factor VIII (Coagulation factor 5/8 C-terminal domain: InterPro IPR000421; SMART 
SM00231; Pfam PF00754) and proteomic analysis of milked venom did not provide evidence 
for their expression in the venom. We conclude that they are not venom toxins and refer to 
them as "Factor 5/8 C-domain proteins" rather than Factor V homologues. 
 
Peptide toxins: The putative peptide toxins with the largest number of unique homologues 
were β-defensins (32 homologues), inhibitor cystine knot (ICK) peptides (27 homologues), and 
Kunitz-type peptides (24 homologues). β-defensins are antimicrobial peptides that are secreted 
as part of the innate immune response in a wide range of taxa (102, 207). However, in sea 
anemone venoms, β-defensin-like peptides have become weaponized to serve as neurotoxins 
that modify the activity of voltage- and ligand-gated ion channels; this family of peptides 
includes both KV type 4 and NaV type 1, 2 and 4 toxins (103, 105, 208). 
The ICK fold is perhaps the most abundant disulfide-rich peptide fold known (209). It is found 
in a wide diversity of organisms including viruses, plants, fungi and animals where they appear 
to primarily provide defence against pathogens (209). Due to the stability (210, 211) and 
evolutionary plasticity (209, 212) provided by the ICK fold, it is also one of the most frequently 
“weaponized” peptide folds. Hence, ICK-type toxins are found in a wide range of animal 
venoms, such as those of cone snails (213) and spiders (179), where they act as neurotoxins 
that affect ion channel function. Only one sea anemone toxin with a putative ICK motif has 
been purified and characterized (88), although its ICK architecture has not yet been confirmed 
by structural or chemical analysis. 
Kunitz-type peptides have been described from the venom and venom glands of a 
taxonomically diverse array of venomous animals, where they act as protease inhibitors and 
ion channel modulators (214, 215). In sea anemones, both TRPV and type II KV channel toxins 
assume a Kunitz fold (27). Interestingly, some sea anemone type II KV channel toxins have 
dual activity, acting both as potassium channel blockers and inhibitors of serine proteases (163, 
216), which enables them to serve both as defense molecules and as neurotoxins that aid in 
prey immobilization (217). 
 37 
Although our expression level analysis lacked replicates, it is worth noting that the most 
abundantly expressed of the putative toxins identified by BLAST were neurotoxin-like 
peptides and FBG domain proteins (Table 2.1). In contrast, the Factor 5/8 C-domain proteins 
and ankyrin repeat proteins were not highly expressed. In fact, we found little correlation 
between the number of homologues within each protein family and its expression level. This 
correlation was better for peptides, where 4 of the 6 most diverse peptide scaffolds were 
represented among the top 10 most highly expressed transcripts. 
 
Table 2.1 – Highly expressed toxin transcripts. Ten most highly expressed transcripts encoding putative toxins 
in the tentacle transcriptome of S. haddoni as identified by BLAST search against the manually curated list of 
animal toxins in UniProt (www.uniprot.org/program/Toxins). Expression levels are shown as ‘transcripts per 
million’ (TPM) for each contig. The accession code and E-value are given for the best UniProt BLAST hit. 
Transcript ID TPM UniProt hit Family E-value 
TR139525_c0_g5_i1_CDS4 11699 P0DMX5 β-defensin 8E-20 
TR11907_c0_g1_i1_CDS3 9165 P0DMZ3 
Sea anemone 8 
toxin family 
7E-36 
TR121578_c2_g1_i1_CDS2 6421 C0HJF3 Kunitz-type 3E-16 
TR131122_c0_g1_i1_CDS5 5757 B2DCR8 Cephalotoxin-like 6E-05 
TR27817_c0_g1_i1_CDS7 5671 D8VNS8 Ficolin lectin 2E-06 
TR131356_c0_g1_i1_CDS3 4341 P0DMZ6 
Sea anemone 8 
toxin family 
1E-44 
TR129689_c0_g1_i2_CDS3 4048 B2G331 Kunitz-type 1E-42 
TR90837_c2_g2_i2_CDS3 3681 P0DMX5 β-defensin 3E-20 
TR122517_c0_g1_i1_CDS3 3180 D8VNS9 Ficolin lectin 4E-05 
TR138219_c4_g1_i1_CDS10 2518 R4ZCU1 
Boundless β-
hairpin 
2E-10 
 
2.3.2 Proteomics of milked venom 
To identify which proteins and peptides are present in S. haddoni milked venom, we used a 
combination of 2DE and shotgun analyses of crude and RP-HPLC fractionated venom. In order 
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to estimate the completeness of our proteomics data, we performed a search for toxins 
previously reported to be present in S. haddoni (127) (see Appendix I). Our RP-HPLC 
fractionation (Figure 2.2A) and 2DE gel (Figure 2.2B) revealed a complex set of both low and 
high molecular weight proteins. However, we found little overlap between the putative toxins 
identified using a purely bioinformatic approach and components identified by the combined 
proteomic/transcriptomic approach. A ProteinPilot search of all the mass spectrometry data 
against our translated transcriptome yielded a total of 131 unique coding sequences (see 
Supplementary Information file S4), of which only 27 were identified as putative toxins during 
functional annotation of the transcriptome. Moreover, the milked venom of S. haddoni 
contained a high proportion of completely novel toxin families. Of the 131 identified 
sequences, only 33 showed significant homology to entries in the UniProt toxin database (see 
Appendix II).  
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The final set of potential toxins identified in the milked venom included eleven known toxin 
families and twelve protein families that could not be assigned a putative function or known 
family. The putative toxins with the greatest number of homologues identified were β-
defensins (7), Kunitz-type peptides (7), and the newly identified toxin family U11-Std (7) 
(Table 2.2). The identified β-defensins included NaV type 1, 2 and 4 toxins as well as KV type 
3 toxins, while the Kunitz-type peptides include KV type 2 and TRPV toxins. Supplementary 
Figure 2.2 – Composition of S. haddoni venom. (A) C18 RP-HPLC chromatogram of desalted crude S. haddoni 
venom. (B) 2DE gel of S. haddoni venom; the first dimension was isoelectric focussing (pH 3–10) followed by 
12.5% SDS-PAGE. Molecular masses of standards are indicated on right of gel. Proteins identified by in-gel 
digestion and LC-MS/MS are annotated according to their respective family. Spots with less than two peptides 
identified in the LC-MS/MS and confidence values below 95% were not annotated. 
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Table S1 (not shown in this thesis) provides a complete list of identified putative toxins 
annotated according to both structural scaffold and traditional sea anemone toxin 
nomenclature. 
 
Table 2.2 – Novel toxin scaffolds identified in S. haddoni venom. Novel protein and peptide families identified 
in the venom of S. haddoni organized into families according to cysteine scaffold and amino acid sequence 
similarity. 'X' indicates any amino acid. 
Toxin 
family 
No. of 
cysteines 
Scaffold 
Length of 
mature 
peptide 
Number of 
homologue
s 
U1-Std 4 x7Cx3Cx5Cx8Cx2 28 4 
U2-Std 6 xCx7Cx6CCx12Cx12Cx3 47 2 
U3-Std 6 x2Cx35Cx3Cx25CxCx22Cx 93 4 
U4-Std 7 x5Cx47CCx10Cx26CCx83C 178 1 
U5-Std 8 x3Cx13Cx3Cx13Cx5CCxCx6Cx4 56 2 
U6-Std 8 x19Cx3Cx6Cx3Cx9Cx3Cx6Cx21Cx23 101 1 
U7-Std 9 x9Cx3CxCx7Cx3Cx6Cx19CxCx4Cx 63 1 
U8-Std 10 x3Cx18Cx3CxCx7Cx3Cx6Cx19CxCx4Cx 76 1 
U9-Std 10 
Cx17Cx8Cx31Cx35Cx7Cx14Cx8Cx9Cx30
Cx5 
174 3 
U10-Std 12 
x7Cx7Cx22Cx8Cx10Cx24Cx41Cx7Cx14C
x8Cx5Cx29Cx4 
198 1 
U11-Std 18 
x3Cx25Cx19Cx18Cx37Cx12Cx16Cx17CxC
Cx60Cx11Cx3Cx46Cx6Cx4Cx13Cx3 
311 28 
U12-Std 20 
x3Cx3Cx6Cx3Cx5CCx13Cx5Cx4CCx4C
x3Cx6Cx2Cx6CCx9Cx5Cx4CCx2 
103 1 
 
Consistent with the toxin profile suggested by expression analyses of the putative toxins 
identified by BLAST search against the UniProt toxin database, our proteomic results show 
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that the primary components in the venom are neurotoxins and one type 2 cytolysin. 
Furthermore, the main fraction in the RP-HPLC chromatogram (elution time ~26 min) is 
composed of an EGF-like neurotoxin and a type 2 cytolysin. Among the toxins identified in 
the venom, we found a Kunitz-type toxin with homology to t-stichotoxin-Hcr2b (UniProt 
B2G331) from Heteractis crispa to have the highest level of expression (Table 2.3). The second 
most highly expressed transcript whose translated product was identified in the milked venom 
encodes a boundless β-hairpin (BBH). Interestingly, the BBH encoded by this transcript is 
similar to each of the four toxins encoded by the UG precursor (UniProt R4ZCU1) from the 
painted anemone Urticina grebelnyi; however, whereas the UG transcript encodes four 
homologous toxins that are post-translationally liberated (24), the S. haddoni transcript 
encodes only a single toxin. Curiously, this is the only BBH-encoding transcript whose product 
was identified in the venom, and one of only two in the entire transcriptome assembly.  
As Trinity-based assembly can mask the full diversity of toxin genes (177, 218), we examined 
the mapped reads to each contig where the ProteinPilot data indicated with high confidence 
that an amino acid substitution was present in the CDS. Of 11 contigs containing potential 
amino acid substitutions, six contained hidden polymorphisms (frequency threshold 0.05), four 
of which result in non-synonymous substitutions in the mature peptide region (Appendix III). 
Interestingly, of the five additional toxin isoforms identified by re-examining mapped reads, 
only one matched an amino acid substitution suggested by our proteomic data 
(TR135650_c2_g2_i1_CDS2; similar to t-stichotoxin-Hcr2b). It is also interesting to note that 
while the BBH-encoding contig corresponding to the toxin identified in the venom contained 
an additional sequence with two polymorphic nucleotide sites, their amino acid sequences were 
identical.  
 
Table 2.3 – Most highly expressed transcripts identified in milked venom. Ten most highly expressed toxin 
candidates identified from proteomic analysis of S. haddoni venom. Expression levels are shown as ‘transcripts 
per million’ (TPM) for each contig. The accession code and E-value are given for the best UniProt BLAST hit. 
Transcript ID TPM 
UniProt 
hit 
Family E-value 
TR129689_c0_g1_i2_CDS3 4048 B2G331 Kunitz-type 1E-42 
TR138219_c4_g1_i1_CDS10 2518 R4ZCU1 
Boundless β-
hairpin 
2E-10 
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To investigate the full diversity of each toxin family identified in milked S. haddoni venom, 
we conducted a BLAST search with each identified coding sequence against the transcriptome. 
This revealed that the known toxin families with the greatest number of unique homologues 
identified in the venom were Kunitz-type (16 homologues), β-defensins (11 homologues) and 
S1 peptidase (16 homologues) (Figure 2.3). The majority of transcripts in each of these families 
were, however, not identified in the milked venom, perhaps indicating that some homologues 
are not venom toxins. Identification of related house-keeping proteins is also a likely scenario 
for CAP proteins and S1 peptidases, where only one and two out of 14 and 16 homologues, 
respectively, were identified in the venom. 
 
TR130412_c0_g1_i1_CDS3 1777 Q76CA0 β-defensin 2E-56 
TR135650_c2_g5_i1_CDS2 1188 B2G331 Kunitz-type 4E-43 
TR135650_c2_g2_i1_CDS2 1166 B2G331 Kunitz-type 9E-43 
TR135650_c2_g6_i1_CDS2 508 B2G331 Kunitz-type 1E-42 
TR104378_c2_g2_i2_CDS3 501 Q9U6X1 
Cytolysin type 
2 
4E-139 
TR69080_c0_g1_i1_CDS11 437 B1B5J0 EGF-like 3E-59 
TR135650_c2_g8_i1_CDS2 370 B2G331 Kunitz-type 8E-36 
TR72284_c0_g1_i1_CDS4 307 A7RMN1 
Sea anemone 
KV type 5 
1E-19 
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Figure 2.3 – Diversity of putative toxins detected in, or absent from, the venom of S. haddoni. Histogram of 
unique protein sequences within each toxin family identified in the transcriptome that were (black) or were not 
(grey) identified in proteomic analyses of milked venom. Putative toxin families U1-Std to U12-Std are new 
scaffolds as described in Table 2.2. 
 
In addition to the hits obtained from the UniProt toxin database, 12 protein families could not 
be assigned a putative function or known family. They were named with a U prefix (U = 
unknown) followed by a subscripted number to indicate the family, then a genus/species 
identifier (Std) to indicate that they the toxins are from S. haddoni (33). All of these novel 
peptide and protein families are cysteine-rich, and the number of cysteines, cystine scaffold, 
and predicted length of the mature peptide are summarized in Table 2.2 (Appendix IV). 
Interestingly, toxins U1–U8 were exclusively found in the venom, with no additional non-
venom homologues recovered by retrospective BLAST searches of the transcriptomic data 
(Figure 2.3). These families also included all the novel peptide scaffolds with predicted 
molecular weight below 10 kDa, suggesting that these are indeed likely novel toxins and not 
housekeeping peptides. 
Although many of the toxin families identified in the venom had highly expressed 
representatives, we did not find that the putative toxins identified in the venom consistently 
had higher expression levels than their homologues that were not identified in the venom 
(Figure 2.4). Moreover, the five most abundantly expressed putative toxins (i.e., β-defensin, 
sea anemone 8 toxin family, Kunitz-type, cephalotoxin, and FBG domain proteins) were not 
detected in the venom (Table 2.3Table 2.4). This included the two most highly expressed forms 
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of two families in the venom. Interestingly, all homologues of the boundless β-hairpin, EGF-
like, KV type 4 and 5, U1- to U8-Std, U10-Std, and U12-Std toxins were identified in our 
proteomic analyses. 
 
Figure 2.4 – Transcript expression levels for putative toxins detected in, or absent from, S. haddoni venom. 
Expression levels (‘transcripts per million’) are shown as box plots for each toxin family. 
 
Table 2.4 – Toxin homologues not detected in the venom proteome. Ten most highly expressed putative toxins 
with homology to sequences identified in the venom of S. haddoni. Expression levels are shown as ‘transcripts 
per million’ (TPM) for each contig. The accession code and E-value are given for the best UniProt BLAST hit. 
Transcript ID TPM UniProt hit Family E-value 
TR139525_c0_g5_i1_CDS4 11699 P0DMX5 β-defensin 8E-20 
TR121578_c2_g1_i1_CDS2 6421 C0HJF3 Kunitz-type 3E-16 
TR90837_c2_g2_i2_CDS3 3681 P0DMX5OS β-defensin 3E-20 
TR90837_c2_g2_i1_CDS3 1788 P0DMX5 β-defensin 8E-20 
TR90837_c2_g3_i1_CDS3 1075 P0DMX5 β-defensin 3E-19 
TR88713_c0_g1_i2_CDS15 389 P35778 CAP 1E-13 
TR145129_c1_g1_i2_CDS8 295 P0DN15 Kunitz-type 6E-32 
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TR105531_c0_g1_i1_CDS2 253 Q58L93 S1 peptidase 5E-41 
TR145129_c1_g1_i1_CDS8 243 P0DN15 Kunitz-type 8E-35 
TR124024_c0_g3_i1_CDS4 237 A6MFK8 S1 peptidase 2E-35 
 
2.4 Discussion 
This study has provided the first holistic overview of sea anemone venom. In contrast to 
previous work that employed an exclusively transcriptomic approach to identify toxin-like 
sequences (170, 177), the current study highlights the importance of combing this information 
with proteomic data to access the complete venom composition. Homology-based annotation 
of toxins from transcriptomic and genomic data is insufficient for providing a full picture of 
the venom arsenal (219) as it is inherently limited to finding candidates with significant 
sequence homology to known toxins, and it is prone to false positives because toxins evolve 
from housekeeping proteins and will often show significant homology to conserved ancestral 
sequences. Proteomics data is therefore essential to determine which proteins can be reliably 
identified as toxins. 
The importance of incorporating proteomic data is evident from the mismatch in both the 
number and types of putative toxin families identified from our homology-based annotation 
versus the combined transcriptomic/proteomic data. The only previous example of a combined 
proteomic/transcriptomic approach to study sea anemone venom was reported by Rodríguez 
and colleagues (168). However, this study focussed on the mass fingerprint of the neurotoxic 
fraction and did not detail other classes of proteins present in the venom. This is the first time, 
to our knowledge, that deep proteomics of sea anemone venom has been used in combination 
with transcriptomics to identify venom constituents. Remarkably, this approach led to the 
discovery of 12 entirely novel protein families in the venom of a species belonging to a genus 
whose venom has been studied for over a century. 
As mentioned above, identifying putative toxins from sequence homology is complicated by 
the fact that toxins typically evolve from proteins with functions unrelated to envenomation 
(215). This is particularly problematic for cnidarians because transcriptome data obtained from 
tentacles or whole body contains transcripts from tissues not specifically involved in venom 
production. One approach to circumvent this problem is to use gene family size to identify 
toxin sequences based on the rationale that large gene families result from the positive selection 
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by which toxins are initially thought to evolve (212, 215, 220). Transcript expression levels 
could also potentially be used to identify putative toxins based on the observation that toxin 
genes are more highly expressed in venom glands that are actively engaged in the process of 
venom regeneration compared to those that are replete (221). 
Application of these two approaches to determine the composition of S. haddoni venom yielded 
substantially different predicted venom profiles. Based on toxin family size, the venom of 
S. haddoni is primarily composed of proteins with enzymatic activity. In contrast, based on 
transcript expression levels, the venom is mainly composed of peptides with neurotoxic 
activity. Since mRNA was extracted from tentacles engaged in venom regeneration, we would 
expect transcripts encoding venom constituents to be highly expressed. Indeed, this hypothesis 
is supported by our proteomic data, which indicate that neurotoxic peptides constitute the 
dominant fraction of S. haddoni venom. However, in contrast with previous studies of snakes 
and venomous arthropods (222), we did not find that expression level was a reliable indicator 
of which members of each toxin family are actually present in the venom. Although the 
detection limits of our proteomic methods could be a potential explanation, we detected 
neurotoxins expressed at very low levels in the milked venom (Figure 2.4). The lack of a 
discrete, dissectible venom-producing tissue is therefore one possible explanation for the 
apparent conflict between our findings and previous work (222). While our transcriptomic data 
was based on extracts from tentacles only, nematocytes are not restricted to sea anemone 
tentacles but rather are found throughout ectoderm-associated organs, some of which are 
known to have different toxin expression profiles  
Another potential explanation for the discrepancy between detected venom components and 
their expression levels could be related to the process of venom regeneration in sea anemones, 
which remains largely uncharacterized. Surprisingly, only one RNAseq-based study of sea 
anemone venoms has so far specifically selected specimens actively engaged in venom 
regeneration (170), while none have considered the effect of regenerative states when assessing 
putative toxin expression levels. In fact, although the morphogenesis of nematocysts is well 
described (12, 223), the regeneration of sea anemone toxins is not. This study is the first to 
consider the regenerative state of the sea anemone venom system, and we obtained preliminary 
data (not shown) indicating that these cnidarians are actively engaged in toxin regeneration 72 
h after venom by electrostimulation. However, further studies are required to more fully define 
the dynamics of toxin-gene expression after venom depletion. It is also important to point out 
that although our data did not include biological or technical replicates, this is also the case for 
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the majority of NGS-based venomics studies. Our data thus present a tale of caution, and 
strongly suggest that the commonly employed search-based and NGS-based gene expression 
level estimation approaches to identify sea anemone toxins from NGS-sequenced 
transcriptomic data alone may not provide an accurate reflection of the venom profile. 
A large number of housekeeping proteins were identified in this study, consistent with previous 
work on cnidarians (178, 224, 225) This is because venom extraction via electrical stimulation 
is likely to induce nematocyst rupture, leading to release of cellular contents into the medium. 
Despite this downside of this method, it is still likely to be one of the “cleanest” methodologies 
for obtaining a complete venom profile. While nematocyst purification (53, 54) excludes 
venom components secreted from gland cells, other methodologies such as whole-tissue 
homogenisation or immersion in distilled water or alcohol leads to massive contamination with 
body proteins not associated with venom due to large-scale cell lysis (163). Although a 
common strategy used to eliminate structural proteins is to require the presence of a signal 
peptide, all structural nematocyst components, such as minicollagens and nematogalectins, 
carry signal peptides with similar motifs to those of toxin transcripts (12, 167, 226). 
Minicollagens in particular also contain cysteine-rich domains with cysteine-patterns that are 
reminiscent of disulfide-rich peptide toxins (12). However, minicollagens also contain 
characteristic Gly-X-Y repeats, which were absent in all novel putative toxins identified in this 
study. Moreover, nematocyst structural proteins have been characterised in detail in the starlet 
sea anemone Nematostella vectensis (53), and any that remain after our centrifugation and 
filtration steps are likely to be sufficiently conserved for identification by BLAST annotation.  
Among the proteins we identified in the venom of S. haddoni, twelve families could not be 
assigned a putative function or protein/peptide family as they have not been previously 
described from any other animal venom. Even though some of the unknown putative toxin 
families are relatively highly expressed, they could not be detected without including 
proteomic evidence. Moreover, some of these families, such as U11-Std, are among the main 
components of the venom of S. haddoni. This highlights the power of combining transcriptomic 
data with proteomic techniques not just for detecting novel bioactive proteins and peptides, but 
also for contributing towards an understanding of the function and evolution of venoms through 
a more complete description of their contents. 
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2.5 Conclusions 
This study represents the first holistic approach to characterising the venom arsenal of a sea 
anemone, and it highlights how little we still know about sea anemone venoms despite decades 
of research. The discovery of 12 entirely new protein families in a genus of anemones that have 
been studied for over a century underscores the power of combining proteomic and 
transcriptomic data when investigating animal venoms. Although there is still much to learn 
about the composition of sea anemone venoms and the role of individual venom components 
in prey capture, defence and intraspecific competition, this work provides a solid foundation 
for future research into the ecology and evolution of these venoms (219). However, much work 
will be required to understand the function of individual venom proteins and peptides, and how 
they contribute to the overall envenomation process. 
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Evolution of the sea anemone venom arsenal 
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Abstract 
Venoms are among nature’s most complex cocktails that are characterised by a diversity of 
molecules, such as large proteins, small peptides, polyamines, and salts, which disrupt the 
physiology of prey animals upon injection. Several gene families encoding venom components 
have been subjected to extensive duplication and have evolved under the influence of positive 
(diversifying) selection. The phylum Cnidaria (sea anemones, jellyfish, corals, sea pens and 
hydroids) is the oldest known venomous animal lineage (~750 million years old). More than a 
century of research on sea anemone venoms as a potential source of novel bioactive 
therapeutics has shown that they contain a diversity of biologically active proteins and peptides. 
However, recent omics studies have revealed that much of the venom proteome remains 
unexplored and that the diversification and molecular evolutionary regimes of toxins encoded 
by these fascinating and ancient animals remain poorly understood. Here, we present the most 
comprehensive insight into the composition and evolution of sea anemone venoms to date. We 
used combined transcriptomic and proteomic data of milked venom from five genera of sea 
anemones to further interrogate previously published transcriptomes from an additional eight 
taxonomically diverse species of sea anemone. Our results reveal more than 1500 unique toxin-
like sequences which were grouped into 38 families. 20 of these 38 families had no blast 
homology to any known protein and peptide family. The presence of a wide range of novel 
proteins and peptides families discovered here highlights these animals as a rich source of novel 
bioactive molecules. Moreover, phylogenetic reconstruction shows fascinating insights into the 
evolutionary origin and diversification of sea anemone toxin. 
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3.1 Introduction 
Venoms are among nature's most complex cocktails and are characterized by a diversity of 
molecules, including large proteins, small peptides, polyamines, and salts, which disrupt the 
physiology of prey animals upon injection (215) Because of their key roles in many inter- and 
intra-specific interactions between animals, venom toxins have independently evolved several 
times across diverse animal lineages, resulting in toxins targeting a variety of functionally 
important protein complexes and macromolecules involved in cellular homeostasis (215).  
Cnidaria is believed to be one of the most ancient venomous eumetazoan lineages, having 
evolved since Neoproterozoic times, 650 million years ago, long before the Cambrian 
radiation (227). There has been resurgence in interest surrounding the nature and evolutionary 
origins of cnidarian venom toxins because the impact on human health (228) and 
biotechnological potencial as source of new pharmacological tools and/or therapeutical leads 
(229). Because certain cnidarians serve pivotal ecological roles and are important model 
organisms in the field of evolutionary developmental biology, genomic and transcriptomic data 
for several cnidarian species have been rapidly accumulating in recent times (85, 230, 231). 
However, proteomic data from cnidarian venoms remains scarce. This is particularly 
problematic for cnidarians because transcriptome data obtained from tentacles or whole body 
contains transcripts from tissues not specifically involved in venom production. As shown in 
Chapter 2, homology-based annotation of toxins from transcriptomic and genomic data is 
insufficient for providing a complete picture of the venom arsenal, as it is inherently limited to 
finding candidates with significant sequence homology to known toxins. In addition, purely 
homology-based methods are prone to false positives due to the fact that toxins typically evolve 
from proteins with functions unrelated to envenomation.  
Sea anemones (Anthozoa) are benthic, sessile cnidarians that use venom for a wide variety of 
functions, such as prey capture, defence, digestion, and inter- and intraspecific competition. As 
a result of hundreds of millions of years of evolution (232-234), and probably also the diversity 
of roles that venom plays, sea anemones have evolved a rich variety of biologically active 
compounds (148, 235). They also appear to be unique among cnidarians in having a venom 
that is rich in peptide toxins (54). This has made sea anemones particularly attractive to drug 
discovery efforts, as evident from the decades of research into the structure and function of sea 
anemone toxins (236). However, despite the long history of biomedical research into sea 
anemone venoms, there is a striking lack of non-activity guided studies on their composition. 
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Reflecting this, sea anemone venoms are in fact rich in peptides and proteins that bear no 
resemblance to any known protein and peptide family (Chapter 2). This wealth of unknown 
structural folds and pharmacological properties, combined with an overall poorly sampled 
taxonomic lineage, limits our understanding of the evolution of sea anemone toxins. 
In this study, we provide the first comprehensive and detailed insight into the evolution of sea 
anemone venom. To access the composition of milked venom from five sea anemone species, 
we used a combination of transcriptomic and proteomic techniques. This approach created an 
accurate and comprehensive list of venom components, and we used this data to identify toxin 
orthologues in an additional eight sea anemone transcriptomes selected from a broad taxon 
sample in order to more accurately identify toxin recruitment and evolutionary events. Our 
results confirm previous findings of dynamic evolution in cnidarian venoms and reveal a 
complex picture of both ancient and lineage-specific recruitments and functional radiations 
among sea anemone toxins.  
 
3.2 Results and Discussion 
To identify the proteins and peptides present in milked venom of A. pulchella, A. tenbrosa, H. 
malu, M. doorensis and S. haddoni, we used a combination of transcriptomics and 2DE and 
shotgun analyses of crude and RP-HPLC fractionated venom (Figure 3.1, methods section for 
transcriptome assembly details). We used next-generation sequencing of poly-A enriched RNA 
extracted from tentacles that were actively regenerating their venom to investigate the diversity 
of toxin-like sequences in sea anemone venom. De novo assembly with Trinity yielded 157,354 
contigs in A. pulchella, 87,485 in A. tenebrosa, 304,320 in H. malu, and 303,941 in M. 
doorensis. The contigs were translated to all possible coding sequences, resulting in 1,108,098 
amino acid sequences in A. pulchella, 457,470 in A. tenebrosa, 2,141,382 in H. malu, and 
2,296,168 in M. doorensis. S. haddoni results presented here were obtained previously on 
chapter 2 but included in this chapter as comparison. Our RP-HPLC fractionation and 2DE gel 
revealed a complex set of both low and high molecular weight proteins, and the toxin types 
present in the milked venom of each species are summarized in Table 3.1. The final set of 
potential toxins identified in the milked venoms included 18 known toxin families and 20 
protein families that could not be assigned a putative function or known family, 12 of which 
were identified previously. These were label as U, referring to unknown, followed by a number. 
Moreover, the numbering order was organised according to the number of cysteines in the 
 53 
mature peptide, where U1 has only 2 cysteine residues and U20 has 20. All the potential toxins 
were combined with all sea anemone toxins in UniProt (96) to generate a comprehensive 
database of confidently annotated sea anemone venom components. 
Even though the present chapter is the first comprehensive insight into toxin recruitment events 
across a wide range of sea anemone taxa, most of the species used for proteomics analyses 
belong to the superfamily Actinioidea, with only one species from Metridioidea included in 
the study. Actinioidea is a larger group and easier to collect, which had an impact in the choice 
of the species. Thus, some ascertainment bias might exist in the present dataset. Another fact 
to be consider is the venom profile across the life cycle. The results presented in this chapter 
were obtained from adult animals. Columbus-Shenkar and colleagues (237) showed that 
different toxins can be presented in different stages of life. Unfortunately, we could not cover 
this topic in this study, and the venom proteome might more diverse than here reported. 
Although outside the scope of this thesis, this would be an interesting topic for a future study. 
To investigate the full diversity of each toxin family identified in our proteomic data and also 
to have information of venom composition in different species, we conducted a BLAST search 
with the custom database against the transcriptomes of an additional eight species across the 
Actiniaria phylogenetic tree (see materials and methods section), as well as those used for 
proteomic characterisation of milked venom. Sea anemone toxins can be classified into three 
major functional groups, which are neurotoxins, enzymes and pore-forming toxins Figure 3.2. 
However, the 20 families of previously undescribed putative protein and peptide toxin families 
may or may not belong to one of these categories require further characterization to confirm if 
sea anemone venom components can still be categorised into only these three broad functional 
groups. 
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Figure 3.1 — Proteomic analyses of five sea anemone venoms. Composition of venom obtained by 
electrostimulation is show as rpHPLC chromatrogams (left) and 2D-PAGE gels (right) for A) Aiptasia pulchella, 
B) Actinia tenebrosa, C) Heteractis malu, and D) Macrodactyla doorensis, as well as E) Stichodactila haddoni 
for comparison (see Chapter 2). For 2DE gels the Isoelectric point (pI) is indicated above and molecular weight 
(kDa) on the right of each gel.  
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Table 3.1 — Summary of protein families in proteomics of sea anemone venoms. Table shows in which 
species in this study was identified the toxin families listed. 
Family A. pulchella A. tenebrosa H. malu M. doorensis S. haddoni 
Acrorhagin  x    
Actinoporin  x    
BBH-like     x 
Defensin-like x x x  x 
EGF-like  x   x 
ICK-like  x  x x 
Kazal-like domain x     
Kunitz-type  x  x x 
Kv type5  x  x x 
PLA2  x    
SCRiP    x  
Sea Anemone 8   x   
ShK-like  x x x  
Peptidase S1     x 
Peptidase M12      
FactorV-like x x    
U1  x x   
U2  x x   
U3 (U1Shd)     x 
U4 x     
U5 (U1Shd)     x 
U6 x     
U7 (U4Shd) x    x 
U8 (U5Shd)     x 
U9 (U6Shd) x    x 
U10   x   
U11 (U7&8Shd)     x 
U12    x  
U13    x  
U14  x  x  
U15 (U9Shd)     x 
U16  x x x  
U17    x  
U18 (U11Shd)     x 
U19 x     
U20 (U12Shd)     x 
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Figure 3.2 – Putative broad functional venom profiles of sea anemones. Putative toxins identified in 
transcriptomes of sea anemones based on our proteomics database. Putative neurotoxins are cysteine-rich venom 
peptides related to known neurotoxic sea anemone. Total number of homologues identified is shown. 
 
Neurotoxins are the major component in sea anemone venoms (Figure 3.2). This is perhaps not 
surprising given the predominantly sessile natural history of sea anemones, most of them spend 
the adult life attached to a surface, such as rocks and/or sediment. Because of that, they rely on 
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the neurotoxic effect of their venom to paralyse and kill prey and also for defence from 
predators (237). Interestingly, the venom of Nematostella vectensis, sister to other sea anemone 
groups, appears to be just composed by enzymes and neurotoxins, and entirely lacking in 
cytolysins (Figure 3.2). Furthermore, this is one of the species with the least number of toxins 
and putative toxin orthologues identified, and we did not find any representatives of any of the 
new unknown putative toxins. In contrast, a substantial fraction of the venom components (13-
35%) in the other species are completely novel (Figure 3.2).  
The sea anemones with greatest number of toxins identified were S. haddoni (320 unique 
sequences), H. malu (216 unique sequences) and M. doorensis (203 unique sequences) (Figure 
3.2). Curiously, these sea anemones have similar ecology and live in association with 
anemonefishes. For establishment and maintenance of this symbiotic relationship, sea 
anemones have to offer potential fitness benefits to the anemonefish and also the other way 
around (238). Anemonefish defends the anemone from its predators and parasites (239). Also, 
sea anemones can benefit of nutrients from the anemonefish's excrement (240). In the other 
hand, sea anemones offer protection to anemonefishes by living within the stinging tentacles 
(241). If toxicity of its venom is too low, anemonefish will not be able to obtain the benefits 
from the association. Moreover, to maximize fitness, anemonefish should choose anemone 
hosts that provide them with the highest quality refuge at the lowest cost to themselves with 
respect to physiological expenditure. These factors could bring extra complexity to the venom 
arsenal of these sea anemones.  
Another factor for the venom of S. haddoni, H. malu and M. doorensis be more diverse than 
the other species studied in this chapter could be the lack of behavioural defence. High 
predation pressure in the marine environment brings strong selective pressure on sessile or 
slow-moving organisms to evolve defence mechanisms. Chemical defence, behavioural 
defence, and a symbiotic partner that provides protection are the main defence strategies which 
sea anemones possess. These strategies can or may not be mutually exclusive. Usually, there 
is an inverse correlation between chemical and behavioural defence. Sea anemones with the 
ability to defend themselves by completely burrow into the sediment do not rely as much on 
the chemical defence as the ones that do not present this behaviour. In this case, the higher 
number of toxins identified in S. haddoni, H. malu and M. doorensis may be sufficient as a 
defence strategy against predators so that withdrawal under the sediment is not required. 
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3.2.1 Neurotoxins 
As mentioned above, the putative toxins with the greatest number of homologues identified by 
BLAST searches were neurotoxins. The final set of potential neurotoxins identified across all 
species studied here were Acrorhagin (28 homologues), ATXIII (7 homologues), BBH-like (53 
homologues), b-defensin-like (151 homologues), EGF-like (16 homologues), ICK-like (194 
homologues), Kazal-like (17 homologues), Kunitz-like (177 homologues), KV type 5 sea 
anemone toxins (12 homologues), SCRiP (30 homologues), Sea anemone 8 (81 homologues) 
and Shk-like (56 homologues) (Figure 3.3). In total, more than eight hundred unique CDSs of 
neurotoxin-like peptides were identified.  
 
Figure 3.3 — Venom neurotoxin scaffold (family) diversity across sea anemones. Function annotation of the 
unique CDSs identified by BLAST search using our proteomics database. Identical sequences were removed using 
CD-HIT. Species were abbreviated according to Oliveira and colleagues (33). Each species is indicated by a 
number and colour as shown in the key at right side. 
 
To have insights about toxin recruitment, we summarise the phylogenetic distribution of the 
neurotoxins in Figure 3.4. ICK-like, Kunitz-like and b-Defensin-like were recruited early in 
evolution and all species studied here have these scaffolds in their venom. Five neurotoxin 
types were identified in the venom of the suborder Edwardsiidae (N. vectensis): ICK-like, 
Kunitz-like, b-Defensin-like, Kazal-like, and KV type 5 sea anemone toxins. Sea anemone 
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family 8 and ShK-like were recruited early in the evolution of Enthemonae suborder. 
Acrorhagin and BBH-like also could have appeared early in the evolution of Enthemonae 
suborder but Acrorhagin was lost in the Aiptasiidae family and BBH-like in some of its species. 
So far only four Acrorhagin-like toxins were reported to be presented in sea anemone venom 
(169). They were discovered in the acrorhagi of the same species. However, here we found 
Acrorhagin-like toxins in species which do not have acrorhagi, suggesting this family is not 
exclusive in Acrorhagi nematocytes.   SCRiP was just recruited by a branch of the family 
Actiniidae. A secondary loss of Kv type 5 and BBH-like is likely to happen in the general 
Bolocera, Urticina, and Epiactis. Similar event apparently happened for EGF-like for some 
species in Enthemonae suborder. ATXIII homologues were just found in two species, both 
from the superfamily Actinioidea (A. viridis and S. haddoni), suggesting this is a recent 
recruitment. Below the three most abundant scaffolds will be described in more details.  
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Figure 3.4 — Phylogenetic distribution of neurotoxins families in sea anemones. A representative 
phylogenetic tree of the species included in this study, showing the phylogenetic distribution of neurotoxin 
families as their earliest respective recruitments.   
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3.2.1.1 ICK-like 
The ICK fold is probably the most widely recruited peptide-fold in animal venoms. This 
frequent “weaponization” is probably attributable to both the stability and evolutionary 
plasticity of the ICK fold (242). ICK toxins are particularly diverse in spider venoms but this 
scaffold is also present in the venoms of scorpions (243), assassin bugs (244), cone snails (245), 
tick saliva (246). Moreover, putative ICK toxins have been identiﬁed in the venoms of ants 
(247), remipedes (248) and centipedes (249). Although the 3D structure of sea anemone ICK 
peptides remain to be confirmed, a toxin displaying cysteine pattern characteristic of the ICK 
structural scaffold, namely PhcrTx1 (p-phymatoxin-Pcf1a) were reported (88). This toxin 
reversibly inhibits acid-sensing ion channels (ASIC) in rat dorsal root ganglia neurons 
(IC50=100 nM). 
In the present work, we found 194 unique sequences with classic cysteine pattern characteristic 
of the ICK signature. Surprisingly, ICK motive is present in the venom of all species analysed 
and it is the scaffold with greatest number of homologues identified. Unfortunately, not enough 
data is available to gain insights of the functional evolution of this structural motif in sea 
anemone venoms. However, the diversity of sea anemone ICKs suggests they interact with a 
range of molecular targets (Figure 3.5). It will be interesting to search for ICK motif outside 
the order Actiniaria to examine its prevalence and evolution in Cnidarians. 
In view of the fact that KV type 5 sea anemone toxins has similar cysteine framework as ICK 
with an extra disulfide bond (242) (C-C-CC-C-C-C-C), we included these in our phylogenetic 
analyses (Figure 3.5). KV type 5 form a distinct clade and is likely evolved from a classic ICK 
signature.  
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Figure 3.5 — Phylogenetic reconstruction of ICK homologues in sea 
anemone venoms. Maximum-likelihood unrooted tree was calculated using 
IQ-Tree, bootstrap support values above 50 are shown at each node, while 
noes with support of 50 or less have been collapsed. Scale bar indicates 
genetic distance under the VT+I+G4 model, which was the best fit model 
according to Bayesian information criterion (BIC). 
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3.2.1.2 Kunitz-like 
Sea anemone toxins with Kunitz-type motif consists of peptides of ~60 amino acid residues 
stabilized by three disulfide bridges (C1–C6, C2–C4, C3–C5). Its 3D structure is characterized 
by an α/β/α motif with a hydrophobic core (144). The peptides of this family have an ancient 
Kunitz fold and some of them are characterized by a unique and intriguing feature of dual 
functionality since they inhibit both proteases and ion channels (27, 250). It has been 
hypothesised that Kunitz peptides in sea anemone venom protect toxins from protease 
degradation during storage but are also paralyze prey through inhibition of ion channels (214). 
Supporting the notion that Kunitz-like toxins are important constituents of sea anemone 
venoms, this is the second most abundant structural motif recruited among the sea anemone 
neurotoxins, with 177 unique sequences identified.  
Phylogenetic analysis of the Kunitz-like toxins found here in addition to the ones already 
submitted at Uniprot database, suggests this family was recruited prior to the split of 
Enthemonae and Edwardsiidae (Figure 3.4). In fact, a recent study discovered kunitz-like 
peptides in the zoanthid Palythoa caribaeorum through transcriptome sequencing (251). This 
suggests an early recruitment in the subclass Hexacorallia, however the lack of research on 
octocorallians venoms prevents us from determining if Kunitz-like toxins were recruited before 
Anthozoans split in these subclasses. 
Since the Kunitz-like toxins appeared in sea anemones, substantial diversification happened. 
Phylogenetic analysis (Figure 3.6) suggests this family original function was protease inhibitor 
of trypsin. This is also a known activity for non-toxin Kunitz-peptides (214). Later on, it 
diversified its function to inhibit other proteases (e.g. serine, cysteine, and aspartic proteinases) 
and the function to inhibit ion channels was acquired. After the ability to block KV1 was 
recruited, it was followed by explosive diversification. This confirms that blocking KV 
channels is a successful strategy for prey capture and defence in sea anemone venoms. Even 
though Kunitz-like peptides are a well-studied sea anemone toxin family, our analysis shows 
there is a large clade of functionally uncharacterised peptides in this family, demonstrating the 
discovery potential even among peptides in relatively well characterised toxin families. 
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Figure 3.6 — Phylogenetic reconstruction of 
Kunitz-like peptides in sea anemone venoms. 
Maximum-likelihood unrooted tree was 
calculated using IQ-Tree, bootstrap support 
values above 50 are shown at each node, while 
noes with support of 50 or less have been 
collapsed. Scale bar indicates genetic distance 
under the VT+R5 model, which was the best fit 
model according to BIC. 
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3.2.1.3 b-Defensin-like 
β-Defensins are antimicrobial peptides that are secreted as part of the innate immune response 
in a wide range of taxa (101, 102). However, in sea anemone venoms, β-defensin-like peptides 
have become weaponized to serve as neurotoxins that modify the activity of voltage- and 
ligand-gated ion channels; this family of peptides includes KV type 3, NaV type 1, 2 and 4 and 
ASIC toxins (103-106). The pharmacological diversity in this neurotoxic lineage is probably 
reflective of an adaptive radiation a and also due the early recruitment. This scaffold is present 
in all sea anemones venoms studied here and it is the third most abundant peptide motif, with 
151 unique sequences identified. It is important to also note that although there are more than 
a hundred sequences deposit at Uniprot database, the target of the vast majority (56 out of 102 
toxins) was assumed by similarity with other toxins. This is a distinction that is critical to be 
able to accurately infer the evolutionary history of this family. Nevertheless, phylogenetic 
analysis of this family suggests KV blockers and NaV modulators are predominantly found in 
different clades (Figure 3.7). These findings differ from those of Jouiaei and colleagues (162), 
who proposed that a subset of sodium channel targeting toxins experienced episodic bursts of 
adaptive selection in Actinioidea and accumulated mutations at an elevated rate, resulting in 
the origination of a novel toxin type that can target potassium ion channels. A critical factor 
was they failed to find homologues of β-defensins which blocks KV channels in sea anemone 
transcriptomes outside Actinioidea (Nematostella vectensis (252), Edwardsiella lineate (253), 
Metridium senile and A. pallida (254)). In contrast, we found in three non-actinoidean species.  
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Figure 3.7 — Phylogenetic reconstruction of b-
Defensin-like peptides in sea anemone venoms. 
Maximum-likelihood unrooted tree was calculated using 
IQ-Tree, bootstrap support values above 50 are shown at 
each node, while noes with support of 50 or less have 
been collapsed. Scale bar indicates genetic distance 
under the VT+R5 model, which was the best fit model 
according to BIC. 
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3.2.2 Pore-forming toxins 
Cytolysins are a group of sea anemone toxins that form pores in cell membranes, and therefore 
belong to a larger group of ‘pore forming toxins’ (PFTs) (44). So far, sea anemone PFTs can 
be classified in five types. We only found actinoporins in our proteomics data (type II). 
Actinoporins are one of the better characterized PFTs from sea anemone venoms. These 
proteins form a pore in cellular membranes containing sphingomyelin. Actinoporins are 
comprised of a single domain (~20 kDa), lack cysteine residues, and are equipped with 
functionally important regions conserved throughout the toxin gene family (50, 59). Our finds 
suggest actinoporin homologues are only present in the venom of Actinioidea (Figure 3.8 and 
Figure 3.9). Recently, the evolution and identification of possible functionally important 
residues of actinoporins were extensively studied by Macrander & Daly (255). Our results 
confirm their finding that no candidate actinoporins were present in either of the two examined 
edwardsioideans (Nematostella vectensis and Edwardsia elegans) (255). On the other hand, 
actinoporin-like toxins have been described in only one non-actiniarian species, Hydra 
magnipapillata (256), making the evolutionary processes of actinoporin further complicated.  
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Figure 3.8 — Phylogenetic distribution of actinoporin and enzymes families in sea anemones. A 
representative phylogenetic tree of the species included in this study, showing the phylogenetic distribution of 
actinoporin and enzyme families as their earliest respective recruitments. 
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Figure 3.9 — Venom pore-forming toxin and enzymes (family) diversity across sea anemones. 
 
3.2.3 Enzymes 
It is believed that enzymes play a major hole in sea anemone venoms to help in defence, prey 
capture and digestion (148). However, there is a large discrepancy between the types of 
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enzymes reported from transcriptomic studies of sea anemones with those reported from 
studies on milked venom. As previously mentioned, sea anemones do not have a centralised 
venom gland, and it is therefore difficult to use transcriptomic techniques to distinguish 
between enzymes that have housekeeping roles and those that play a role in envenomation. 
This makes the present work important to identify which families of enzymes are actually 
venom constituent. Five families of enzymes were found in our proteomics data and also across 
the species in analyses (Figure 3.9). They are PLA2, venom prothrombin activator, peptidase 
S1, peptidase M12 and factor V-like. PLA2, factor V-like, peptidase S1 and M12 are widely 
distributed, being present in both Enthemonae and Edwardsiidae suborder (Figure 3.8). This 
suggests an early recruitment before these suborders split. Venom prothrombin activator was 
found only in Actinoidea. Unfortunately, activity data is really scarce to give support for further 
phylogenetic analyses. 
 
3.2.4 Venom components without BLAST homology 
In total, 399 unique sequences with no blast homology were found (Figure 3.10). These were 
organised in 20 families, many of which were both abundant and diverse. All of these novel 
peptide and protein families are cysteine-rich (Figure 3.12Figure 3.13). This highlights the 
power of combining transcriptomic data with proteomic techniques not just for detecting novel 
bioactive proteins and peptides, but also for contributing towards an understanding of the 
function and evolution of venoms through a more complete description of their contents. The 
3 most abundant families were U2, U11 and U15, with 41, 45 and 48 unique sequences 
identified across all species, respectively (Figure 3.10). These families are present in almost all 
species of Enthemonae suborder, suggesting they share an ancestor. Characterization of these 
new families is essential for better classification and further phylogenetic analysis.  
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Figure 3.10 — Diversity of proteins with no blast homology across sea anemones. 
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Figure 3.11 — Phylogenetic distribution of proteins with no blast homologies in sea anemones. A 
representative phylogenetic tree of the species included in this study, showing the phylogenetic distribution of 
these novel families. A Families U1 to U10, and in B Families from U11 to U20. 
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Figure 3.12 — Representative sequence of proteins with no blast homology. Alignment of representative 
sequences of U1 to U10. 
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Figure 3.13 — Representative sequence of proteins with no blast homology. Alignment of representative 
sequences of U11 to U20. 
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3.3 Conclusion 
This study has provided the first holistic overview of sea anemone venom composition and 
evolution. In contrast to previous work that employed an exclusively transcriptomic approach 
to identify toxin-like sequences, the current study highlights the importance of combing this 
information with proteomic data to access the complete venom composition. The importance 
of incorporating proteomic data is evident from the number of families with discovered. This 
approach led to the discovery of 20 entirely novel protein families and homologues in different 
species. 
Among the proteins we identified in the venom proteomics, twenty families could not be 
assigned a putative function or protein/peptide family as they have not been previously 
described from any other animal venom. Even though some of the unknown putative toxin 
families are relatively highly abundant and diverse, they could not be detected without 
including proteomic evidence. Moreover, some of these families, such as U11, are present in 
most of the venoms studied here. This highlights the power of combining transcriptomic data 
with proteomic techniques not just for detecting novel bioactive proteins and peptides, but also 
for contributing towards an understanding of the function and evolution of venoms through a 
more complete description of their contents. 
This study represents the first holistic approach to characterising the venom arsenal of a sea 
anemone, and it highlights how little we still know about sea anemone venoms despite decades 
of research. The discovery of 20 entirely new protein families underscores the power of 
combining proteomic and transcriptomic data when investigating animal venoms. Although 
there is still much to learn about the composition of sea anemone venoms and the role of 
individual venom components in prey capture, defence and intraspecific competition, this work 
provides a solid foundation for future research into the ecology and evolution of these venoms 
(219). However, much work will be required to understand the function of individual venom 
proteins and peptides, and how they contribute to the overall envenomation processes. 
Hopefully, our contribution will help spark a greater interest in ecological and evolutionary 
aspect of these venoms.  
 
 76 
3.4 Materials and methods 
3.4.1 Specimen and Venom Collection 
Sea anemones were collected at North Stradbroke Island, Queensland, Australia (27°15 S, 
153°15 E) then housed in aquaria at the University of Queensland. Venom was obtained after 
a starvation period of at least 48 h. Briefly, the sea anemone was rinsed, placed in a minimal 
volume of artificial seawater, and the nematocysts induced to discharge by electrical 
stimulation (179). The water, which contains the venom, was lyophilized and then the venom 
was desalted by dialysis at 4°C (Biotech Cellulose Ester membrane, 0.1–0.5 kDa cut-off; 
Spectrum Labs, USA). 
 
3.4.2 2DE Analysis 
Desalted venom (0.4 mg) was solubilized in 125 µL of DeStreak Rehydration Solution (GE 
Life Sciences, USA). The sample was mixed and centrifuged to pellet insoluble material, then 
1% Immobilized pH Gradient (IPG) buffer (pH 3–10 NL; GE Life Sciences) and 10 mM DTT 
were added to the supernatant before loading onto isoelectric focusing (IEF) strips (ReadyStrip, 
non-linear pH 3–10, 7 cm; Bio-Rad, USA) for 24 h passive rehydration. Proteins were 
electrophoresed in an Ettan IPGphor3 IEF system (GE Life Sciences, USA) under the 
following conditions: 100 V for 1 h, 300 V for 200 Volt-hours (V-h), 300 to 1000 V for 300 
V-h, 1000 to 5000 V for 4000 V-h, and 5000 V for 1250 V-h. The IPG strip was then 
equilibrated for 10 min in reducing equilibration buffer (50 mM Tris-HCl, pH 8.8, 6 M urea, 
2% SDS, 30% glycerol, 1.5% DTT) followed by a second incubation for 20 min in alkylating 
equilibration buffer (50 mM Tris-HCl, pH 8.8, 6 M urea, 2% SDS, 30% glycerol, 2% 
iodoacetamide). The IPG strip was then embedded on top of a 12.5% polyacrylamide gel 
(PowerPac Electrophoresis unit; Bio-Rad) and covered with 0.5% agarose. Second dimension 
electrophoresis was performed at 4°C for 1 h at 150 V per gel. The resulting gel was stained 
overnight with 0.2% colloidal Coomassie brilliant blue G250 (34% methanol, 3% phosphoric 
acid, 170 g/L ammonium sulfate, 1 g/L Coomassie blue G250), then destained in 1% acetic 
acid/H2O. Visible spots were subsequently picked from the gel and digested overnight at 37°C 
using sequencing-grade trypsin (Sigma, USA). Briefly, gel spots were washed with ultrapure 
water, destained (40 mM NH4CO3/50% acetonitrile (ACN)) and dehydrated (100% ACN). Gel 
spots were rehydrated in 10 µL of 20 µg/ml proteomics-grade trypsin (Sigma-Aldrich) and 
incubated overnight at 37°C. Digests were eluted by washing the gel spots for 30 min with 
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each of the following solutions: 50 µL 50% ACN/1% formic acid (FA), followed by 50 µL 
70% ACN/1% FA. The samples were then dried by evaporation using a vacuum centrifuge and 
reconstituted in 20 µL of 1% FA prior to analysis by LC-MS/MS. 
 
3.4.3 HPLC 
Reversed-phase (RP) HPLC analysis of crude venom was performed using a Shimadzu 
Prominence system. Venom (1 mg) was fractionated on a C18 column (4.6 × 250 mm, 5 µm 
particle size, 300 Å pore size) using a flow rate of 1 ml/min and the following gradient of 
solvent B (0.043% trifluoroacetic acid (TFA) in 90% ACN) in solvent A (0.043% TFA in 
water): 10% solvent B for 15 min, 10–65% solvent B over 50 min, 45–70% solvent B over 5 
min. Fractions were collected manually, dried by evaporation using a vacuum centrifuge, then 
prepared for LC-MS/MS analysis as described below. 
 
3.4.4 Protein identification using LC-MS/MS 
To identify proteins present in the milked venom we used a bottom-up proteomics approach to 
analyze the digested 2DE gel spots, RP-HPLC fractions, as well as crude desalted venom. 
Reduction and alkylation of cysteine residues in venom proteins and peptides was performed 
as reported previously (180). Reduced/alkylated venom was incubated overnight at 37°C in 
10 µL of 40 ng/µL proteomics-grade trypsin (Sigma) in 40 mM NH4CO3, pH 8. The digested 
reduced/alkylated samples were then resuspended in a final concentration of 1% FA and 
centrifuged for 15 min at 12,000 g prior to LC-MS/MS. For analysis of RP-HPLC fractions 
and in-gel digests, tryptic peptides were fractionated on an Agilent Zorbax stable-bond C18 
column (2.1 mm × 100 mm, 1.8 µm particle size, 300 Å pore size) using a flow rate of 180 
µl/min and a gradient of 1–40% solvent B (90% ACN, 0.1% FA) in 0.1% FA over 15 min on 
a Shimadzu Nexera UHPLC coupled with an AB SCIEX 5600 mass spectrometer equipped 
with a Turbo V ion source heated to 500°C. MS/MS spectra were acquired at a rate of 20 
scans/s, with accumulation time of 0.25 ms, resulting in a cycle time of 2.3 s, and optimized 
for high resolution. Precursor ions with m/z of 300–1,800 m/z, a charge of +2 to +5, and an 
intensity of at least 120 counts/s were selected, with a unit mass precursor ion inclusion window 
of ± 0.7 Da, and excluding isotopes within ±2 Da for MS/MS. The crude venom digest was 
analyzed as above except using a gradient of 1–40% solvent B (90% ACN, 0.1% FA) in 0.1% 
FA over 60 min. 
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Mass spectra were searched against predicted coding sequences (CDSs) from the assembled 
transcriptome (see below) using ProteinPilot v4.5 (AB SCIEX). Searches were run as thorough 
identification searches, specifying tryptic digestion and the alkylation reagent as appropriate. 
Biological modifications and amino acid substitutions were allowed in order to maximize the 
identification of protein sequences from the transcriptome despite the inherent variability of 
toxins, potential isoform mismatch with the transcriptomic data, and to account for 
experimental artifacts leading to chemical modifications. We used a stringent detected protein 
threshold score of 1% false discovery rate (FDR) as calculated by decoy searches. 
 
3.4.5 Transcriptome sequencing, assembly, and expression analysis 
Tentacle tissue from A. pulchella, A. tenebrosa, H. malu, M. doreensis and S. haddoni were 
collected with tweezers and flash frozen before total RNA was extracted using TRIzol (Life 
Technologies) and enriched for mRNA using a DynaBeads Direct mRNA kit (Life 
Technologies) as described (257). mRNA (~ 350 ng) was supplied to the Institute for Molecular 
Bioscience Sequencing Facility for library preparation and sequencing. A paired-end cDNA 
library (180 bp insert size) was prepared using a TruSeq-3 library kit and sequenced on an 
Illumina NextSeq 500 (mid-output, 150 bp paired-end reads). In addition to the transcriptomes 
sequenced here, SRAs from Aiptasia sp (SRR1648361), Anemonia viridis (SRR1573633), 
Anthopleura elegantissima (SRR2300240), Bolocera tuediae (SRR504347), Cnidopus 
japonicus (Red form — SRR2134406; Yellow form — SRR2134407), Hormathia digitata 
(SRR504348), Nematostella vectensis (ERR1368849), and Urticina eques (SRR942796) were 
analysed. The resulting reads were trimmed using Trimmomatic v0.35 (183) to remove adapter 
sequences and low-quality reads. Window function-based quality trimming was performed 
using a windowsize of 75 and windowquality of 34, and sequences with a resulting length of 
<100 bp were removed. After quality control, paired-end sequences were de novo assembled 
into contigs using Trinity v2.0.6 (258) using default parameters. For inspection of assembled 
contigs, trimmed paired reads were mapped to the Trinity assembled reads using bowtie v2.2.6 
(259) and visualised using the Integrative Genomics Viewer v2.4.x (260, 261). 
 
3.4.6 Functional annotation of transcriptome 
In order to identify potential toxin-like transcripts, we compared the translated transcriptome 
to all curated animal toxin sequences. Coding sequences (CDSs) were identified using the 
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Galaxy tool ‘Get open reading frames (ORFs) or coding sequences (CDSs)’ (189). A minimum 
CDS length cut-off of 30 residues was used to minimize the probability of not identifying short 
toxin CDSs. BLASTp searches of the resulting translated CDSs against the proteomics 
database we generated in addition to sea anemone toxins deposit to UniProt venom database 
(190) were performed with the upper-limit for the E-value set to 1E-6. Candidate toxin-like 
transcripts were further processed by removing redundant protein sequences using CD-HIT 
(191) as well as sequences not containing a signal peptide that could be detected using SignalP 
(version 4.1) (192). Finally, the toxin candidates were classified into categories according to 
predicted structure and/or function. 
 
3.4.7 Functional annotation of proteomics data 
CDSs from the venom transcriptome were used as a protein database for proteomic analyses. 
LC-MS/MS spectra were searched against the CDS database using ProteinPilot v4.5 (AB 
SCIEX). Sequences with less than two peptides with 95% confidence were excluded; the 
selected sequences from ProteinPilot were extracted using Galaxy tools. These sequences were 
then BLAST searched against the UniProt animal toxin database 
(www.uniprot.org/program/toxins) and annotated according to the methodology described for 
the transcriptome annotation. Sequences without matches to the UniProt toxin database were 
functionally annotated using a combination of BLAST searches against the NCBI non-
redundant protein database and InterProScan (193) using Blast2GO (194). Sequences without 
known functional or structural motifs were considered "unknowns" (U). To identify the full 
molecular diversity contained within each of the putative toxin families, sequences identified 
in the milked venom were then BLAST searched against the translated transcriptome. 
Redundant protein sequences were removed using CD-HIT and only sequences containing a 
predicted signal peptide were considered as putative toxin candidates. 
 
3.4.8 Phylogenetic Analyses 
Translated nucleotide sequences of each toxin types were aligned using mafft v7.304b (262) 
and refined using the tool re-alignment. CLC Main Workbench v7.6.1 (CLCbio, QIAGEN, 
Denmark) were used for visualization. Maximum likelihood phylogenies reconstructed with 
IQ-Tree v1.5.5 (263) for each toxin type. Evolutionary models were estimated using 
ModelFinder (264), while support values were estimated by ultrafast bootstrap using 1000 
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iterations (265). Trees were displayed using the online tool ‘Interactive Tree of Life’ (iTOL) 
(266).  
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CHAPTER 4  
PHAB toxins: a unique family of sea anemone toxins evolving via 
intra-gene concerted evolution defines a new peptide fold 
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Abstract 
Sea anemone venoms have long been recognised as a rich source of peptides with diverse 
structure and pharmacological properties, but they still contain many uncharacterised bioactive 
compounds. Here we report the discovery, three-dimensional structure, activity, tissue 
localisation, and putative function of a novel peptide toxin that constitutes a new, sixth type of 
voltage-gated potassium channel (KV) toxin from sea anemones. Comprised of just 17 residues, 
k-actitoxin-Ate1a (Ate1a) is the shortest sea anemone toxin reported to date, and it adopts a 
novel three-dimensional structure that we named the Proline-Hinged Asymmetric b-hairpin 
(PHAB) fold. Mass spectrometry imaging and bioassays suggest that Ate1a serves a primarily 
predatory function by immobilising prey, and we show that this is achieved via inhibition of 
Shaker-type KV channels. Ate1a is encoded as a multi-domain precursor protein that yields 
multiple identical mature peptides, which likely evolved by multiple domain duplication events 
in an actiniodean ancestor. Despite this ancient evolutionary history, the PHAB-encoding gene 
family exhibits remarkable sequence conservation in the mature peptide domains. We 
demonstrate that this conservation is likely due to intra-gene concerted evolution, which has 
not previously been reported for toxin genes. We propose that the concerted evolution of toxin 
domains provides a hitherto unrecognised way to circumvent the effects of the costly 
evolutionary arms race considered to drive toxin gene evolution by ensuring efficient secretion 
of ecologically important predatory toxins. 
 
Significance 
Sea anemone venoms are a rich source of peptide toxins that have found application as 
pharmacological tools and drug leads. Here we describe a new sea anemone toxin, Ate1a, 
which is the first representative of a previously undescribed peptide family that adopts a novel 
b-hairpin-like three-dimensional fold. Ate1a lacks the antimicrobial activity characteristic of 
many b-hairpin peptides, and instead it is used to paralyse envenomated prey. In contrast with 
most venom toxins, the Ate1a peptide family comprises a few, highly conserved genes 
encoding multiple copies of the mature toxin. These domains evolve by intra-gene concerted 
evolution, a process never before documented for animal toxins. We propose that this process 
represents an unrecognised strategy for efficient secretion of ecologically important toxins. 
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4.1 Introduction 
Venoms are complex cocktails of bioactive molecules that disrupt the physiology of 
envenomated prey (267, 268). Although these toxins include a wide range of molecules, such 
as proteins, peptides, polyamines, and salts, the impressive molecular diversity of most 
invertebrate venoms is due to disulfide-rich peptides (269). In animals that rely on venom for 
prey capture, diet and foraging ecology are thought to be major drivers of toxin evolution, with 
the acquisition of resistance in prey countered by diversifying selection acting on toxin genes 
in the predator (270). As a result, the venoms of predatory animals tend to be highly diverse, 
often containing hundreds to thousands of unique bioactive toxins (269). One such group is sea 
anemones, which are benthic, sessile cnidarians that use venom for a variety of ecological 
functions, including prey capture, defence, digestion, and inter- and intraspecific competition. 
Given the ecological importance of venom in sea anemones, and the fact that the cnidarian 
venom system has been evolving for >700 million years (227), it is not surprising that sea 
anemones have evolved a rich variety of venom toxins including enzymes, cytolysins, and 
neurotoxins (148, 235). Of these, disulfide-rich peptide neurotoxins constitute the largest 
molecular diversity. According to the classification system proposed by Mikov and Kozlov 
(271), at least 17 different peptide folds have been identified in sea anemone venoms (272), 
although recent proteomics studies suggest that they likely contain 30 or more (273). 
In addition to being the most diverse components of sea anemone venoms, neuroactive peptides 
are also the most well studied. They have been used as tools for probing ion channel structure 
and function, and for developing novel therapies (235). For example, ShK, a venom peptide 
from the sea anemone Stichodactyla helianthus, recently completed Phase 1 clinical trials for 
treatment of autoimmune disease (274). Neurotoxins from sea anemone venoms act on a 
diverse range of ion channels, including acid-sensing ion channels (ASIC), transient receptor 
potential ion (TRP) channels, and voltage-gated sodium (NaV) and potassium (KV) channels. 
Of these, KV toxins are the most diverse group, comprising 136 of the 320 annotated sea 
anemone toxins in UniProtKB. These KV toxins are currently divided into five distinct types 
based on their sequence, disulfide-bridge pattern, and activity (94). 
Here we describe the structure, activity, function and evolution of a new, sixth type of sea 
anemone KV toxin. k-Actitoxin-Ate1a (henceforth Ate1a), from venom of the Waratah sea 
anemone Actinia tenebrosa, is the shortest sea anemone toxin reported to date, and it adopts a 
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novel b-hairpin-like 3D fold. In contrast with many b-hairpin peptides, Ate1a lacks 
antimicrobial activity and instead serves a predatory function via potent inhibition of prey KV 
channels. While most families of predatory toxins evolve via bursts of extensive duplication 
and diversification, this is not the case for the Ate1a toxin family, whose members remain 
remarkably well conserved despite their ancient evolution. Our data suggest that this extreme 
conservation is due to intra-gene concerted evolution, a process that has not been previously 
reported for any toxin family and which we propose is a hitherto unrecognised mechanism of 
maintaining efficient secretion of ecologically important toxins. 
 
4.2 Results 
4.2.1 Discovery of Ate1a 
Specimens of A. tenebrosa were collected off the coast of North Stradbroke Island, 
Queensland, Australia (27°15 S, 153°15 E), and venom obtained by electrical stimulation 
(273). Fractionation of venom using reversed-phase chromatography revealed a conspicuous 
early-eluting peak containing an unusually low-mass component (Figure 4.1A), which we 
confirmed to be a disulfide-rich peptide by de novo sequencing using in-source dissociation 
(ISD) matrix-assisted laser desorption/ionization mass spectrometry (MALDI MS) (Figure 
4.1B). The toxin, which we named Ate1a, is a 17-residue peptide with two disulfide bonds and 
an amidated C-terminus (RCKTCSKGRCRPKPNCG-NH2), yielding a monoisotopic mass of 
1887.93 Da. Ate1a is a novel peptide with no BLAST hits in UniProtKB or NCBI databases. 
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Figure 4.1 – Isolation and sequencing of Ate1a. (A) C18 RP-HPLC chromatogram showing fractionation of 
crude A. tenebrosa venom. The early-eluting peak containing Ate1a is highlighted in red. Inset shows average 
mass and isotope family for Ate1a. (B) De novo sequencing of Ate1a using ISD-MALDI MS. 
 
To confirm the amino acid sequence of Ate1a and identify any venom homologues, we 
constructed a transcriptome from tentacles actively regenerating venom, as described 
previously (273). De novo assembly with Trinity yielded 87,485 contigs, which translated to 
457,470 potential coding sequences (CDS). A BLAST search was used to identify the transcript 
encoding Ate1a, and this returned a single contig containing a partial CDS with multiple copies 
of a peptide domain encoding a sequence identical to that determined by ISD-MALDI-MS. 
Analysis of remapped reads revealed that this contig represents two unique transcripts whose 
CDS differ by two synonymous and two non-synonymous mutations in the propeptide regions 
of the Ate1a preproprotein (Appendix Figure V.i, NCBI SRA accession SRR6282389). 
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4.2.2 Ate1a belongs to a novel peptide family that evolves by intra-gene concerted evolution 
We used the complete sequence of the Ate1a precursor to search for related sequences. A 
BLAST search against the UniProtKB and GenBank nr databases returned no significant hits, 
but BLAST searches against the NCBI expressed sequence tag (EST) database returned one 
full-length and two partial Ate1a-like prepropeptide sequence in Anemonia viridis. Similarly, 
a BLAST search against our published tentacle transcriptome from Stichodactyla haddoni 
(273) yielded three unique contigs, including one full-length prepropeptide. These species 
include two separate families (Actinidae and Stichodactylidae), suggesting that the Ate1a 
toxin-gene family arose in a common ancestor of the superfamily Actinioidea (2). 
All identified Ate1a-like prepropeptides are comprised of the same set of domains separated 
by dibasic cleavage sites: a signal peptide, one or two cysteine-containing propeptide domains, 
and three cysteine-free propeptide domains that each precede an Ate1a-like domain (Figure 
4.2A). The domain architecture is also the same for all prepropeptides except for the position 
of the cysteine-containing propeptide, which in Stichodactylidae (S. haddoni) is found as a 
single copy immediately following the signal peptide, but in Actinidae (A. tenebrosa and A. 
viridis) exists as two copies that each follow the first two Ate1a-like domains. This suggests 
that the Ate1a precursor gene underwent early domain duplication events followed by either 
multiple domain deletions or convergent deletions and duplications. Strikingly, however, the 
domains share almost 100% nucleotide identity with corresponding domains within the same 
prepropeptide (Figure 4.2B). Phylogenetic analysis revealed that domains from each species 
form well-supported clades with respect to those from other species (Figure 4.2C). This 
suggests that the extreme sequence conservation observed in domains of the Ate1a gene family 
is due to concerted evolution, an evolutionary phenomenon that, to our knowledge, has 
previously only been demonstrated for a single animal toxin gene family (275), but never for 
within-gene toxin domains. 
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Figure 4.2 – Domain architecture and evolution of Ate1a precursors. (A) Domain architecture of Ate1a and 
Ate1a-like contigs. Prepropeptides are composed of a signal peptide (SignalP), one or two cysteine-containing 
propeptide domains (CysProP), and three cysteine-free propeptide domains (LinearProP) that each precede an 
Ate1a-like PHAB domain. (B) Nucleotide sequence alignments for each domain. (C) Maximum likelihood 
phylogenetic reconstructions for each domain. Bootstrap support values are shown at the nodes, while horizontal 
bars indicate genetic distance. Sequence accessions are for S. haddoni (1–3) TR75252_c0_g2_i1–3 and A. viridis 
(1) FK754894, (2) FK726055, and (3) FK733314. 
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4.2.3 Ate1a defines a new peptide fold 
The unique primary structure of Ate1a prompted us to characterise its solution structure using 
NMR spectroscopy. We synthesised Ate1a using solid phase peptide synthesis and confirmed 
correct folding of the synthetic product by HPLC co-elution with native peptide (Appendix 
Figure VI.i). 
The 3D structure of Ate1a (Figure 4.3) was determined using homonuclear NMR methods, and 
statistics for the ensemble of structures are shown in Appendix Table XI.i. MolProbity analysis 
(276) revealed that the structure has excellent stereochemical quality, with no steric clashes 
and ~90% of residues in the most favoured Ramachandran region. The precision of the 
structure, however, is not very high (backbone RMSD 1.11± 0.28 Å), suggesting that it is 
highly dynamic, particularly within the longer loop 3. This may be due the presence of two 
proline residues, which leads Ate1a to adopt two distinct conformations (Figure 4.3A). Both 
conformations adopt a fold similar to that of b-hairpin-like peptides (277), where the C- and 
N- termini are connected via two semi-parallel disulfide bonds (C1-C4 and C2-C3). One face 
of the toxin has a high proportion of positively charged residues (Figure 4.3B) whereas the 
opposite face is rich in hydrophobic residues (Figure 4.3C). 
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Although Ate1a displays a hairpin-like structure (Figure 4.4A), it is neither a true hairpin 
scaffold nor similar to any other previously described hairpin-like peptide fold. The two 
disulfide-enclosed loops of Ate1a differ substantially in length, with loop 1 containing just two 
residues compared to five in loop 3. In combination with the two prolines in loop 3, this 
asymmetry prevents the formation of secondary structures characteristic of other disulfide-
enclosed hairpin-like structures such as b-hairpin antimicrobial peptides (AMPs) (277) (Figure 
4.4B) or the cystine-stabilised a/a (CSaa) fold (278) (Figure 4.4C). Ate1a also differs from 
Figure 4.3 – 3D structure of Ate1a. (A) Solution structure of Ate1a (ensemble of 20 structures; PDB 
code 6AZA). Disulfide bonds are highlighted in orange and proline side chains are shown in blue. (B) 
Surface representation of Ate1a with cationic and uncharged residues shown in blue and grey, 
respectively. (C) Surface representation of Ate1a showing relative hydrophobicity, which increases from 
white to red. 
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other hairpin-like folds found in animal toxins, such as the boundless b-hairpin (BBH) (24) 
(Figure 4.4D) and disulfide-directed hairpin (DDH) fold (279) (Figure 4.4E), or the two-
disulfide fold of RhTx from venom of the centipede Scolopendra subspinipes (280) (Figure 
4.4F). Thus, Ate1a is the prototypic member of a previously undescribed peptide fold that we 
coined the Proline-hinged asymmetric b-hairpin-like (PHAB) fold. 
 
 
4.2.4 Ate1a represents a new type of sea anemone KV-toxin 
Many Arg/Lys-rich, disulfide-stabilised b-hairpin peptides (e.g., gomesin and tachyplesin-1) 
function as AMPs in the innate immune system. They often have high affinity for lipid 
membranes and possess both anticancer and antimicrobial activity (281). Although Ate1a does 
not adopt a typical b-hairpin fold, it is highly positively-charged. However, Ate1a had no 
antimicrobial activity at concentrations up to 256 µg/mL (Error! Reference source not 
found.Appendix Table XII.i). Similarly, Ate1a was not cytotoxic or cytolytic against cultured 
Figure 4.4 – Ate1a is the first member of the new PHAB fold. Comparison of the PHAB fold with 
other peptide folds containing two disulfide bonds and a similar number of residues (16-29 
residues). Disulfide bonds are shown as orange tubes and N- and C-termini are labelled. (A) Ate1a; 
(B) b-hairpin fold represented by the spider peptide gomesin (PDB 1KFP); (C) CS α/α motif represented 
by the scorpion toxin k-hefutoxin1 (PDB 1HP9); (D) Boundless b-hairpin motif represented by sea 
anemone toxin π-AnmTX Ugr 9a-1 (PDB: 2LZO); (E) Disulfide-directed hairpin represented by 
scorpion toxin U1-Liotoxin-Lw1a (PDB 2KYJ); (F) Unstructured two-disulfide peptide fold represented 
by centipede toxin RhTx (PDB 2MVA). 
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human cancer cell lines or erythrocytes (Appendix Figure VII.i). Consistent with these results, 
Ate1a displayed only weak affinity for, and rapid dissociation from, lipid membranes compared 
to gomesin (282) (Appendix Figure VIII.i). Taken together, Ate1a’s lack of antimicrobial and 
cytolytic activity, as well as its low affinity for lipid membranes, suggests that it does not play 
a role in defence against pathogens. 
Ion channels are the most common molecular target of disulfide-rich venom peptides, and we 
therefore used electrophysiology to screen Ate1a against eight NaV channels, twelve KV 
channels, and four ASIC subtypes. Ate1a was found to selectively target several members of 
the Shaker subfamily of KV channels; at 3 µM it inhibited currents mediated by KV1.1 
(84% ± 4%), KV1.2 (94% ± 3%), KV1.3 (38% ± 4%), KV1.6 (92% ± 2%) and Shaker IR 
(23% ± 2%) channels (Appendix Figure IX.iA). No activity was observed on other channels at 
the same concentration (Appendix Figure X.i). Fitting of the Hill equation to concentration–
response curves for KV1.1, KV1.2, KV1.3 and KV1.6 yielded IC50 values of 353 nM, 146 nM, 
3051 nM and 191 nM, respectively (Appendix Figure IX.iB). Thus, given its unique sequence 
and structure, Ate1a represents a new, sixth type of sea anemone KV toxin. 
 
4.2.5 Ate1a is a toxin with a predatory function 
Although the pharmacological activity of a toxin can provide clues to its ecological function, 
it is not by itself definitive. However, the near-universal distribution of nematocytes in the 
epithelium of sea anemones means that toxin function can be inferred from tissue distribution 
(170, 283, 284). We therefore investigated the tissue distribution of Ate1a using MALDI-MS 
imaging (MSI), which allows visualization of the spatial distribution of unlabelled low mass 
biomolecules (1–20 kDa) (285-287). A peak corresponding to the average mass of Ate1a was 
clearly observed in MALDI-TOF-MSI spectra acquired from cross-sectioned A. tenebrosa. 
The identity of this peak was further supported by on-tissue gas-phase reduction and alkylation, 
which resulted in a peak shift matching the alkylation of four cystines (Figure 4.5A). Finally, 
ultra-high mass resolution analysis by MALDI-FT-ICR-MSI allowed us to fit the predicted 
isotope structure of Ate1a to the observed spectra and confirm its identity (Figure 4.5B). MSI 
revealed that Ate1a is non-uniformly distributed within the body of A. tenebrosa, with almost 
exclusive localization in tentacles (Figure 4.5C), suggesting that it is involved in prey capture. 
Ate1a mass signals were weak or absent in actinopharynx, mesenterial filaments, and 
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gastrovascular cavity, indicating that Ate1a does not play a role in prey digestion. Moreover, 
A. tenebrosa normally retracts its tentacles in response to disturbances, and thus the weak Ate1a 
signal in the trunk region indicates it is not primarily involved in defence. 
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Figure 4.5 – Tissue distribution of Ate1a determined using MSI. (A) MSI linear positive mode 
spectra acquired from a cross-sectioned animal, with peaks corresponding to Ate1a filled in. The 
spectrum of native tissue is blue while the spectrum obtained after on-tissue gas-phase reduction and 
alkylation is shown in red. Inset shows a mass difference of 180 Da, corresponding to ethanolylation 
of four cysteine residues. (B) Ultra-high mass resolution analysis of the peak corresponding to Ate1a 
acquired by MALDI-FT-ICR-MSI at a resolution of 16,000,000 and resolving power at 1890 m/z of > 
500,000, showing observed (top) and calculated (bottom) spectra. (C) Left: Histological image of the 
sea anemone section used for MSI experiments, stained with hematoxylin and eosin. Right: distribution 
of the peak corresponding to the average mass of Ate1a as observed by MALDI-TOF MSI. 
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In addition to nematocytes, sea anemones also produce toxins in ectodermal gland cells (10). 
Unlike nematocytes, which are stinging cells that inject venom, gland-cell toxins are released 
into the water and absorbed by prey. To determine which cell type produces Ate1a, we 
conducted toxicity bioassays using brine shrimp and amphipods, the latter being a major prey 
item of Actinia spp. (288, 289). Injection of Ate1a into amphipods resulted in impaired 
swimming followed by contractile paralysis. In contrast, Ate1a did not affect either species 
when dissolved into the medium (artificial sea water). Taken together, our data suggest that 
Ate1a is a neurotoxin produced in nematocytes and used primarily for prey capture. 
 
4.3 Discussion 
4.3.1 Ate1a is the founding member of a new, sixth type of sea anemone KV toxin 
Although sea anemone venoms are a rich source of bioactive peptides, recent omics studies 
have highlighted how little we still know about their composition, function, and evolution (170, 
273). Here we described the discovery and functional characterization of a new peptide class 
from venom of the sea anemone A. tenebrosa, one of the most commonly encountered sea 
anemones in intertidal zones around Australia and New Zealand (290). Ate1a has a primary 
structure unlike any previously described peptide, and assumes a unique 3D fold that is 
reminiscent of b-hairpin AMPs (277). 
In contrast to β-hairpin AMPs, the 3D structure of Ate1a is devoid of regular secondary 
structure. Instead, the asymmetry of the two sides of the β-hairpin-like structure of Ate1a 
prevents β-sheet formation, and distinguishes the 3D structure from previously described two-
disulfide peptide folds (Figure 4.4). The longer of the two ‘loops’ is also highly dynamic 
(Figure 4.3A), a property facilitated by the presence of two prolines that are conserved in all 
identified Ate1a homologues. Proline-containing peptides have the ability to populate two 
discrete conformations, and this cis-trans conformational switch works like a hinge that can 
potentially serve as a precise regulator of biological function (291, 292). While proline hinges 
play a diversity of roles in protein biology, one of these roles is reorienting surface loops to 
modulate protein binding surfaces and in turn ligand recognition (293). Thus, we predict that 
the proline-hinged loop of Ate1a represents a region that is important for the function of this 
toxin family. Given the structural and likely functional importance of this structural feature, 
we named this new structural scaffold the “proline-hinged asymmetric b-hairpin-like” (PHAB) 
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fold. 
Reflecting the structural distinctiveness of the PHAB fold from β-hairpin-like peptides, Ate1a 
does not have antimicrobial, antifungal, or cytolytic activity, nor strong affinity for lipid 
membranes (Appendix Figure VII.iAppendix Figure VIII.i). Instead, it is a potent inhibitor of 
Shaker-type KV channels, with nanomolar potency on KV1.1, KV1.2 and KV1.6. KV channels 
play crucial roles in neuronal signalling, muscle contraction and secretion (294), and hence 
they are a common target of animal toxins. Many venomous taxa have convergently evolved 
toxins that target KV channels to induce paralysis, general hyperexcitability, cardiac disorders, 
convulsions and death (267). This is also the case in sea anemones, where KV toxins are 
represented by five unique peptide folds: ShK (type 1), Kunitz-domain (type 2), b-defensin-
like (type 3), boundless b-hairpin (type 4), and an unknown fold predicted to form an inhibitor 
cystine knot (type 5) (94). The PHAB fold is unlike any of these structural scaffolds, and 
therefore it represents a new, sixth type of sea anemone KV toxin. 
 
4.3.2 Ate1a is a predatory toxin produced in nematocytes 
Although Ate1a is a novel KV toxin, correlating toxin activity with ecological function is often 
not straightforward (295). However, like other cnidarians, sea anemones lack a centralised 
venom delivery system, and instead rely on localised production of toxins to complement their 
functional anatomy (170, 283, 284). In A. tenebrosa, toxins are produced in five tissues and 
regions that have distinct ecological functions: acrorhagi (aggressive intraspecific encounters), 
tentacles (prey capture and immobilisation), mesenteric filaments (used principally in 
digestion), column (external defence after retracting tentacles), and actinopharynx (prey 
immobilisation and digestion). In addition, sea anemones produce toxins in two distinct cell 
types that deliver venom by either injection (nematocytes) or absorption following secretion 
into the water column (gland cells) (10). Ate1a is found predominantly in the tentacles of 
A. tenebrosa (Figure 4.5), which is suggestive of a predatory function. Moreover, Ate1a 
impaired swimming and led to paralysis and death when injected in amphipods, a major prey 
of Actinia species, but had no effect when dissolved into the medium. We conclude that Ate1a 
is a predatory toxin that cannot reach its KV targets without being inoculated into prey by 
nematocysts. 
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4.3.3 PHAB toxins evolve via intra-gene concerted evolution 
Venom proteins are thought to evolve via toxin recruitment events, whereby a gene encoding 
a normal body protein is duplicated and expressed in the venom-producing tissue (270). 
Functionally important toxin types are reinforced through duplication and diversification, and 
this is considered a hallmark of toxin evolution in predatory venoms, where toxins evolve 
continuously to counter acquisition of prey resistance (270). Although recent research suggests 
that venoms evolve via a two-step process in which initial rapid toxin diversification is 
followed by periods of purifying selection due to the metabolic costs of diversifying selection 
(220, 296), predatory toxins nevertheless tend to be part of large, highly diverse gene families. 
Strikingly, however, this diversity is entirely absent in the PHAB gene family, despite their 
likely role in predation. Instead, its members are highly conserved and consist of just 2–3 
almost identical copies in each species (Figure 4.2B). 
The sequence conservation at the nucleotide level is not limited to between-gene copies of each 
species, but extends to the domains encoded by each transcript. Despite the emergence and 
domain duplication of the PHAB fold in an actinioidean ancestor, all four domain types (signal 
peptide, two propeptide domains, and PHAB domain; Figure 4.2A) are remarkably well 
conserved. Furthermore, the nucleotide sequences encoding each domain type are more similar 
to the respective domains contained on the same transcript than to corresponding domain 
copies in other species (Figure 4.2C). This form of domain conservation is likely to have 
occurred by concerted evolution, an evolutionary process driven by continuous recombination 
that results in homogenisation of genetic variance across gene copies and so-called ‘horizontal 
evolution’ (297). Although this process has been described for a number of gene families, 
including NaV Type I toxins from Nematostella vectensis and Actinia equina (275), it is 
considered rare for intra-gene protein domain repeats (298), and has never previously been 
reported within toxin gene domains. 
In contrast with the general view of gene duplication as a facilitator of toxin gene 
diversification, recent studies have suggested that gene duplication may be of immediate 
importance for increased expression levels rather than generation of sequence diversity (299). 
Similarly, the concerted evolution of NaV Type I toxins from N. vectensis and A. equina has 
been suggested to confer a selective advantage through a ‘dosage’ effect of gene expression 
(275). In the PHAB gene family, this lack of high gene-copy numbers is compensated for by 
encoding multiple, identical toxin precursors, thereby effectively multiplying toxin expression 
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levels. Concerted evolution may also facilitate ‘transmission’ of advantageous mutations from 
a single toxin gene locus to other loci, or preventing the loss of highly effective toxins. 
Reflecting this, concerted evolution of protein domain repeats has been proposed to be 
triggered by arms-race type co-evolution (298). 
Thus, concerted evolution of toxin-domain repeats may provide a hitherto unrecognised 
mechanism of circumventing the effects of the metabolically expensive evolutionary arms race 
typically considered to drive toxin gene evolution. In the case of Ate1a and other members of 
the PHAB family, this has led to efficient secretion of structurally unusual but ecologically 
important, predatory KV toxins. 
 
4.4 Materials and Methods 
4.4.1 Venom Collection and Fractionation 
Sea anemones were collected at North Stradbroke Island, Queensland, Australia (27°15 S, 
153°15 E) then housed in aquaria at The University of Queensland. Venom was obtained after 
a starvation period of at least 48 h. Briefly, the sea anemone was rinsed, placed in a minimal 
volume of artificial seawater, and nematocysts induced to discharge by electrical stimulation 
(179). The water, which contains the venom was lyophilized and then the venom was 
fractionated on a C18 column (4.6 × 250 mm, 5 µm particle size, 300 Å pore size) using a flow 
rate of 1 mL/min and the following gradient of solvent B (0.043% trifluoroacetic acid (TFA) 
in 90% acetonitrile (ACN)) in solvent A (0.043% TFA in water): 10% solvent B for 15 min, 
10–65% solvent B over 50 min, 45–70% solvent B over 5 min.  
 
4.4.2 Mass Spectrometry 
4.4.2.1 MALDI-TOF/TOF Mass spectrometry 
Peptide masses in lyophilized RP-HPLC fractions were analysed by MALDI-TOF MS using 
an AB SCIEX 5800 MALDI-TOF/TOF mass spectrometer. RP-HPLC fractions were mixed 
1:1 (v/v) with α-cyano-4-hyroxy-cinnamic acid (CHCA) (7.5 mg/mL in 50/50 ACN/H2O, 0.1% 
TFA). MALDI–TOF mass spectra were collected in reflector positive mode and reported 
masses are monoisotopic M+H+ ions. For sequencing of intact Ate1a by in-source dissociation 
TOF-MS, 1,5-diaminonaphthalene (1,5-DAN) was used as a reductive matrix (300). The 
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sample was mixed 1:1 (v/v) with 1,5-DAN (15 mg/mL in 50/50 ACN/H2O, 0.1% formic acid 
(FA)), and spectra were interpreted manually. 
 
4.4.2.2 MALDI Mass Spectrometry Imaging  
MALDI-MSI was guided by published protocols (301, 302) but with sample preparation 
optimized as recently described (303). Briefly, specimens of A. tenebrosa were left in 50% 
RCL2/ethanol at room temperature overnight, sequentially dehydrated into ethanol (3 × 15 min 
at each concentration), cleared in xylene for 30 min, and embedded in paraffin wax. A whole 
embedded animal was sectioned transversally at 7 µm thickness. Sections were de-paraffinized 
by careful washing with xylene, and optically imaged prior to applying CHCA (7 mg/mL in 
50% ACN, 0.2% TFA) using a Bruker ImagePrep automated matrix sprayer. The on-tissue 
reduction and alkylation of cystines was carried out on de-paraffinized tissue sections using a 
volatile reaction protocol described previously (304), but with a 3.5 mL reaction volume in a 
50 mL Corning Falcon tube (Thermo Fisher).  
FlexControl 3.3 (Bruker) was used to operate an UltraFlex III TOF-TOF mass spectrometer 
(Bruker) in linear positive mode, with the range set to 1,000–20,000 m/z. A small laser size 
was chosen to achieve a spatial resolution of 50 µm, and matrix ion suppression was enabled 
up to 980 m/z. Individual MSI experiments were performed using FlexImaging 4.0 (Bruker). 
FlexImaging was used to establish the geometry and location of the section on the slide based 
upon the optical image, choose the spatial resolution, and call upon FlexControl to acquire 
individual spectra, accumulating 200 shots per raster point. FlexImaging was subsequently 
used to visualize the data in 2D ion-intensity maps, producing an averaged spectrum based 
upon the normalized individual spectra collected during the experiment.  
For ultra-high mass resolution MSI we used a SolariX XR 7T FT-ICR mass spectrometer 
Bruker-Daltonik, Bremen, Germany) was used and operated in the positive ion mode. Data size 
was set to 1M across the mass range 400–6000 m/z. MALDI source was set to a laser power = 
50%, a total of 500 shots per scan at a frequency of 2kHz, smart walk was enabled with a width 
of 90 µm. The Collision Cell RF Frequency was set to 1.4 MHz, Collision RF Amplitude 1100 
Vpp, Transfer Optics Time of Flight = 1.5 ms at a frequency of 2 MHz with RF Amplitude = 
400 Vpp. The sweep excitation was set to 20%. For isotopic fine structure analysis, data size 
was set to 4M across the mass range 200–3000 m/z. Data was collected and averaged across 8 
scans. MALDI source was set to a laser power = 50%, a total of 5000 shots per scan at 
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frequency of 2 kHz, the laser spots was manually moved across sample area. For isolation the 
quadrupole was set to 1890.00 with an isolation window of 5 m/z. The Collision Cell RF 
Frequency was set to 2 MHz and Collision RF Amplitude set to 1200 VPP. The Transfer Optics 
were set to a Time of flight = 1.5 ms, Frequency set to 4 Mhz with RF Amplitude set to 400 
Vpp. Sweep excitation set to 19%. For data analysis Bruker (Bruker-Daltonik, Bremen, 
Germany) DataAnalysis 5.0 and for image analysis Bruker FlexImaging 5.0 and Bruker SCiLS 
Lab 2017a were used. 
 
4.4.3 Transcriptomics 
Tentacle tissue from A. tenebrosa was collected with tweezers and flash frozen before total 
RNA was extracted using TRIzol (Life Technologies) and enriched for mRNA using a 
DynaBeads Direct mRNA kit (Life Technologies) as described (257). mRNA (350 ng) was 
supplied to the Institute for Molecular Bioscience Sequencing Facility for library preparation 
and sequencing. A paired-end cDNA library (180 bp insert size) was prepared using a TruSeq-
3 library kit and sequenced on an Illumina NextSeq 500 (mid-output, 150 bp paired-end reads). 
The resulting reads were trimmed using Trimmomatic v0.35 (183) to remove adapter 
sequences and low-quality reads. Window function-based quality trimming was performed 
using a windowsize of 75 and windowquality of 34, and sequences with a resulting length of 
<100 bp were removed. After quality control, paired-end sequences were de novo assembled 
into contigs using Trinity v2.0.6 (258) using default parameters. For inspection of assembled 
contigs, trimmed paired reads were mapped to the Trinity assembled reads using bowtie v2.2.6 
(259) and visualised using the Integrative Genomics Viewer v2.4.x (260, 261). Raw sequences 
reads (SRA: SRR6282389) and Trinity assembled contigs have been deposited with links to 
BioProject accession number PRJNA414357 in the NCBI BioProject database 
(https://www.ncbi.nlm.nih.gov/bioproject/). Coding sequences (CDSs) were identified using 
the Galaxy tool ‘Get open reading frames (ORFs) or coding sequences (CDSs)’ (305). A 
minimum CDS length cut-off of 30 residues was used to minimize the probability of not 
identifying short toxin CDSs. The sequence determined by ISD-MALDI-MS was used to 
search the translated transcriptome using NCBI BLAST+ blastp (306). 
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4.4.4 Evolution of Ate1a 
The Ate1a prepropeptide sequence was used to search for homologues in UniProtKB, NCBI 
nr and EST, and a tentacle transcriptome of S. haddoni (273) using NCBI BLAST+ blastp. 
Nucleotide sequences were retrieved and aligned using mafft v7.304b (262); domains were 
extracted using CLC Main Workbench v7.6.1 and maximum likelihood phylogenies 
reconstructed with IQ-Tree v1.5.5 (307) for each domain type. The evolutionary model 
(FLU+G4) was determined using ModelFinder (308), and support values estimated by ultrafast 
bootstrap using 10000 iterations (309). 
 
4.4.5 Ate1a Synthesis 
Fmoc amino acids and O-(1H-6-chlorobenzotriazole-1-yl)-1,1,3,3-tetramethyluronium 
hexafluorophosphate (HCTU) were from Iris Biotech (Marktredwitz, Germany), 
dimethylformamide (DMF) and diisopropylethylamine (DIEA) were from Auspep 
(Melbourne, Australia). All other reagents were obtained from Sigma Aldrich. 
Ate1a (H-RCKTCSKGRCRPKPNCG-NH2) was assembled on a 0.1 mmol scale using Fmoc 
chemistry on a Symphony automated peptide synthesizer (Protein Technologies Inc., Tucson, 
AZ, USA) on Fmoc-Rink-amide polystyrene resin (substitution value 0.67 mmol/g). Fmoc 
deprotections were accomplished by treatment with 30% piperidine/DMF (1 × 1 min, then 1 × 
3 min). Amino acids were coupled using five equivalents of Fmoc amino acid/HCTU/DIEA 
(1:1:1) relative to resin loading (1 × 4 min then 1 × 8 min). Side-chain protecting groups used 
were: Arg(Pbf), Asn(Trt), Cys(Trt), Lys(Boc), Ser(tBu) and Thr(tBu). Cleavage from the resin 
and removal of side-chain protecting groups was achieved with 95% TFA/2.5% TIPS/ 2.5% 
H2O for 2 h at room temperature. TFA was removed under a stream of nitrogen, then crude 
product was precipitated using cold diethyl ether (Et2O). The product was washed with Et2O, 
redissolved in 50% ACN/0.1% TFA/H2O and lyophilised. ESI-MS (m/z): calc. (avg) 632.1 
[M+3H]3+, found 632.0. The crude product was oxidised by stirring in 0.1 M NH4HCO3 (pH 
8.1) at room temperature for 3 days to give a single major isomer that was isolated by 
preparative HPLC. ESI-MS (m/z): calc. (avg) 630.8 [M+3H]3+, found 631.0. 
RP-HPLC solvent A was 0.05% TFA/H2O and solvent B was 0.043%TFA/ 90% ACN/H2O. 
Analytical HPLC was performed on a Shimadzu LC20AT system using a Thermo Hypersil 
GOLD C18 2.1 × 100 mm column and a gradient of 0–30% B over 30 min at flow rate of 0.3 
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mL/min. Absorbance was recorded at 214 nm. Preparative HPLC was performed on a Waters 
600 system using a Vydac 218TP 22 × 250 mm column with a gradient of 0–30% B over 30 
min at a flow rate of 16 mL/min. Mass spectra were recorded in positive ionisation mode on 
an AB SCIEX API 2000 triple quadrupole mass spectrometer. 
 
4.4.6 Ate1a Structure 
The solution structure of Ate1a was determined using 2D NMR spectroscopy. The NMR 
sample contained 1 mM synthetic Ate1a in 20 mM sodium phosphate, pH 6 and 5% D2O. 
Spectra were acquired at 10°C on a Bruker AVANCE 600 MHz spectrometer equipped with a 
cryoprobe (Bruker, Billerica MA, USA). Resonance assignments were accomplished using a 
combination of 2D 1H-15N HSQC, 2D 1H-13C HSQC, 2D 1H-1H TOCSY and 2D 1H-1H 
NOESY spectra. The 2D NOESY spectrum (mixing time of 350 ms) was used to obtain 
interproton distance restraints. Spectra were processed using Topspin 3.5.b.91 pl 7 and 
analysed using CcpNmr Analysis 2.4.1 (310). 97.8% of resonances were assigned and they 
have been deposited in the BioMagResBank (accession number 30342). Dihedral-angle 
restraints were derived using TALOS-N (310) and the restraint range set to twice the estimated 
standard deviation. The NOESY spectrum was manually peak-picked, then the peak list was 
automatically assigned and structures calculated using the torsion angle dynamics package 
CYANA 3.97 (311). During the process of automatic NOESY assignment, CYANA assigned 
96.3% of all cross peaks. The final structure was calculated using 66 interproton distance 
restraints, 6 disulfide-bond restraints and 23 dihedral-angle restraints. 200 structures were 
calculated, then the 20 best structures (chosen in the basis of the final CYANA target function 
values and stereochemical quality as judged by Molprobity) were used to represent the solution 
structure of Ate1a. The structural ensemble is available from the Protein Data Bank (accession 
code 6AZA). 
 
4.4.7 Activity of Ate1a 
4.4.7.1 Electrophysiological characterisation of Ate1a  
Two-electrode voltage-clamp oocyte electrophysiology 
The pharmacological effect of Ate1a was analysed by heterologous expression of rKV1.1, 
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rKV1.2, hKV1.3, rKV1.4, rKV1.5, rKV1.6, Shaker IR, rKV2.1, hKV3.1, rKV4.2, KV7.2, KV11.1, 
rNaV1.2, rNaV1.3, rNaV1.4, hNaV1.5, mNaV1.6, hNaV1.7, rNaV1.8, rASIC1a, rASIC1b, 
rASIC2a, and rASIC3 in Xenopus laevis oocytes. The linearized plasmids were transcribed 
using the T7 or SP6 mMESSAGE-mMACHINE transcription kit (Ambion, Waltham, MA, 
USA). The KV1.1 triple mutant channel was constructed as previously describes (312). Oocytes 
were injected with 50 nL of cRNA at a concentration of 0.05–1 ng/nL using a micro-injector 
(Drummond Scientific, Broomall, PA, USA). The oocytes were maintained in an ND96 
solution (in mM: 96 NaCl, 2 KCl, 1.8 CaCl2, 2 MgCl2 and 5 HEPES; pH 7.4), supplemented 
with 50 µg/mL gentamicin sulfate. 
Two-electrode voltage-clamp recordings were performed at room temperature (18–22 °C) 
using a Geneclamp 500 or Axoclamp 900A amplifier (Molecular Devices, Sunnyvale, CA, 
USA) controlled by a pClamp data acquisition system (Axon Instruments, Union City, CA, 
USA). Whole cell currents from oocytes were recorded 1–5 days after injection. The bath 
solution composition was ND96 (in mM: 2 NaCl, 96 KCl, 1.8 CaCl2, 2 MgCl2 and 5 HEPES; 
pH 7.4). Voltage and current electrodes were filled with KCl (3 M). The resistance of both 
electrodes was kept between 0.8 and 1.0 MΩ. KV currents were filtered at 0.5 or 2 kHz using a 
four-pole low-pass Bessel filter, and leak subtraction was performed using a −P/4 protocol. 
KV1.1−KV1.6 and Shaker IR currents were evoked by 500 ms depolarization to 0 mV followed 
by a 500 ms pulse to −50 mV, from a holding potential of −90 mV. KV2.1, KV3.1, KV4.2 and 
KV4.3 currents were elicited by 500 ms pulses to +20 mV from a holding potential of −90 mV. 
Current traces of hERG channels were elicited by applying a +40 mV pulse for 2.5 s followed 
by a step to −120 mV for 2.5 s. NaV current were evoked by 100 ms depolarization pulse from 
a holding potential of −90 mV to −20 mV, with the exception of NaV1.8 which were pulsed to 
0 mV. NaV data were digitized at 20 kHz; leak and background conductance were identified 
by blocking channels with tetrodotoxin and subtracted from currents. ASIC currents were 
acquired (digitized 2 kHz and filtered at 0.01 Hz) and elicited by a drop in pH from 7.45 to 6.5, 
5.5, 4.5, and 6.3 (for ASIC1a, ASIC1b, ASIC2a, and ASIC3, respectively).  
 Manual patch clamp electrophysiology 
Due to the lack of a functional NaV1.1 clone for oocyte screening, activity was assessed by 
manual patch clamp electrophysiology. HEK293 cells heterologously expressing hNaV1.1 (SB 
Drug Discovery, Glasgow, UK) were maintained at 37 °C in a humidified 5% CO2 incubator 
in minimal essential medium supplemented with 10% FBS v/v, 2 mM L-glutamine and 
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selection antibiotics as recommended by the manufacturer. Cells were grown to 70–80% 
confluence and passaged every 2–4 days using Detachin (Genlantis, San Diego, CA, USA). 
Whole cell patch-clamp recordings were obtained using a MultiClamp 700B amplifier 
(Molecular Devices, Sunnyvale, CA, USA). Patch pipettes were pulled from standard wall 
borosilicate glass capillaries (1.5 mm x 0.86 mm, OD/ID; SDR Scientific, Sydney, AUS) using 
a microelectrode puller (P-97; Sutter Instrument Co., Novato, CA, USA) and had a resistance 
of 1.2–1.5 MW when filled with pipette solution. The pipette solution was composed of (in 
mM) 150 CsCl, 1 EGTA, 10 HEPES and was adjusted to pH 7.2 with CsOH. The external bath 
solution consisted of (in mM) 140 NaCl, 4 KCl, 1 MgCl2, 2 CaCl2, 10 HEPES and adjusted to 
pH 7.4 with NaOH. Currents were monitored for at least 5 min after establishing whole-cell 
configuration to allow currents to stabilize. The pulse protocol consisted of cells being held at 
-90 mV for 10 s, followed by a hyperpolarizing step to -120 mV for 200 ms, then a depolarizing 
step to -15 mV for 50 ms. Series resistance and prediction compensation between 50–75% was 
applied to reduce voltage errors. Recorded currents were acquired with a Digidata 1550B 
(Molecular Devices) converter at 50 kHz after passing through a low-pass Bessel filter of 10 
kHz. A P/6 subtraction protocol provided by the Clampex (Molecular Devices) acquisition 
software was used to remove linear leak and residual capacitance artifacts. 
 Data analysis 
To assess the Ate1a concentration–response relationships, data were fitted with the Hill 
equation y = 100/[1 + (IC50/[toxin])h], where y is the amplitude of the toxin-induced effect, 
IC50 is the toxin concentration at half-maximal efficacy, [toxin] is the toxin concentration 
and h is the Hill coefficient. In order to investigate the current–voltage (I–V) relationship, 
current traces were evoked by 10 mV depolarization steps from a holding potential of −90 mV. 
The values of IK were plotted as function of voltage and fitted using the Boltzmann 
equation IK/Imax = [1 + exp(Vg − V)/k]−1, where Imax represents maximal IK, Vg is the voltage 
corresponding to half-maximal current and k is the slope factor. To assess the concentration 
dependence of the Ate1a induced inhibitory effects, a concentration–response curve was 
constructed in which the percentage of current inhibition was plotted as a function of toxin 
concentration. Data were fitted with the Hill equation. All data represent at least three 
independent experiments (n ≥ 3) and are presented as mean ± standard error. Comparison of 
two sample means was made using a paired Student's t test (P < 0.05). All data were analyzed 
using clampfit 10.3 (Molecular Devices) and origin 7.5 software (Origin Lab., Northampton, 
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MA, USA). 
 
4.4.7.2 Antimicrobial Assays 
Antimicrobial screening was performed by the Community for Antimicrobial Drug Discovery 
(CO-ADD; www.co-add.org). Ate1a was prepared at 10 mg/mL in DMSO and diluted in 
Mueller Hinton Broth (MHB; BD, Cat. No.211443). Initial antimicrobial screening was 
conducted by whole-cell growth inhibition assays using a single Ate1a concentration of 256 
µg/mL, in duplicate. Inhibition of growth was measured against five bacteria: Escherichia coli 
(ATCC 25922), Klebsiella pneumoniae (ATCC 700603), Acinetobacter baumannii (ATCC 
19606), Pseudomonas aeruginosa (ATCC 27853) and Staphylococcus aureus (MRSA; ATCC 
43300), and two fungi: Candida albicans (ATCC 90028) and Cryptococcus neoformans 
(ATCC 208821). Dose-response was also examined with two-fold across the wells of 96-well 
non-binding surface (NBS) plates (Corning; Cat. No. 3641) in duplicate. 
Bacterial strains were cultured in MHB at 37°C overnight, then diluted 40-fold and incubated 
at 37°C for a further 2–3 h. The resultant mid-log phase cultures were diluted in MHB and 
added to each well of the compound-containing 96-well plates to give a final cell density of 
5x105 CFU/mL. The final Ate1a concentration range was 256 – 0.125 µg/mL. The plates were 
covered and incubated at 37°C for 20 h. Optical density was read at 600 nm (OD600) using a 
Tecan M1000 Pro Spectrophotometer. Minimal inhibitory concentration (MIC) was 
determined as the lowest concentration corresponding to ≥95% growth inhibition, relative to a 
growth control, as measured from the OD600. 
For antifungal assays Ate1a was serially diluted in Yeast Nitrogen Broth (YNB) two-fold 
across the wells of 96-well non-binding surface (NBS) plates (Corning; Cat. No. 3641) plated 
in duplicate. Candida albicans and Cryptococcus neoformans were cultured on YPD agar at 
35°C for 24 and 48 h respectively. A minimum of five single colonies were taken from each 
agar plate and dissolved in sterile water; the solution was then adjusted to OD530 = 0.3. The 
solution was diluted in YNB and added to each well of the Ate1a-containing 96-well plates 
giving a final cell density of 2.5x103 CFU/mL and a final Ate1a concentration of 256–0.125 
µg/mL. The plates were covered and incubated at 35°C for 36 h. MIC was the lowest 
concentration with ≥85% growth inhibition and was determined by optical density after 36 h 
incubation using a Biotek Synergy HTx Plate reader following at OD630 for Candida albicans 
and at OD570-600 for Cryptococcus neoformans. 
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4.4.7.3 Interactions of Ate1a with lipid bilayers 
Surface plasmon resonance (SPR) was used to monitor the affinity of Ate1a for lipid 
membranes using a Biacore 3000 instrument (GE healthcare) at 25ºC. Synthetic POPC (1-
palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine) and POPS (1-palmitoyl-2-oleoyl-sn-
glycero-3-phosphoserine) (Avanti polar lipids) were used to prepare small unilamellar vesicles 
(SUVs, 50 nm diameter) composed of POPC or POPC/POPS (4:1 molar ratio) dispersed in 
HEPES buffer (10 mM HEPES containing 150 mM NaCl, pH 7.4) and homogenized by 
extrusion. SUVs were deposited onto an L1 chip for 40 min at a flow rate of 2 µL/min. Serial 
two-fold dilutions of Ate1a, starting from 64 µM, were injected over deposited lipid bilayers 
for 180 s at a flow rate of 5 µL/min (association phase); dissociation was followed for 600 s 
(313, 314). An N-to-C cyclized version of gomesin was included for comparison. The chip was 
regenerated as before (315). All solutions were freshly prepared and filtered using a 0.22 µm 
filter; HEPES buffer was used as running buffer. Response units were normalized to peptide-
to-lipid ratio (P/L) as previously described (313). 
 
4.4.7.4 Hemolysis studies 
Erythrocytes were isolated from fresh human blood collected from three healthy donors using 
protocols approved by the Human Research Ethics Committee at The University of 
Queensland. Erythrocytes were resuspended at 0.25% (v/v) in phosphate-buffered saline (PBS; 
137 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 1.8 mM KH2PO4) and incubated with two-fold 
dilutions of Ate1a for 1 h at 37ºC. Hemolysis was quantified as described (316) by measuring 
hemoglobin release at 405 nm. Melittin and cyclic gomesin were used as controls. 
 
4.4.7.5 Cell culture and cell viability assays 
HeLa, MCF-7, HFF-1 were grown in DMEM supplemented with 1% penicillin/streptomycin 
and 10% v/v (HeLa, MCF-7) or 15% v/v (HFF-1) FBS. Cells were incubated in a humidified 
atmosphere (5% CO2, 37ºC) and split by dilution after reaching confluency. Toxicity of Ate1a 
was determined using a resazurin colorimetric assay, as described (317). Briefly, cells were 
seeded in a 96-well plate (5x103 cells/well) the day before the assay. Ate1a was diluted in 
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medium without serum (two-fold dilutions starting at 64 µM) and added to cells; resazurin 
(0.05% w/v) was added 2 h after the peptide and incubated for another 24 h. Fluorescence 
emission intensity (excitation 565 nm, emission 584 nm) was measured using a plate reader 
(Tecan M1000 Pro Spectrophotometer). Melittin and cyclic gomesin were included as controls, 
and samples with buffer or Triton X-100 (0.1% v/v) were included to estimate 100% and 0% 
viability, respectively. Assays were repeated at least three times. 
 
4.4.7.6 Toxicity bioassays 
Toxicity of Ate1a to brine shrimps (A. salina) and amphipods (family Talitridae) was examined 
as previously described (18, 318). For assays where the toxin was dissolved in medium, 
synthetic Ate1a was dissolved to a concentration of 0.5 mg/mL in filtered artificial seawater. 
Assays were performed in 24-well plates for shrimps and 6-well plates for amphipods 
(Thermo-Fisher Scientific). Paralysis and lethality were assessed by microscopic observation 
and responsiveness to contact with a plastic tip. Bovine serum albumin (5 mg/mL) was used as 
a control (no toxicity). For injection assays, Ate1a was diluted with a physiological solution 
for crustaceans (in mM: NaCl 470.4, KCl 8.0, CaCl2 18.0, MgCl21.5, NaHCO3 6.0 and glucose 
5.6). The injection volume was 9.4 nL. Groups of ten amphipods (4.35–11.53 mg) were 
challenged with 5.3 mM of toxin and observed for mortality or paralysis up to 4 h.  
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The ultimate aim of this thesis was to provide the first comprehensive insight into the 
composition and biodiscovery potential of sea anemone venoms. Through a uniquely 
multifaceted approach we studied multiple aspects of these venoms. As discussed below, 
together this thesis gives the to date most comprehensive insight into one of the oldest extant 
venom systems known, and is thereby a substantial contribution to the field of venomics. 
 
5.1 Sea anemone venom composition 
Previously published works were using mainly transcriptomic and genomic approaches to 
access sea anemone venoms composition. However, homology-based annotation of toxins 
from transcriptomic and genomic data is insufficient for providing a full picture of the venom 
arsenal as it is inherently limited to finding candidates with significant sequence homology to 
known toxins, and it is prone to false positives by the fact that toxins typically evolve from 
proteins with functions unrelated to envenomation. In addition, this is particularly problematic 
for cnidarians because transcriptome data obtained from tentacles or whole body contains 
transcripts from tissues not specifically involved in venom production. In this thesis, we 
highlighted the importance of using a combined transcriptomics/proteomics approach to 
provide a holistic overview of the complexity of the venom arsenal of sea anemones. Even 
though this project was likely to discover novel venom components, it was surprising that the 
application of this approach to a representative of the well-studied genus Stichodactyla 
uncovered twelve new families of putative toxins. These new families contained no known 
structural or functional domains nor showed any sequence homology to any characterized 
protein, highlighting how much there is still to be learnt about sea anemone venoms. 
Another surprise was the differences between purely transcriptome and proteomics analyses. 
Previously published works using only transcriptomic, usually use transcript expression levels 
to identify putative toxins based on the observation that toxin genes are more highly expressed 
in venom glands that are actively engaged in the process of venom regeneration compared to 
those that are replete. However, cnidarians represent the only lineage of venomous animals that 
lack a centralized venom system and the process of venom regeneration remains largely 
uncharacterized. Our results showed poor correlation between toxin transcript levels and 
abundance in venom. Altogether, this thesis highlighted the importance of using proteomics of 
milked venom to correctly identify venom proteins/peptides, both known and novel, while 
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minimizing false positive identifications from non-toxin homologues identified in 
transcriptomes of venom-producing tissues. 
Another benefit from that this thesis brought, is the improvement in the sea anemone toxins 
database in the protein level. Transcriptome annotation is limited by the lack of a 
comprehensive cnidarian proteomics database to match against the transcripts. In addition, 
final matching of proteome and transcriptome data requires multiple bioinformatics tools. We 
developed a pipeline using Galaxy that contains all tools required for these analyse. 
 
5.2 Biodiscovery potential of sea anemone venoms 
Sea anemone venoms have long been recognised as a rich source of peptides with diverse 
structure and pharmacological properties, but they still contain many uncharacterised bioactive 
compounds with novel scaffolds. While the majority of studies target medically-important or 
abundant organisms for ethical or practical reasons, research on rare organisms or less-studied 
species often provides a promising source of novelty. As described in chapter 3, here we 
reported the structure, activity, function and evolution of a new, sixth type of sea anemone KV 
toxin. k-Actitoxin-Ate1a (henceforth Ate1a), from venom of the Waratah sea anemone Actinia 
tenebrosa. Comprised of just 17 residues, Ate1a is the shortest sea anemone toxin reported to 
date, and it adopts a novel three-dimensional structure that we named the Proline-Hinged 
Asymmetric b-hairpin (PHAB) fold. 
Aiming to understand the function of Ate1a, we used a combination of toxicity assays and a 
wide molecular target screening. Ate1a lacks antimicrobial activity and instead serves a 
predatory function via potent inhibition of prey KV channels. Although the pharmacological 
activity of a toxin can provide clues to its ecological function, it is not by itself definitive. 
However, the near-universal distribution of nematocytes in the epithelium of sea anemones 
means that toxin function can be inferred from tissue distribution. We therefore investigated 
the tissue distribution of Ate1a using MALDI-MS imaging (MSI). MSI revealed that Ate1a is 
non-uniformly distributed within the body of A. tenebrosa, with almost exclusive localization 
in tentacles, suggesting that it is involved in prey capture. IMS was a powerful technique that, 
in combination with the toxicity assays and molecular target, gave us insights about the 
ecological role of Ate1a. 
We also searched for the presence of analogues of Ate1a in other sea anemones. This family 
of toxin has evolved in a particular way. While most families of predatory toxins evolve via 
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bursts of extensive duplication and diversification, this is not the case for the Ate1a toxin 
family, whose members remain remarkably well conserved despite their ancient evolution. Our 
data suggest that this extreme conservation is due to intra-gene concerted evolution, a process 
that has not been previously reported for any toxin family and which we propose is a hitherto 
unrecognised mechanism of maintaining efficient secretion of ecologically important toxins. 
Ate1a is only one example of how the combination of multiple techniques is essential for fully 
characterization of a toxin. Similar approach should be applied for other toxins to gather 
enough data to give us insights of how the combination of these toxins work together in the 
process of envenomation. This is essential for understanding of the ecological role of sea 
anemone venoms. 
 
5.3 Future directions 
While the works presented herein provides a first holistic insight into a sea anemone venom 
and a full characterization of a new scaffold (Ate1a), it also raises a large number of questions 
and prospects for future studies. This thesis has uncovered a vast number of proteins and 
peptides that still need structure and functional characterization to provide insight into their 
roles in sea anemone venoms. Moreover, the venom of other species remained unexplored and 
it will be interesting to see the outcomes of future studies addressing this shortcoming of our 
current understanding of sea anemone venom composition, ecological role and the evolutionary 
forces that shape it. 
 
5.4 Conclusions 
Although there is still much to learn about the composition of sea anemone venoms and the 
role of individual venom components in prey capture, defence and intraspecific competition, 
this thesis lays the foundation for uncovering the role of individual toxins in sea anemone 
venom and how they contribute to the envenomation of prey, predators, and competitors. 
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Appendices of Chapter 2 
Appendix I Sequence alignment with toxins reported by Honma et al. (2008). 
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Delta-stichotoxin-Shd3a - B1B5I9 (NA24_STIHA)  
 
 
 
Omega-stichotoxin-Shd4a - B1B5J0 (SHTX5_STIHA) 
 
 
 
Kappa-stichotoxin-Shd5a - E2S062 (K1A_STIHA) 
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KappaPI-stichotoxin-Shd2a - B1B5I8 (VKT3_STIHA) 
 
 
 
Kappa-stichotoxin-Shd1a/kappa-stichotoxin-Shd1b - P0C7W7 (TX9A_STIHA) 
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Appendix II  Summary of the 33 toxins identified via proteomic analysis of S. haddoni milked venom that showed significant homology to entries 
in the UniProt toxin database. 
Transcript Top BLAST hit e-value Type Organism Family/Scafold Size 
TR138219_c4_g1_i1_CDS10|leng
th 
sp|R4ZCU1|TX9A_URTGR,sp|R4ZCU1|TX9A_URTGR,sp|R4ZCU1|TX9A_UR
TGR 
2e-10,1e-08,3e-
10 ASIC 
Sea 
anemone 
Boundless beta-
hairpin Peptide 
TR130412_c0_g1_i1_CDS3|lengt
h sp|Q76CA0|NA2G3_STIGI 2.00E-56 Nav type2 
Sea 
anemone Defensin Peptide 
TR130412_c0_g2_i1_CDS3|lengt
h sp|Q76CA0|NA2G3_STIGI 4.00E-54 Nav type2 
Sea 
anemone Defensin Peptide 
TR134234_c17_g1_i1_CDS4|leng
th sp|P0DMX5|BDS2C_ANTEL 4.00E-08 Kv type3 
Sea 
anemone Defensin Peptide 
TR50156_c0_g1_i1_CDS2|length sp|Q9NJQ2|NA11_ACTEQ 6.00E-57 Nav type1 Sea anemone Defensin Peptide 
TR72914_c0_g1_i1_CDS2|length sp|Q76CA3|NA1G2_STIGI,sp|Q76CA3|NA1G2_STIGI 6e-50,6e-50 Nav type1 Sea anemone Defensin Peptide 
TR72914_c0_g2_i1_CDS2|length sp|Q76CA3|NA1G2_STIGI,sp|Q76CA3|NA1G2_STIGI 6e-50,6e-50 Nav type2 Sea anemone Defensin Peptide 
TR18604_c0_g1_i1_CDS1|length sp|Q76CA0|NA2G3_STIGI 2.00E-56 Nav type2 Sea anemone Defensin Peptide 
TR69080_c0_g1_i1_CDS11|lengt
h sp|B1B5J0|SHTX5_STIHA 3.00E-59 
EGF-like sea 
anemone 
Sea 
anemone EGF-like Peptide 
TR71631_c0_g6_i1_CDS1|length sp|B1P1G9|JZ20A_CHIGU 6.00E-05 ICK - Unknow Spider ICK Peptide 
TR71631_c0_g6_i2_CDS2|length sp|B1P1G9|JZ20A_CHIGU 5.00E-05 ICK - Unknow Spider ICK Peptide 
TR129689_c0_g1_i2_CDS3|lengt
h sp|B2G331|VKT1_HETCR 1.00E-42 TRPV1 
Sea 
anemone Kunitz-type Peptide 
TR135650_c2_g2_i1_CDS2|lengt
h sp|B2G331|VKT1_HETCR 9.00E-43 TRPV1 
Sea 
anemone Kunitz-type Peptide 
TR135650_c2_g5_i1_CDS2|lengt
h sp|B2G331|VKT1_HETCR 4.00E-43 TRPV1 
Sea 
anemone Kunitz-type Peptide 
TR135650_c2_g6_i1_CDS2|lengt
h sp|B2G331|VKT1_HETCR 1.00E-42 TRPV2 
Sea 
anemone Kunitz-type Peptide 
TR135650_c2_g7_i1_CDS2|lengt
h sp|B2G331|VKT1_HETCR 4.00E-43 TRPV1 
Sea 
anemone Kunitz-type Peptide 
TR135650_c2_g8_i1_CDS2|lengt
h sp|B2G331|VKT1_HETCR 8.00E-36 TRPV1 
Sea 
anemone Kunitz-type Peptide 
TR145129_c1_g1_i3_CDS8|lengt
h sp|P0DN15|VKTB_ANEVI 5.00E-35 Kv type2 
Sea 
anemone Kunitz-type Peptide 
TR130412_c6_g8_i3_CDS2|lengt
h sp|P0C7W7|TX9A_STIHA,sp|P0C7W7|TX9A_STIHA 3e-04,3e-04 Kv type4 
Sea 
anemone Kv type4 Peptide 
TR138219_c4_g2_i1_CDS10|leng
th sp|P0C7W7|TX9A_STIHA 4.00E-14 Kv type4 
Sea 
anemone Kv type4 Peptide 
 139 
TR72284_c0_g1_i1_CDS4|length sp|A7RMN1|KV51_NEMVE 1.00E-19 Kv Type5 Sea anemone Kv Type5 Peptide 
TR107289_c0_g1_i1_CDS3|lengt
h sp|Q0EAE5|K1A_ANEER 1.00E-23 Kv type1 
Sea 
anemone ShKT domain Peptide 
TR93500_c0_g1_i2_CDS4|length sp|O16846|K1A_HETMG 1.00E-46 Kv type1 Sea anemone ShKT domain Peptide 
TR93500_c2_g3_i1_CDS4|length sp|O16846|K1A_HETMG 1.00E-42 Kv type1 Sea anemone ShKT domain Peptide 
TR96729_c4_g1_i3_CDS26|lengt
h sp|Q9TWG1|K1B_ANESU 3.00E-10 Kv type1 
Sea 
anemone ShKT domain Peptide 
TR110527_c0_g1_i2_CDS3|lengt
h sp|A9YME1|VA5_MICHY 1.00E-16 Venom allergen 5 Wasp CAP Protein 
TR104378_c2_g2_i1_CDS3|lengt
h sp|Q9U6X1|ACTP3_HETMG 1.00E-143 Cytolysin type2 
Sea 
anemone Cytolysin Protein 
TR104378_c2_g2_i2_CDS3|lengt
h sp|Q9U6X1|ACTP3_HETMG 4.00E-139 Cytolysin type2 
Sea 
anemone Cytolysin Protein 
TR148434_c0_g2_i1_CDS3|lengt
h sp|Q9U6X1|ACTP3_HETMG 5.00E-06 Cytolysin type2 
Sea 
anemone Cytolysin Protein 
TR65582_c0_g1_i4_CDS2|length sp|Q9U6X1|ACTP3_HETMG 8.00E-116 Cytolysin type2 Sea anemone Cytolysin Protein 
TR65582_c0_g1_i5_CDS2|length sp|Q9U6X1|ACTP3_HETMG 8.00E-116 Cytolysin type3 Sea anemone Cytolysin Protein 
TR111298_c2_g1_i1_CDS2|lengt
h sp|Q58L93|FAXD_PSEPO 1.00E-34 
Prothrombin 
activator Snake S1 peptidase Protein 
TR111298_c2_g1_i2_CDS2|lengt
h sp|Q58L93|FAXD_PSEPO 1.00E-34 
Prothrombin 
activator Snake S1 peptidase Protein 
 
  
 140 
Appendix III Hidden polymorphisms 
 
 
 
β-defensin - NaV Type 2 
Accessions Top	BLAST	hit Type Family/Scafold Unused Total %Cov %Cov(50) %Cov(95) Contrib Conf Sequence Modifications Cleavages dMass Prec	MW Prec	m/z Theor	MW Theor	m/z Theor	z Sc Spectrum Time PrecursorSignal PrecursorElution
TR111298_c2_g1_i2_CDS2|length;	TR111298_c2_g1_i1_CDS2|length sp|Q58L93|FAXD_PSEPO Prothrombin	activator	 S1	peptidase 14.35 14.35 40.29 35.16 35.16 0 99.00 HDVALLQLAQPVTLTK Gln->Lys@10 -0.01 1746.03 874.02 1746.04 874.03 2 21 1.1.1.1894.3 7.0831 5460 7.0635
TR130412_c6_g8_i2_CDS3|length;	TR130412_c6_g8_i1_CDS2|length sp|P0C7W7|TX9A_STIHA,sp|P0C7W7|TX9A_STIHA Kv	type4	 Kv	type4 15.05 15.05 44.12 42.65 42.65 0.35 99.00 AIIDRNSCRGKCNRMDHLGKCRK Ile->Asn@2 missed	R-N@5;	missed	R-G@9;	missed	K-C@11;	missed	R-M@14;	missed	K-C@20;	missed	R-K@22 0.03 2806.40 562.29 2806.37 562.28 5 15 1.1.1.1726.16 14.4415 141369 14.3726
TR130412_c6_g8_i3_CDS2|length sp|P0C7W7|TX9A_STIHA,sp|P0C7W7|TX9A_STIHA Kv	type4	 Kv	type4 8.15 8.15 40.91 40.91 40.91 0 99.00 KCYKKDANGVCRKVFGCEP Val->Thr@10;	Glu->Gln@18 missed	K-C@1;	missed	K-K@4;	missed	R-K@12;	missed	K-V@13 -0.01 2277.09 570.28 2277.11 570.28 4 17 1.1.1.1740.4 15.7306 128548 15.6154
TR135650_c2_g2_i1_CDS2|length sp|B2G331|VKT1_HETCR TRPV1	 Kunitz-type 22.19 22.19 80.77 78.21 78.21 0.15 99.00 GICSEPKVVGPCRAAIPR Arg->Lys@13	TR135650_c2_g2_i3 cleaved	G-G@N-term;	missed	K-V@7;	missed	R-A@13 0.00 1912.03 638.35 1912.03 638.35 3 15 1.1.1.2122.15 16.4481 37195 16.1938
TR135650_c2_g2_i1_CDS2|length sp|B2G331|VKT1_HETCR TRPV1	 Kunitz-type 22.19 22.19 80.77 78.21 78.21 0 99.00 GGICSEPKVVGPCR Arg->Lys@14	TR135650_c2_g2_i3 cleaved	A-G@N-term;	missed	K-V@8 0.05 1460.78 487.93 1460.74 487.92 3 18 1.1.1.2117.4 15.929 18299 15.9077
TR135650_c2_g2_i1_CDS2|length sp|B2G331|VKT1_HETCR TRPV1	 Kunitz-type 22.19 22.19 80.77 78.21 78.21 0 99.00 AAIPRFYFDSETGECKPFMYGGCKGNGNNFETLHACRGICRA Glu->Lys@14;	Deamidated(N)@26 missed	R-F@5;	missed	K-G@24;	missed	R-G@37;	missed	R-A@41 -0.02 4806.21 802.04 4806.23 802.05 6 19 1.1.1.2142.10 18.3143 53490 17.8936
TR135650_c2_g2_i1_CDS2|length sp|B2G331|VKT1_HETCR TRPV1	 Kunitz-type 22.19 22.19 80.77 78.21 78.21 0 99.00 AAIPRFYFDSETGECKPFMYGGCKGNGNNFETLHACR Glu->Met@11 missed	R-F@5;	missed	K-G@24 0.01 4263.92 711.66 4263.91 711.66 6 16 1.1.1.2150.4 19.0706 14087 19.1345
TR135650_c2_g2_i1_CDS2|length sp|B2G331|VKT1_HETCR TRPV1	 Kunitz-type 22.02 22.02 80.77 71.79 71.79 0 99.00 GGICSEPKVVGPCR Lys->Arg@8 cleaved	A-G@N-term;	missed	K-V@8 -0.01 1516.74 506.59 1516.75 506.59 3 16 1.1.1.2139.5 16.4088 29469 16.4806
TR135650_c2_g2_i1_CDS2|length sp|B2G331|VKT1_HETCR TRPV1	 Kunitz-type 11.57 11.57 73.08 71.79 71.79 0 99.00 AAIPRFYFDSETGECKPFMYGGCKGNGNNFETLHACRGICRA Lys->Glu@16 missed	R-F@5;	missed	K-G@24;	missed	R-G@37;	missed	R-A@41 0.10 4807.23 687.76 4807.14 687.74 7 16 1.1.1.2298.8 17.6551 210995 17.7145
TR135650_c2_g2_i1_CDS2|length sp|B2G331|VKT1_HETCR TRPV1	 Kunitz-type 22.19 22.19 80.77 78.21 78.21 0 99.00 AAIPRFYFDSETGECKPFMYGGCKGNGNNFETLHACRGICRA Lys->Glu@16 missed	R-F@5;	missed	K-G@24;	missed	R-G@37;	missed	R-A@41 0.07 4807.21 687.75 4807.14 687.74 7 18 1.1.1.2154.2 19.4472 8105 19.2316
TR135650_c2_g2_i1_CDS2|length sp|B2G331|VKT1_HETCR TRPV1	 Kunitz-type 22.19 22.19 80.77 78.21 78.21 0 99.00 AAIPRFYFDSETGECKPFMYGGCKGNGNNFETLHACRGICRA Lys->Glu@16 missed	R-F@5;	missed	K-G@24;	missed	R-G@37;	missed	R-A@41 0.14 4807.27 687.76 4807.14 687.74 7 15 1.1.1.2174.2 21.4166 721 21.2696
TR135650_c2_g2_i1_CDS2|length sp|B2G331|VKT1_HETCR TRPV1	 Kunitz-type 22.19 22.19 80.77 78.21 78.21 0 99.00 AAIPRFYFDSETGECKPFMYGGCKGNGNNFETLHACR Lys->Glu@24;	Deamidated(N)@26 missed	R-F@5;	missed	K-G@24 0.05 4263.89 711.66 4263.84 711.65 6 17 1.1.1.2170.3 21.0279 6329 21.0751
TR135650_c2_g2_i1_CDS2|length sp|B2G331|VKT1_HETCR TRPV1	 Kunitz-type 22.19 22.19 80.77 78.21 78.21 0 99.00 AAIPRFYFDSETGECKPFMYGGCKGNGNNFETLHACRGICRA Lys->Met@16 missed	R-F@5;	missed	K-G@24;	missed	R-G@37;	missed	R-A@41 0.12 4809.26 688.04 4809.14 688.03 7 18 1.1.1.2943.2 29.2783 3362 29.1879
TR135650_c2_g2_i1_CDS2|length sp|B2G331|VKT1_HETCR TRPV1	 Kunitz-type 22.19 22.19 80.77 78.21 78.21 0 99.00 AAIPRFYFDSETGECKPFMYGGCKGNGNNFETLHACRGICRA Lys->Met@16 missed	R-F@5;	missed	K-G@24;	missed	R-G@37;	missed	R-A@41 0.03 4809.17 802.54 4809.14 802.53 6 15 1.1.1.2166.5 20.6814 5595 20.5899
TR135650_c2_g2_i1_CDS2|length sp|B2G331|VKT1_HETCR TRPV1	 Kunitz-type 22.19 22.19 80.77 78.21 78.21 0 99.00 AAIPRFYFDSETGECKPFMYGGCKGNGNNFETLHACRGICRA Pro->Lys@17;	Oxidation(M)@19 missed	R-F@5;	missed	K-G@24;	missed	R-G@37;	missed	R-A@41 0.00 4853.23 809.88 4853.23 809.88 6 15 1.1.1.2134.15 17.5803 3120 17.5162
TR135650_c2_g2_i1_CDS2|length sp|B2G331|VKT1_HETCR TRPV1	 Kunitz-type 22.19 22.19 80.77 78.21 78.21 0 99.00 AAIPRFYFDSETGECKPFMYGGCKGNGNNFETLHACR Pro->Thr@17 missed	R-F@5;	missed	K-G@24 0.02 4265.93 712.00 4265.91 711.99 6 16 1.1.1.2144.3 18.4749 2782 18.5552
TR135650_c2_g2_i1_CDS2|length sp|B2G331|VKT1_HETCR TRPV1	 Kunitz-type 11.57 11.57 73.08 71.79 71.79 0 99.00 AAIPRFYFDSETGECKPFMYGGCKGNGNNFETLHACRGICRA Pro->Thr@17;	Deamidated(N)@28 missed	R-F@5;	missed	K-G@24;	missed	R-G@37;	missed	R-A@41 0.03 4811.20 688.32 4811.17 688.32 7 16 1.1.1.2299.11 17.7632 39586 17.8102
TR135650_c2_g2_i1_CDS2|length sp|B2G331|VKT1_HETCR TRPV1	 Kunitz-type 22.19 22.19 80.77 78.21 78.21 0 99.00 AAIPRFYFDSETGECKPFMYGGCKGNGNNFETLHACRGICRA Pro->Val@17 missed	R-F@5;	missed	K-G@24;	missed	R-G@37;	missed	R-A@41 0.05 4808.26 687.90 4808.21 687.89 7 15 1.1.1.2814.2 25.9859 3139 25.992
TR135650_c2_g2_i1_CDS2|length sp|B2G331|VKT1_HETCR TRPV1	 Kunitz-type 10.54 10.54 88.46 88.46 73.08 0 99.00 GGICSEPKVVGPCRAAIPR Ser->Lys@5 cleaved	A-G@N-term;	missed	K-V@8;	missed	R-A@14 0.01 2038.13 510.54 2038.12 510.54 4 17 1.1.1.2142.3 16.7065 27530 16.599
TR135650_c2_g2_i1_CDS2|length sp|B2G331|VKT1_HETCR TRPV1	 Kunitz-type 22.19 22.19 80.77 78.21 78.21 0 99.00 GGICSEPKVVGPCR Ser->Lys@5; cleaved	A-G@N-term;	missed	K-V@8 0.00 1529.81 510.94 1529.81 510.94 3 14 1.1.1.2117.9 15.9498 47346 16.0051
TR145129_c1_g1_i3_CDS8|length sp|P0DN15|VKTB_ANEVI Kv	type2	 Kunitz-type 8.07 8.07 46.88 46.88 45.83 0 99.00 RCEPFIYGGCGGNANNFEDKAQCEEKCLGR Asp->Ser@19;	Lys->Arg@20 missed	R-C@1;	missed	K-A@20;	missed	K-C@26 -0.01 3483.54 697.71 3483.54 697.72 5 27 1.1.1.2854.17 26.6027 7020 26.5291
TR148434_c0_g2_i1_CDS3|length sp|Q9U6X1|ACTP3_HETMG Cytolysin	type2	 Cytolysin 6 6 30.16 30.16 30.16 0 99.00 RWYHGSNYGSIGSGN Arg->Glu@1;	Tyr->Trp@3 cleaved	N-S@C-term;	missed	R-W@1 0.01 1649.70 825.86 1649.69 825.85 2 17 1.1.1.2027.21 18.1955 58872 18.2009
TR148434_c0_g2_i1_CDS3|length sp|Q9U6X1|ACTP3_HETMG Cytolysin	type2	 Cytolysin 6 6 30.16 30.16 30.16 0 99.00 RWYHGSNYGSIGSGN Arg->Glu@1;	Tyr->Trp@3 cleaved	N-S@C-term;	missed	R-W@1 0.01 1649.70 825.86 1649.69 825.85 2 18 1.1.1.2028.18 18.2788 58872 18.2009
TR148434_c0_g2_i1_CDS3|length sp|Q9U6X1|ACTP3_HETMG Cytolysin	type2	 Cytolysin 6 6 30.16 30.16 30.16 0 99.00 RWYHGSNYGSIGSGN Arg->Glu@1;	Tyr->Trp@3 cleaved	N-S@C-term;	missed	R-W@1 0.01 1649.70 825.86 1649.69 825.85 2 18 1.1.1.2029.12 18.3794 64970 18.2009
TR148434_c0_g2_i1_CDS3|length sp|Q9U6X1|ACTP3_HETMG Cytolysin	type2	 Cytolysin 6 6 30.16 30.16 30.16 0 99.00 RWYHGSNYGSIGSGN Arg->Glu@1;	Tyr->Trp@3 cleaved	N-S@C-term;	missed	R-W@1 0.02 1649.70 825.86 1649.69 825.85 2 18 1.1.1.2033.11 18.7663 79726 18.2009
TR148434_c0_g2_i1_CDS3|length sp|Q9U6X1|ACTP3_HETMG Cytolysin	type2	 Cytolysin 6 6 30.16 30.16 30.16 0 99.00 RWYHGSNYGSIGSGN Arg->Glu@1;	Tyr->Trp@3 cleaved	N-S@C-term;	missed	R-W@1 0.02 1649.71 825.86 1649.69 825.85 2 19 1.1.1.2043.5 19.7244 128832 19.6496
TR148434_c0_g2_i1_CDS3|length sp|Q9U6X1|ACTP3_HETMG Cytolysin	type2	 Cytolysin 6 6 30.16 30.16 30.16 0 99.00 RWYHGSNYGSIGSGN Arg->Glu@1;	Tyr->Trp@3 cleaved	N-S@C-term;	missed	R-W@1 0.02 1649.71 825.86 1649.69 825.85 2 19 1.1.1.2044.6 19.8206 130640 19.6496
TR148434_c0_g2_i1_CDS3|length sp|Q9U6X1|ACTP3_HETMG Cytolysin	type2	 Cytolysin 6 6 30.16 30.16 30.16 0 99.00 RWYHGSNYGSIGSGN Arg->Glu@1;	Tyr->Trp@3 cleaved	N-S@C-term;	missed	R-W@1 0.02 1649.71 825.86 1649.69 825.85 2 18 1.1.1.2045.5 19.9001 130640 19.6496
TR148434_c0_g2_i1_CDS3|length sp|Q9U6X1|ACTP3_HETMG Cytolysin	type2	 Cytolysin 6 6 30.16 30.16 30.16 0 99.00 RWYHGSNYGSIGSGN Arg->Glu@1;	Tyr->Trp@3 cleaved	N-S@C-term;	missed	R-W@1 0.02 1649.71 825.86 1649.69 825.85 2 18 1.1.1.2046.6 20.013 130640 19.6496
TR148434_c0_g2_i1_CDS3|length sp|Q9U6X1|ACTP3_HETMG Cytolysin	type2	 Cytolysin 6 6 30.16 30.16 30.16 0 99.00 RWYHGSNYGSIGSGN Arg->Glu@1;	Tyr->Trp@3 cleaved	N-S@C-term;	missed	R-W@1 0.02 1649.71 825.86 1649.69 825.85 2 17 1.1.1.2047.5 20.1247 131959 19.6496
TR148434_c0_g2_i1_CDS3|length sp|Q9U6X1|ACTP3_HETMG Cytolysin	type2	 Cytolysin 6 6 30.16 30.16 30.16 0 99.00 RWYHGSNYGSIGSGN Arg->Glu@1;	Tyr->Trp@3 cleaved	N-S@C-term;	missed	R-W@1 0.02 1649.71 825.86 1649.69 825.85 2 18 1.1.1.2048.6 20.204 128832 19.6496
TR148434_c0_g2_i1_CDS3|length sp|Q9U6X1|ACTP3_HETMG Cytolysin	type2	 Cytolysin 6 6 30.16 30.16 30.16 0 99.00 RWYHGSNYGSIGSGN Arg->Glu@1;	Tyr->Trp@3 cleaved	N-S@C-term;	missed	R-W@1 0.02 1649.71 825.86 1649.69 825.85 2 17 1.1.1.2049.3 20.2881 131959 19.6496
TR148434_c0_g2_i1_CDS3|length sp|Q9U6X1|ACTP3_HETMG Cytolysin	type2	 Cytolysin 6 6 30.16 30.16 30.16 0 99.00 RWYHGSNYGSIGSGN Arg->Glu@1;	Tyr->Trp@3 cleaved	N-S@C-term;	missed	R-W@1 0.02 1649.70 825.86 1649.69 825.85 2 15 1.1.1.2053.4 20.7047 115869 19.6496
TR148434_c0_g2_i1_CDS3|length sp|Q9U6X1|ACTP3_HETMG Cytolysin	type2	 Cytolysin 6 6 30.16 30.16 30.16 0 99.00 RWYHGSNYGSIGSGN Arg->Glu@1;	Tyr->Trp@3 cleaved	N-S@C-term;	missed	R-W@1 0.01 1649.70 825.86 1649.69 825.85 2 18 1.1.1.2056.3 20.9951 54130 19.9387
TR148434_c0_g2_i1_CDS3|length sp|Q9U6X1|ACTP3_HETMG Cytolysin	type2	 Cytolysin 6 6 30.16 30.16 30.16 2 99.00 RWYHGSNYGSIGSGN Arg->Phe@1;	Deamidated(N)@7 cleaved	N-S@C-term;	missed	R-W@1 0.00 1645.67 823.84 1645.68 823.85 2 15 1.1.1.2050.5 20.3807 6045 20.4193
TR148434_c0_g2_i1_CDS3|length sp|Q9U6X1|ACTP3_HETMG Cytolysin	type2	 Cytolysin 6 6 30.16 30.16 30.16 0 99.00 RWYHGSNYGSIGSGN Dioxidation(W)@2;	His->Glu@4 cleaved	N-S@C-term;	missed	R-W@1 0.00 1677.70 839.86 1677.70 839.86 2 16 1.1.1.2041.7 19.5472 29194 19.5527
TR148434_c0_g2_i1_CDS3|length sp|Q9U6X1|ACTP3_HETMG Cytolysin	type2	 Cytolysin 6 6 30.16 30.16 30.16 0 99.00 RWYHGSNYGSIGSGN Dioxidation(W)@2;	His->Glu@4 cleaved	N-S@C-term;	missed	R-W@1 0.00 1677.70 839.86 1677.70 839.86 2 17 1.1.1.2042.7 19.6442 29194 19.5527
TR148434_c0_g2_i1_CDS3|length sp|Q9U6X1|ACTP3_HETMG Cytolysin	type2	 Cytolysin 6 6 30.16 30.16 30.16 0 99.00 RWYHGSNYGSIGSGN Dioxidation(W)@2;	His->Glu@4 cleaved	N-S@C-term;	missed	R-W@1 0.00 1677.70 839.86 1677.70 839.86 2 16 1.1.1.2043.6 19.741 29194 19.5527
TR148434_c0_g2_i1_CDS3|length sp|Q9U6X1|ACTP3_HETMG Cytolysin	type2	 Cytolysin 6 6 30.16 30.16 30.16 0 99.00 RWYHGSNYGSIGSGN Dioxidation(W)@2;	His->Glu@4 cleaved	N-S@C-term;	missed	R-W@1 0.00 1677.70 839.86 1677.70 839.86 2 15 1.1.1.2045.6 19.9167 29194 19.5527
TR148434_c0_g2_i1_CDS3|length sp|Q9U6X1|ACTP3_HETMG Cytolysin	type2	 Cytolysin 6 6 30.16 30.16 30.16 0 99.00 RWYHGSNYGSIGSGN His->Met@4 cleaved	N-S@C-term;	missed	R-W@1 -0.02 1647.69 824.85 1647.71 824.86 2 18 1.1.1.2036.7 19.0654 64339 19.0714
TR148434_c0_g2_i1_CDS3|length sp|Q9U6X1|ACTP3_HETMG Cytolysin	type2	 Cytolysin 6 6 30.16 30.16 30.16 0 99.00 RWYHGSNYGSIGSGN His->Met@4 cleaved	N-S@C-term;	missed	R-W@1 -0.02 1647.69 824.85 1647.71 824.86 2 17 1.1.1.2037.8 19.1615 64339 19.0714
TR148434_c0_g2_i1_CDS3|length sp|Q9U6X1|ACTP3_HETMG Cytolysin	type2	 Cytolysin 6 6 30.16 30.16 30.16 0 99.00 RWYHGSNYGSIGSGN His->Met@4 cleaved	N-S@C-term;	missed	R-W@1 -0.02 1647.69 824.85 1647.71 824.86 2 18 1.1.1.2038.7 19.2448 64339 19.0714
TR148434_c0_g2_i1_CDS3|length sp|Q9U6X1|ACTP3_HETMG Cytolysin	type2	 Cytolysin 6 6 30.16 30.16 30.16 0 99.00 RWYHGSNYGSIGSGN His->Met@4 cleaved	N-S@C-term;	missed	R-W@1 -0.02 1647.69 824.85 1647.71 824.86 2 17 1.1.1.2039.6 19.3537 64339 19.0714
TR148434_c0_g2_i1_CDS3|length sp|Q9U6X1|ACTP3_HETMG Cytolysin	type2	 Cytolysin 6 6 30.16 30.16 30.16 0 99.00 RWYHGSNYGSIGSGN His->Met@4;	Deamidated(N)@7 cleaved	N-S@C-term;	missed	R-W@1 0.00 1648.69 825.35 1648.69 825.35 2 13 1.1.1.2040.5 19.4505 81836 19.0714
TR148434_c0_g2_i1_CDS3|length sp|Q9U6X1|ACTP3_HETMG Cytolysin	type2	 Cytolysin 6 6 30.16 30.16 30.16 0 99.00 RWYHGSNYGSIGSGN Trp->Kynurenin(W)@2;	His->Glu@4 cleaved	N-S@C-term;	missed	R-W@1 0.00 1649.71 825.86 1649.71 825.86 2 19 1.1.1.2042.6 19.6275 130640 19.6496
TR148434_c0_g2_i1_CDS3|length sp|Q9U6X1|ACTP3_HETMG Cytolysin	type2	 Cytolysin 6 6 30.16 30.16 30.16 0 99.00 RWYHGSNYGSIGSGN Trp->Kynurenin(W)@2;	His->Glu@4 cleaved	N-S@C-term;	missed	R-W@1 -0.01 1649.70 825.86 1649.71 825.86 2 16 1.1.1.2057.4 21.0915 29561 20.035
TR18604_c0_g1_i1_CDS1|length;	TR130412_c0_g1_i1_CDS3|length sp|Q76CA0|NA2G3_STIGI Nav	type2	 Defensin 19.34 19.34 41.67 41.67 41.67 0 99.00 SATLTGTVDLGSCNEGWEK Asp->Asn@9;	Dioxidation(W)@17 -0.02 2041.91 681.64 2041.93 681.65 3 15 1.1.1.2851.13 26.2991 8714 26.2421
TR18604_c0_g1_i1_CDS1|length;	TR130412_c0_g1_i1_CDS3|length sp|Q76CA0|NA2G3_STIGI Nav	type2	 Defensin 19.34 19.34 41.67 41.67 41.67 0 99.00 SATLTGTVDLGSCNEGWEK Gly->Thr@6 -0.02 2054.93 685.98 2054.95 685.99 3 19 1.1.1.2858.14 26.9733 12621 26.4334
TR18604_c0_g1_i1_CDS1|length;	TR130412_c0_g1_i1_CDS3|length sp|Q76CA0|NA2G3_STIGI Nav	type2	 Defensin 19.34 19.34 41.67 41.67 41.67 2 99.00 CASFYTIFADCCRRPR Phe->Leu@8 missed	R-R@13 0.01 2005.96 502.50 2005.95 502.50 4 19 1.1.1.2884.2 29.4074 107714 29.2106
TR18604_c0_g1_i1_CDS1|length;	TR130412_c0_g1_i1_CDS3|length sp|Q76CA0|NA2G3_STIGI Nav	type2	 Defensin 19.34 19.34 41.67 41.67 41.67 0 99.00 CASFYTIFADCCRRPR Phe->Leu@8 missed	R-R@13 0.01 2005.96 502.50 2005.95 502.50 4 18 1.1.1.2880.3 29.0449 107714 29.2106
TR18604_c0_g1_i1_CDS1|length;	TR130412_c0_g1_i1_CDS3|length sp|Q76CA0|NA2G3_STIGI Nav	type2	 Defensin 19.34 19.34 41.67 41.67 41.67 0 99.00 CASFYTIFADCCRRPR Phe->Leu@8 missed	R-R@13 0.01 2005.96 502.50 2005.95 502.50 4 19 1.1.1.2882.2 29.22 107714 29.2106
TR18604_c0_g1_i1_CDS1|length;	TR130412_c0_g1_i1_CDS3|length sp|Q76CA0|NA2G3_STIGI Nav	type2	 Defensin 19.34 19.34 41.67 41.67 41.67 0 99.00 CASFYTIFADCCRRPR Phe->Leu@8 missed	R-R@13 0.01 2005.96 502.50 2005.95 502.50 4 19 1.1.1.2883.2 29.3137 107714 29.2106
TR18604_c0_g1_i1_CDS1|length;	TR130412_c0_g1_i1_CDS3|length sp|Q76CA0|NA2G3_STIGI Nav	type2	 Defensin 19.34 19.34 41.67 41.67 41.67 0 99.00 CASFYTIFADCCRRPR Phe->Leu@8 missed	R-R@13 0.01 2005.96 502.50 2005.95 502.50 4 19 1.1.1.2885.2 29.5011 107714 29.2106
TR18604_c0_g1_i1_CDS1|length;	TR130412_c0_g1_i1_CDS3|length sp|Q76CA0|NA2G3_STIGI Nav	type2	 Defensin 19.34 19.34 41.67 41.67 41.67 0 99.00 CASFYTIFADCCRRPR Phe->Leu@8 missed	R-R@13 0.01 2005.96 502.50 2005.95 502.50 4 18 1.1.1.2886.2 29.5948 107714 29.2106
TR18604_c0_g1_i1_CDS1|length;	TR130412_c0_g1_i1_CDS3|length sp|Q76CA0|NA2G3_STIGI Nav	type2	 Defensin 19.34 19.34 41.67 41.67 41.67 0 99.00 CASFYTIFADCCRRPR Phe->Leu@8 missed	R-R@13 0.01 2005.96 502.50 2005.95 502.50 4 18 1.1.1.2888.2 29.7823 107714 29.2106
TR18604_c0_g1_i1_CDS1|length;	TR130412_c0_g1_i1_CDS3|length sp|Q76CA0|NA2G3_STIGI Nav	type2	 Defensin 19.34 19.34 41.67 41.67 41.67 0 99.00 CASFYTIFADCCRRPR Phe->Leu@8 missed	R-R@13 0.01 2005.96 502.50 2005.95 502.50 4 17 1.1.1.2881.2 29.1262 107714 29.2106
TR18604_c0_g1_i1_CDS1|length;	TR130412_c0_g1_i1_CDS3|length sp|Q76CA0|NA2G3_STIGI Nav	type2	 Defensin 19.34 19.34 41.67 41.67 41.67 0 99.00 CASFYTIFADCCRRPR Phe->Leu@8 missed	R-R@13 0.01 2005.96 502.50 2005.95 502.50 4 16 1.1.1.2887.2 29.6887 107714 29.2106
TR18604_c0_g1_i1_CDS1|length;	TR130412_c0_g1_i1_CDS3|length sp|Q76CA0|NA2G3_STIGI Nav	type2	 Defensin 19.34 19.34 41.67 41.67 41.67 0 99.00 CASFYTIFADCCRRPR Phe->Leu@8 missed	R-R@13 0.01 2005.96 502.50 2005.95 502.50 4 14 1.1.1.2879.3 28.9412 107714 29.2106
TR18604_c0_g1_i1_CDS1|length;	TR130412_c0_g1_i1_CDS3|length sp|Q76CA0|NA2G3_STIGI Nav	type2	 Defensin 19.34 19.34 41.67 41.67 41.67 0 99.00 SATLTGTVDLGSCNEGWEK Thr->Asn@7;	Val->Met@8 0.00 2055.89 686.30 2055.89 686.30 3 18 1.1.1.2851.15 26.3074 6401 26.2421
TR18604_c0_g1_i1_CDS1|length;	TR130412_c0_g1_i1_CDS3|length sp|Q76CA0|NA2G3_STIGI Nav	type2	 Defensin 19.34 19.34 41.67 41.67 41.67 0 99.00 SATLTGTVDLGSCNEGWEK Thr->Asp@7 0.00 2024.90 675.97 2024.90 675.97 3 16 1.1.1.2854.15 26.5944 9874 26.2421
TR18604_c0_g1_i1_CDS1|length;	TR130412_c0_g1_i1_CDS3|length sp|Q76CA0|NA2G3_STIGI Nav	type2	 Defensin 19.34 19.34 41.67 41.67 41.67 0 99.00 SATLTGTVDLGSCNEGWEK Val->Asn@8 0.02 2025.91 676.31 2025.89 676.31 3 17 1.1.1.2851.12 26.2949 11274 26.2421
TR18604_c0_g1_i1_CDS1|length;	TR130412_c0_g1_i1_CDS3|length sp|Q76CA0|NA2G3_STIGI Nav	type2	 Defensin 19.34 19.34 41.67 41.67 41.67 0 99.00 SATLTGTVDLGSCNEGWEK Val->Pro@8;	Oxidation(W)@17 -0.01 2024.89 1013.45 2024.90 1013.46 2 16 1.1.1.2850.21 26.2369 278 26.1465
TR69080_c0_g1_i1_CDS11|length sp|B1B5J0|SHTX5_STIHA EGF-like	sea	anemone EGF-like 2.5 2.5 26.74 26.74 26.74 0.5 99.00 RDEGVACTGQHASSFCLNGGTCR Arg->Phe@1 missed	R-D@1 0.01 2491.07 831.36 2491.06 831.36 3 21 1.1.1.2303.19 16.7408 61081 16.7544
TR69080_c0_g1_i1_CDS11|length sp|B1B5J0|SHTX5_STIHA EGF-like	sea	anemone EGF-like 8 8 56.98 55.81 55.81 0 99.00 RDEGVACTGQHASSFCLNGGTCR Arg->Phe@1 missed	R-D@1 -0.03 2491.03 831.35 2491.06 831.36 3 15 1.1.1.2164.11 20.4875 4580 20.396
TR69080_c0_g1_i1_CDS11|length sp|B1B5J0|SHTX5_STIHA EGF-like	sea	anemone EGF-like 8 8 56.98 55.81 55.81 0 99.00 HIASLGEYYCICPGDYTGHRCDQKS Asp->Asn@22 cleaved	S-G@C-term;	missed	R-C@20;	missed	K-S@24 -0.07 2946.24 983.09 2946.31 983.11 3 19 1.1.1.2125.19 16.7464 46134 16.76
TR69080_c0_g1_i1_CDS11|length sp|B1B5J0|SHTX5_STIHA EGF-like	sea	anemone EGF-like 8 8 56.98 55.81 55.81 0 99.00 HIASLGEYYCICPGDYTGHRCDQKS Asp->Asn@22 cleaved	S-G@C-term;	missed	R-C@20;	missed	K-S@24 -0.07 2946.24 983.09 2946.31 983.11 3 20 1.1.1.2126.20 16.8444 46134 16.76
TR71631_c0_g6_i2_CDS2|length;	TR71631_c0_g6_i1_CDS1|length sp|B1P1G9|JZ20A_CHIGU ICK	-	Unknow	 ICK 4 4 44.05 23.81 23.81 2 99.00 GLACYPDPYESGRYVCSKER Glu->Gln@19 missed	R-Y@13 -0.01 2379.09 595.78 2379.10 595.78 4 16 1.1.1.1536.4 16.899 30613 16.8783
TR71631_c0_g6_i2_CDS2|length;	TR71631_c0_g6_i1_CDS1|length sp|B1P1G9|JZ20A_CHIGU ICK	-	Unknow	 ICK 4 4 44.05 23.81 23.81 0 99.00 GLACYPDPYESGRYVCSKER Glu->Gln@19 missed	R-Y@13 -0.01 2379.09 595.78 2379.10 595.78 4 15 1.1.1.1534.6 16.7149 30613 16.8783
TR71631_c0_g6_i2_CDS2|length;	TR71631_c0_g6_i1_CDS1|length sp|B1P1G9|JZ20A_CHIGU ICK	-	Unknow	 ICK 4 4 44.05 23.81 23.81 0 99.00 GLACYPDPYESGRYVCSKER Glu->Gln@19 missed	R-Y@13 -0.01 2379.09 595.78 2379.10 595.78 4 16 1.1.1.1535.6 16.8106 30613 16.8783
TR71631_c0_g6_i2_CDS2|length;	TR71631_c0_g6_i1_CDS1|length sp|B1P1G9|JZ20A_CHIGU ICK	-	Unknow	 ICK 4 4 44.05 23.81 23.81 0 99.00 GLACYPDPYESGRYVCSKER Glu->Gln@19 missed	R-Y@13 -0.01 2379.09 595.78 2379.10 595.78 4 17 1.1.1.1537.3 16.9917 30613 16.8783
TR72284_c0_g1_i1_CDS4|length sp|A7RMN1|KV51_NEMVE Kv	Type5	 Kv	Type5 13.14 13.14 66.67 62.67 62.67 2 99.00 KYQRCTSNSQCCKTPKDFAGRTLR Ser->Gly@7 missed	K-Y@1;	missed	R-C@4;	missed	K-T@13;	missed	R-T@21 0.05 2892.47 579.50 2892.42 579.49 5 20 1.1.1.2113.5 15.5574 50996 15.524
TR72284_c0_g1_i1_CDS4|length sp|A7RMN1|KV51_NEMVE Kv	Type5	 Kv	Type6 13.14 13.14 66.67 62.67 62.67 0 99.00 KYQRCTSNSQCCKTPKDFAGRTLR Ser->Gly@7 missed	K-Y@1;	missed	R-C@4;	missed	K-T@13;	missed	R-T@21 0.05 2892.47 579.50 2892.42 579.49 5 18 1.1.1.2112.8 15.4687 50996 15.524
TR72284_c0_g1_i1_CDS4|length sp|A7RMN1|KV51_NEMVE Kv	Type5	 Kv	Type7 13.14 13.14 66.67 62.67 62.67 0 99.00 KYQRCTSNSQCCKTPKDFAGRTLR Ser->Gly@7 missed	K-Y@1;	missed	R-C@4;	missed	K-T@13;	missed	R-T@21 0.12 2892.53 483.10 2892.42 483.08 6 16 1.1.1.2113.2 15.5365 51163 15.524
TR96729_c4_g2_i1_CDS1|length;	TR96729_c4_g1_i3_CDS26|length sp|Q9TWG1|K1B_ANESU Kv	type1	 ShKT	domain 6.01 6.02 32.43 32.43 32.43 0 99.00 ACKDSLPSHICQNVKQNHSCGSEKYKTHCAKTCGAC Gln->Met@16 missed	K-Q@15;	missed	K-Y@24;	missed	K-T@26;	missed	K-T@31 0.05 4145.91 691.99 4145.86 691.98 6 15 1.1.1.1518.17 15.2127 109928 14.8523
TR96729_c4_g2_i1_CDS1|length;	TR96729_c4_g1_i3_CDS26|length sp|Q9TWG1|K1B_ANESU Kv	type1	 ShKT	domain 6.01 6.02 32.43 32.43 32.43 0 99.00 ACKDSLPSHICQNVKQNHSCGSEKYKTHCAKTCGAC Gln->Met@16 missed	K-Q@15;	missed	K-Y@24;	missed	K-T@26;	missed	K-T@31 0.05 4145.91 691.99 4145.86 691.98 6 15 1.1.1.1518.17 15.2127 109928 14.8523
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β-defensin - NaV Type 2 
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Kunitz-TRPV1 
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KV type 4 / sea anemone structural class 9a 
TR138219_g4_c1_i1  
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Kunitz – KV type 2 
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Appendix IV .Sequence alignment of putative toxins with no matches to any database entries. 
 
Alignment of representative sequences from the putative toxin families U1-Std to U12-Std 
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Appendices of Chapter 3 
 
Appendix V Hidden polymorphism within the Trinity assembled Ate1a-encoding contig. 
 
Appendix Figure V.i – Compressed global view of the CDS region of TR5054|c0_g1_i1 showing mapped 
quality trimmed reads with bases identical to the contig in grey and polymorphisms in colour. Red square 
in top panel indicates viewed portion of the full length contig, while vertical coloured bars in the read 
coverage display indicates relative frequencies of polymorphisms. 
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Appendix VI Co-elution of native and synthetic Ate1a 
 
Appendix Figure VI.i – RP-HPLC chromatograms showing the retention times for native Ate1a, synthetic 
Ate1a, and a mixture of native and synthetic Ate1a (co-injection). 
  
 157 
Appendix VII Ate1a is neither cytotoxic nor haemolytic 
Ate1a was not toxic against tested cultured cell lines (HeLa, human cervical adenocarcinoma 
cells; MCF-7, human breast adenocarcinoma; and HFF-1, human foreskin fibroblast non-
cancerous cells), and did not causes hemolysis of human red blood cells (hRBCs) up to 64 µM. 
Melittin, a bee venom-peptide known to disrupt cell membranes, and a cyclic version of 
gomesin (cGm), an antimicrobial peptide from spider hemocytes, were included as controls. 
Melittin shows toxicity at low micromolar concentrations, whereas cGm shows mild toxicity 
against all tested cells. 
 
 
Appendix Figure VII.i – Toxicity induced by Ate1a against HeLa, MCF-7, HFF-1 as measured by a 
resazurin assay, and hemolysis induced against human red blood cells, as measured by release of 
haemoglobin. Melittin and cyclic Gomesin (cGm) were included as controls. Data points are mean ± SD of 
three independent replicates. 
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Appendix VIII Ate1a interacts only weakly with lipid bilayers 
The ability of Ate1a to bind to lipid bilayers was examined by Surface Plasmon Resonance 
(SPR). Ate1a has weak affinity for neutral (POPC) membranes, only slightly improved with 
negatively-charged POPC/POPS (4:1) membranes, as shown by the dose response curves 
(Appendix Figure VIII.iA), and by sensorgrams obtained with 64 µM (Appendix Figure VIII.i). 
cGm, included for comparison, shows high affinity for negatively-charged model membranes. 
 
 
Appendix Figure VIII.i – Binding of Ate1a to model membranes as examined by surface plasmon 
resonance. Peptide samples were injected for 180 s (association phase) over lipid bilayers composed of 
POPC or POPC/POPS (4:1 molar ratio) deposited onto an L1 chip. Dissociation from the membrane was 
followed for 600 s (dissociation phase). Response units (RU) were converted into peptide-to-lipid ratio (P/L 
(mol/mol) by converting RUs into amount of peptide and normalized to the amount of lipid deposited onto 
the chip surface (1 RU = 1pg/mm2 of lipid or peptide). cGm was included as control. (A) Dose-response 
curves using a reporting point at the end of association phase (injection at t = 170 s). (B) Sensorgrams obtained 
upon injection of peptide at 64 µM. 
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Appendix IX Electrophysiological characterization of KV isoforms inhibited by Ate1a 
 
 
Appendix Figure IX.i – Electrophysiological characterization of KV isoforms inhibited by Ate1a. (A) 
Representative whole-cell current traces obtained from KV channels expressed in Xenopus oocytes in the absence 
(control) and presence (*) of 3 µM Ate1a. (B) Concentration-response curves obtained by plotting current 
inhibition as a function of increasing Ate1a concentration. 
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Appendix X Ate1a is not active on NaV and ASIC channels 
 
 
Appendix Figure X.i – Representative whole-cell current traces obtained from NaV or ASIC channels 
expressed in Xenopus oocytes in the absence (control) and presence (*) of 3 µM Ate1a. Ate1a has no 
significant effect on any of these channels. 
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Appendix XI Structural statistics for the ensemble of Ate1a 
 
Appendix Table XI.i Structural statistics for the ensemble of Ate1aa 
Experimental restraints  
Inter-proton distance restraints  
Total 66 
Intra-residue (i = j) 21 
Sequential (|i - j| = 1) 37 
Medium range (1 < |i – j| < 5) 8 
Long range (|i – j| ³ 5) 0 
Disulfide bond restraints 6 
Dihedral-angle restraints  
f dihedral angle restraints 11 
y dihedral angle restraints 13 
c1 angle restraints 1 
Total number of restraints per residue 5.4 
Violations of experimental restraints 0 
RMSD from mean coordinate structure (Å)b  
All backbone atoms   1.11 ± 0.26 
All heavy atoms   2.06 ± 0.39 
Stereochemical qualityc  
Ramachandran plot statistics  
Residues in most favored 
Ramachandran region (%) 
95.0 ± 4.8 
Disallowed regions (%) 0.0 ± 0.0 
Unfavorable sidechain rotamers (%) 7.5 ± 6.7 
Clashscore, all atomsd 0.0 ± 0.0 
Overall MolProbity score 1.34 ± 0.38 
 
a All statistics are given as mean ± S.D. 
b Mean RMSD calculated over the entire ensemble of 20 structures. 
c Sterochemical quality according to MolProbity (http://helix.research.duhs.duke.edu).  
d Clashscore is defined the number of steric overlaps >0.4 Å per 1000 atoms. 
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Appendix XII Antimicrobial assay: SI_Ate1a_Antimicrobial.xlsx  
 
 
Appendix Table XII.i Antimicrobial activity of Ate1a toward five bacteria: Escherichia coli, Klebsiella pneumoniae, Acinetobacter baumannii, 
Pseudomonas aeruginosa and Staphylococcus aureus, and two yeast: Candida albicans and Cryptococcus neoformans. 
CompoundID CompoundName ProjectID RunID Hit Tox Sa (MSSA) Sa Ec Kp Pa Ab Ca Cn Hk Unit Media Plate size 
C0303419 Ate1a P0426 HVR00067 0 0  >32 >32 >32 >32 >32 >32 >32 >32 ug/mL CA-MHB 384-w 
Cooper data Gomesin     32  4 32 8 4-8 16 1   MHB 384-w 
Cooper data Gomesin      128 16 64 16 16 16 2 >100  MHB 96-w 
 
